Back to Search
NKTR

Content

  • All
  • News
  • Community
Quantexa News
09/16
Nektar Therapeutics (NASDAQ:NKTR) Receives Average Rating of “Hold” from Analysts

Nektar Therapeutics ( NASDAQ:NKTR – Get Free Report ) has been given an average rating of “Hold” by the five analysts that are currently covering the firm, Marketbeat.com reports. One equities researc...

Mayfield Recorder
Quantexa News
09/19
Nektar Therapeutics (NASDAQ:NKTR) Shares Sold by Primecap Management Co. CA

Primecap Management Co. CA trimmed its position in Nektar Therapeutics (NASDAQ:NKTR – Free Report) by 13.6% in the 2nd quarter, according to the company in its most recent disclosure with the Securiti...

Defense World
Quantexa News
09/25
Victory Capital Management Inc. Takes $29,000 Position in Nektar Therapeutics (NASDAQ:NKTR)

Victory Capital Management Inc. bought a new stake in Nektar Therapeutics (NASDAQ:NKTR – Free Report) in the second quarter, according to its most recent Form 13F filing with the SEC. The institutiona...

Defense World
Yahoo Finance News
09/25
Nektar Therapeutics Announces Multiple Presentations for Rezpegaldesleukin at EADV 2024

Nektar Therapeutics Announces Multiple Presentations for Rezpegaldesleukin at EADV 2024 PR Newswire Wed, Sep 25, 2024, 1:30 AM 8 min read In This Article: NKTR -4.13% - New proteomic analyses show tha...

PR Newswire
Yahoo Finance Community
09/26
Comment

Up 100% since last fall on 850,000 shares. Meanwhile clowns going to clown!...
Votes: 1 1

None
Yahoo Finance Community
09/27
Comment

wow. why won't it go down????? if bankruptcy is imminent in 12 months you'd think this would be going down not up!...
Votes: 1 1

None
Yahoo Finance Community
09/27
Comment

how worth will it be dum chynnnnnnnaaboi????...
Votes: 1 1

None
Yahoo Finance Community
09/27
Comment

where is lobo?...
Votes: 1 1

None
Yahoo Finance Community
09/27
Comment

$0.06 up! What a penny stock! Zero in 2026 with failed REZPEG!...

None
Quantexa News
09/30
BTIG Assumes Nektar Therapeutics (NKTR) at Buy

September 30, 2024 7:21 AM EDT Tweet BTIG analyst Julian Harrison assumes coverage on Nektar Therapeutics (NASDAQ: NKTR) with a Buy rating and a price target of ... This is a premium only article....

StreetInsider
Quantexa News
09/30
Nektar Therapeutics (NASDAQ:NKTR) Earns “Buy” Rating from BTIG Research

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report)‘s stock had its “buy” rating reissued by BTIG Research in a report released on Monday, Marketbeat.com reports. They currently have a $4.00 target pr...

ETF Daily News
Quantexa News
09/30
BTIG Research Reiterates “Buy” Rating for Nektar Therapeutics (NASDAQ:NKTR)

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report)‘s stock had its “buy” rating reissued by BTIG Research in a research note issued on Monday, Marketbeat Ratings reports. They currently have a $4.00...

Zolmax News
Quantexa News
09/30
BTIG Research Reiterates "Buy" Rating for Nektar Therapeutics (NASDAQ:NKTR)

Nektar Therapeutics (NASDAQ:NKTR - Get Free Report)'s stock had its "buy" rating reissued by BTIG Research in a research note issued on Monday, Marketbeat Ratings reports. They currently have a $4.00...

Upworthy
Quantexa News
09/30
Nektar rises 11% as BTIG initiates buy rating on autoimmune disorders asset

Pgiam BTIG has initiated Nektar Therapeutics ( NASDAQ: NKTR ) with a buy rating, citing the potential of rezpegaldesleukin, a potential first-in-class regulatory T cell stimulator, for autoimmune dis...

Seeking Alpha
Quantexa News
09/30
Nektar Therapeutics (NASDAQ:NKTR) Receives "Buy" Rating from BTIG Research

Nektar Therapeutics (NASDAQ:NKTR - Get Free Report)'s stock had its "buy" rating reaffirmed by equities research analysts at BTIG Research in a note issued to investors on Monday, Marketbeat.com repor...

MarketBeat.com
Quantexa News
10/01
Nektar Therapeutics' (NKTR) Buy Rating Reaffirmed at BTIG Research

BTIG Research reiterated their buy rating on shares of Nektar Therapeutics ( NASDAQ:NKTR – Free Report in a report issued on Monday morning, Marketbeat reports. BTIG Research currently has a $4.00 tar...

PressOracle
Quantexa News
10/01
Nektar Therapeutics (NKTR) is 3.51% away from 50-day simple Moving Average despite all headwinds

Nektar Therapeutics (NASDAQ: NKTR) kicked off on Monday, up 11.11% from the previous trading day, before settling in for the closing price of $1.17. Over the past 52 weeks, NKTR has traded in a range...

Newsdaemon.com
Quantexa News
10/01
Nantahala Capital Management LLC Acquires 1,634,046 Shares of Nektar Therapeutics (NASDAQ:NKTR)

Nantahala Capital Management LLC lifted its stake in shares of Nektar Therapeutics (NASDAQ:NKTR – Free Report) by 66.0% during the second quarter, Holdings Channel.com reports. The firm owned 4,110,00...

ETF Daily News
Quantexa News
10/02
BTIG Research Reiterates “Buy” Rating for Nektar Therapeutics (NASDAQ:NKTR)

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report)‘s stock had its “buy” rating restated by BTIG Research in a report issued on Monday, Marketbeat.com reports. They currently have a $4.00 price targe...

Dakota Financial News
Quantexa News
10/02
Nektar Therapeutics (NASDAQ:NKTR) Stock Rating Reaffirmed by BTIG Research

Nektar Therapeutics ( – ‘s stock had its “buy” rating reissued by BTIG Research in a research report issued to clients and investors on Monday, reports. They presently have a $4.00 price objective on...

The Markets Daily
Quantexa News
10/03
Nektar Therapeutics’ (NKTR) Buy Rating Reiterated at BTIG Research

BTIG Research reaffirmed their buy rating on shares of Nektar Therapeutics (NASDAQ:NKTR – Free Report) in a report published on Monday, MarketBeat Ratings reports. BTIG Research currently has a $4.00...

Daily Political
Quantexa News
10/03
Nektar Therapeutics' (NKTR) Buy Rating Reaffirmed at BTIG Research

BTIG Research reissued their buy rating on shares of Nektar Therapeutics ( NASDAQ:NKTR – Free Report in a research report report published on Monday morning, MarketBeat reports. BTIG Research currentl...

Mayfield Recorder
Quantexa News
10/04
Pay Attention to this Trade Activity as Nektar Therapeutics (NKTR) last week performance was 17.12%

Nektar Therapeutics (NASDAQ: NKTR) started the day on Thursday, with a price decrease of -2.26% at $1.30, before settling in for the price of $1.33 at the close. Taking a more long-term approach, NKTR...

Newsdaemon.com
Yahoo Finance Community
10/08
Comment

NVDA up $5.17 and this scam up $0.02! CB/Fuzzyball/Leaker of Howard's bawls is a fraud who has pumped this scam using multiple ID's for several years. She might be Howard's former secretary....

None
Quantexa News
10/09
Nektar Therapeutics (NASDAQ:NKTR) Receives $2.33 Consensus Price Target from Analysts

Nektar Therapeutics ( NASDAQ:NKTR – Get Free Report ) has received an average rating of “Hold” from the six ratings firms that are covering the stock, MarketBeat reports. One investment analyst has ra...

PressOracle
Quantexa News
10/09
Nektar Therapeutics (NASDAQ:NKTR) Receives $2.33 Consensus Target Price from Analysts

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) has received an average recommendation of “Hold” from the six ratings firms that are covering the company, MarketBeat reports. One equities research...

Ticker Report
Yahoo Finance Community
10/10
Comment

NVDA is close to all time closing high! Up $2.20 while a fake company CB has been pumping using several different ID's for years is down 3.5%! She is clueless about who I am. Gravitational push for NKTR SP? What a low EYE-Q liar who loves leaking Howard R's and JZ's bawls!...

None
Quantexa News
10/11
Nektar Therapeutics (NASDAQ:NKTR) Receives Consensus Recommendation of “Hold” from Analysts

Shares of Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) have been given an average rating of “Hold” by the six brokerages that are currently covering the stock, Marketbeat Ratings reports. One i...

ETF Daily News
Quantexa News
10/11
Nektar Therapeutics (NASDAQ:NKTR) Given Consensus Recommendation of “Hold” by Brokerages

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) has earned an average recommendation of “Hold” from the six ratings firms that are currently covering the stock, Marketbeat Ratings reports. One inv...

Dakota Financial News
Yahoo Finance Community
10/11
Comment

"dum chynnnnaboi jensen"? What an eadeat! NVDA is down 1 cent or 0.01%. It is just a few cents below all time high closing price!...

None
Quantexa News
10/13
Brokerages Set Nektar Therapeutics (NASDAQ:NKTR) Target Price at $2.33

Nektar Therapeutics ( NASDAQ:NKTR – Get Free Report ) has been given an average recommendation of “Hold” by the six ratings firms that are covering the firm, Marketbeat.com reports. One research analy...

Transcript Daily
Yahoo Finance Community
10/13
Comment

at least the kllowns now acknowledge my position herefor those new to the discussion, it's 850k shares @ 0.58 basis, or about 25% of my net worth...
Votes: 1 2

None
Yahoo Finance Community
10/14
Comment

I love "gravitational push" by CB (aka. Fuzzyball). NVDA is at all time high. up $3.2. NKTR down only 6.5 cents. but a whopping 4.78% gravitational PUSH!...

None
Yahoo Finance Community
10/15
Comment

TPST is on the rise- Tempest Therapeutics protecting investors, time to get defensive- Black Rock 2 min ago TPST just did a poison pill that will bring the stock over 15.00, Black Rock and Wells Fargo just increased positions Time to make some money The Container store did poison pill last week and went from 7.00 to 17.00 in 2 days Tempest Therapeutics just did a poison pill and is expected to be over 15.00 - 25.00 Roche Partner Benzings 2 min ago...

None
Quantexa News
10/16
Nektar Therapeutics (NKTR) Stock Price and Analyst Predictions

The stock has a 36-month beta value of 0.60. Opinions on the stock are mixed, with 5 analysts rating it as a “buy,” 5 as “overweight,” 1 as “hold,” and 0 as “sell.” The public float for NKTR is 177.8...

Newsheater.com
Quantexa News
10/17
Nektar Therapeutics (NASDAQ:NKTR) jumps 45.11% In 2024; How Attractive Is It At $1.38?

In last trading session, Nektar Therapeutics (NASDAQ:NKTR) saw 3.9 million shares changing hands with its beta currently measuring 0.60. Company's recent per share price level of $1.38 trading at $0.0...

Marketingsentinel.com
Yahoo Finance News
10/17
Nektar Announces Publication in Blood of Phase 1 Data for Novel IL-15 Agonist NKTR-255 in Combination with Autologous CD19-22 CAR-T Cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia

Nektar Announces Publication in Blood of Phase 1 Data for Novel IL-15 Agonist NKTR-255 in Combination with Autologous CD19-22 CAR-T Cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia PR...

PR Newswire
Quantexa News
10/17
Nektar Announces Publication in Blood of Phase 1 Data for Novel IL-15 Agonist NKTR-255 in Combination with Autologous CD19-22 CAR-T Cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia

– Relapse-free/progression-free survival for NKTR-255 plus CD19-22 CAR-T cell therapy at 12 months was double that of historical controls (67% vs 38%) – – Eight of nine patients achieved complete rem...

Yahoo! Finance News
Yahoo Finance News
10/17
Nektar Therapeutics Up After Leukemia Candidate Found Beneficial in Early-Stage Study

PREMIUM Nektar Therapeutics Up After Leukemia Candidate Found Beneficial in Early-Stage Study MT Newswires Thu, Oct 17, 2024, 9:33 AM 1 min read In This Article: NKTR +5.07% Nektar Therapeutics Up Aft...

MT Newswires
Quantexa News
10/17
Nektar Announces Publication in Blood of Phase 1 Data for Novel IL-15 Agonist NKTR-255 in Combination with Autologous CD19-22 CAR-T Cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia

News provided by – Relapse-free/progression-free survival for NKTR-255 plus CD19-22 CAR-T cell therapy at 12 months was double that of historical controls (67% vs 38%) – – Eight of nine patients ach...

PR Newswire
Quantexa News
10/17
Nektar Announces Publication in Blood of Phase 1 Data for Novel IL-15 Agonist NKTR-255 in Combination with Autologous CD19-22 CAR-T Cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia

– Relapse-free/progression-free survival for NKTR-255 plus CD19-22 CAR-T cell therapy at 12 months was double that of historical controls (67% vs 38%) – – Eight of nine patients achieved complete rem...

Stockhouse Newswire
Quantexa News
10/17
Nektar Announces Publication in Blood of Phase 1 Data for Novel IL-15 Agonist NKTR-255 in Combination with Autologous CD19-22 CAR-T Cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia

Werbung – Eight of nine patients achieved complete remission, all without detectable MRD – SAN FRANCISCO Oct. 17, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced the publicat...

finanzen.net
Quantexa News
10/17
Nektar Announces Publication in Blood of Phase 1 Data for Novel IL-15 Agonist NKTR-255 in Combination with Autologous CD19-22 CAR-T Cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia

– Relapse-free/progression-free survival for NKTR-255 plus CD19-22 CAR-T cell therapy at 12 months was double that of historical controls (67% vs 38%) – – Eight of nine patients achieved complete rem...

Latin Business Today
Quantexa News
10/17
Nektar Announces Publication in Blood of Phase 1 Data for Novel IL-15 Agonist NKTR-255 in Combination with Autologous CD19-22 CAR-T Cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia

– Relapse-free/progression-free survival for NKTR-255 plus CD19-22 CAR-T cell therapy at 12 months was double that of historical controls (67% vs 38%) – – Eight of nine patients achieved complete remi...

Port Arthur News, The (TX)
Quantexa News
10/17
Nektar Therapeutics (NKTR) Announces Publication in Blood of Phase 1 Data for Novel IL-15 Agonist NKTR-255 in Combination with Autologous CD19-22 CAR-T Cell Therapy

October 17, 2024 12:07 PM EDT Nektar Therapeutics (Nasdaq: NKTR ) today announced the publication of the first clinical data from a Phase 1 study evaluating NKTR-255 in combination with an autologous...

StreetInsider
Quantexa News
10/17
Nektar Therapeutics Announces Publication in Blood of Phase 1 Data for Novel II-15 Agonist NKTR-255 in Combination with Autologous CD19-22 Car-T Cell Therapy in Patients with B-Cell Acute Lymphoblastic Leukemia

Nektar Therapeutics announced the publication of the first clinical data from a Phase 1 study evaluating NKTR-255 in combination with an autologous bispecific chimeric antigen receptor (CAR)-T cell th...

MarketScreener
Quantexa News
10/17
Nektar Announces Publication in Blood of Phase 1 Data for Novel IL-15 Agonist NKTR-255 in Combination with Autologous CD19-22 CAR-T Cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia

Nektar Therapeutics today announced the publication of the first clinical data from a Phase 1 study evaluating NKTR-255 in combination with an autologous bispecific chimeric antigen receptor (CAR)-T c...

Le Lézard (English)
Quantexa News
10/17
Nektar Announces Publication in Blood of Phase 1 Data for Novel IL-15 Agonist NKTR-255 in Combination with Autologous CD19-22 CAR-T Cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia

– Relapse-free/progression-free survival for NKTR-255 plus CD19-22 CAR-T cell therapy at 12 months was double that of historical controls (67% vs 38%) – – Eight of nine patients achieved complete rem...

Associated Press News
Yahoo Finance Community
10/17
Comment

The study was run by Stanford. Not Nktr. This is positive....
Votes: 5 1

None
Quantexa News
10/18
Nektar Therapeutics (NASDAQ:NKTR) Has Seen A Rose Of 158.93% This Year, Is It Still A Better Option Than Others?

In last trading session, Nektar Therapeutics (NASDAQ:NKTR) saw 2.8 million shares changing hands with its beta currently measuring 0.60. Company's recent per share price level of $1.45 trading at $0.0...

Marketingsentinel.com
Yahoo Finance Community
10/18
Comment

NKTR was a fraud. NKTR is a fraud. NKTR will be a fraud. They will NEVER develop a profitable and effective drug. NEVER. EVER! In 2026, NKTR will go bankrupt and NVDA will be even more prosperous as the #1 company in the world!...

None
Yahoo Finance Community
10/18
Comment

it's amazing the near-perfect inverse correlation between this stock's movement and the amount of kllown you see on this message board truly amazing...

None
Yahoo Finance Community
10/21
Comment

NVDA is experiencing great "gravitational PUSH" after "COLLAPSING" a few days ago. It just broke $142! All TIME HIGH!CB (aka Fuzzyball) is a dishonest eadeat who claims that she owns a flourishing business and got her Ph.D. from Harvard.I bet she is related to Howard Secs-loving Robin....
Votes: 1 0

None
Quantexa News
10/22
Nektar Therapeutics (NASDAQ:NKTR) Stock Crosses Above Two Hundred Day Moving Average – What’s Next?

Shares of Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) passed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $1.34 and tra...

Defense World
Quantexa News
10/22
Nektar Therapeutics (NASDAQ:NKTR) Stock Crosses Above Two Hundred Day Moving Average - What's Next?

Shares of Nektar Therapeutics (NASDAQ:NKTR - Get Free Report) passed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $1.34 and tra...

MarketBeat.com
Yahoo Finance Community
10/22
Comment

A Topic Dermatitis...

None
Quantexa News
10/25
Nektar Therapeutics (NKTR) Shares Down Despite Recent Market Volatility

Nektar Therapeutics (NASDAQ: NKTR) has seen a decline in its stock price by -4.26 in relation to its previous close of 1.41. However, the company has experienced a -6.90% decline in its stock price ov...

Newsheater.com
Quantexa News
10/28
Nektar Therapeutics (NASDAQ:NKTR) Short Interest Update

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) was the recipient of a significant decline in short interest in the month of October. As of October 15th, there was short interest totalling 6,040,0...

The Markets Daily
Quantexa News
10/28
Nektar Therapeutics (NASDAQ:NKTR) Short Interest Update

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) saw a large drop in short interest in October. As of October 15th, there was short interest totalling 6,040,000 shares, a drop of 17.4% from the Sep...

Dakota Financial News
Quantexa News
10/29
Nektar Therapeutics (NKTR) last year's performance of 177.78% is a clear signal for an entertaining trading season.

On Monday, Nektar Therapeutics (NASDAQ: NKTR) opened higher 3.03% from the last session, before settling in for the closing price of $1.32. Price fluctuations for NKTR have ranged from $0.41 to $1.93...

Newsdaemon.com
Quantexa News
10/29
Nektar Announces Publication in Nature Communications of Results from Phase 1b Studies of Rezpegaldesleukin in Two Inflammatory Skin Diseases

Werbung - Biomarker analyses demonstrate plurality of Treg-mediated pathways with potential effect on tissue resident memory T cell populations resulting in sustained efficacy seen in the antigen cha...

finanzen.net
Quantexa News
10/29
Nektar's rezpegaldesleukin Phase 1 study featured in peer-reviewed publication

Nektar ( NKTR ) announced the publication of peer-reviewed data from two Phase 1b studies in Nature Communications highlighting the efficacy, safety, and tolerability of rezpegaldesleukin in patients...

Markets Businessinsider.com
Quantexa News
10/31
Nektar Therapeutics (NASDAQ:NKTR) Given Average Rating of “Hold” by Brokerages

Shares of Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) have received a consensus rating of “Hold” from the six brokerages that are currently covering the stock, MarketBeat.com reports. One inve...

Ticker Report
Quantexa News
10/31
Nektar Therapeutics (NASDAQ: NKTR)'s Upside Potential Is High

Nektar Therapeutics (NASDAQ:NKTR) shares, rose in value, with the stock price down by -1.57% to the previous day's close as strong demand from buyers drove the stock to $1.25. Actively observing the...

Stocksregister
Quantexa News
10/31
Nektar to Announce Financial Results for the Third Quarter 2024 on Thursday, November 7, 2024, After Close of U.S.-Based Financial Markets

News provided by SAN FRANCISCO Oct. 31, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR ) will announce its financial results for the third quarter 2024 on Thursday, November 7, 2024 , after t...

PR Newswire
Quantexa News
10/31
Nektar Therapeutics Nektar to Announce Financial Results for the Third Quarter 2024 on Thursday, November 7, 2024, After Close of U.S.-Based Financial Markets (PR Newswire)

Nektar to Announce Financial Results for the Third Quarter 2024 on Thursday, November 7, 2024, After Close of U.S.-Based Financial Markets PR Newswire SAN FRANCISCO, Oct. 31, 2024 SAN FRANCISCO ,...

Avanza
Quantexa News
10/31
Nektar to Announce Financial Results for the Third Quarter 2024 on Thursday

SAN FRANCISCO Oct. 31, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: ) will announce its financial results for the third quarter 2024 on Thursday, November 7, 2024 , after the close of U.S.-based...

sogotradedev.websol.barchart.com
Quantexa News
10/31
Nektar to Announce Financial Results for the Third Quarter 2024 on Thursday, November 7, 2024, After Close of U.S.-Based Financial Markets

October 31, 2024 at 06:01 pm EDT SAN FRANCISCO Oct. 31, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the third quarter 2024 on Thursday, November 7,...

MarketScreener
Quantexa News
10/31
Nektar to Announce Financial Results for the Third Quarter 2024 on Thursday, November 7, 2024, After Close of U.S.-Based Financial Markets

Nektar Therapeutics will announce its financial results for the third quarter 2024 on Thursday, November 7, 2024, after the close of U.S.-based financial markets. Howard Robin, President and Chief Exe...

Le Lézard (English)
Quantexa News
10/31
Nektar to Announce Financial Results for the Third Quarter 2024 on Thursday, November 7, 2024, After Close of U.S.-Based Financial Markets

PR Newswire SAN FRANCISCO, Oct. 31, 2024 SAN FRANCISCO Oct. 31, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the third quarter 2024 on Thursday, No...

Central Charts EN
Quantexa News
10/31
Nektar to Announce Financial Results for the Third Quarter 2024 on Thursday, November 7, 2024, After Close of U.S.-Based Financial Markets PR Newswire Today at 11:00pm GMT+1

PR Newswire SAN FRANCISCO, Oct. 31, 2024 SAN FRANCISCO Oct. 31, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the third quarter 2024 on Thursday, No...

Daily Leader, The (Brookhaven, MS)
Quantexa News
10/31
Small Business

PR Newswire SAN FRANCISCO, Oct. 31, 2024 SAN FRANCISCO Oct. 31, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the third quarter 2024 on Thursday, No...

Ironton Tribune, The (Ohio)
Quantexa News
10/31
Nektar to Announce Financial Results for the Third Quarter 2024 on Thursday, November 7, 2024, After Close of U.S.-Based Financial Markets PR Newswire Today at 11:00pm GMT+1

Nektar to Announce Financial Results for the Third Quarter 2024 on Thursday, November 7, 2024, After Close of U.S.-Based Financial Markets PR Newswire SAN FRANCISCO, Oct. 31, 2024 SAN FRANCISCO O...

Elizabethton Star (TN)
Quantexa News
10/31
Nektar to Announce Financial Results for the Third Quarter 2024 on Thursday, November 7, 2024, After Close of U.S.-Based Financial Markets

SAN FRANCISCO Oct. 31, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the third quarter 2024 on Thursday, November 7, 2024 , after the close of U.S.-b...

Advanced Financial Network
Quantexa News
10/31
Nektar to Announce Financial Results for the Third Quarter 2024 on Thursday, November 7, 2024, After Close of U.S.-Based Financial Markets

PR Newswire Today at 11:00pm GMT+1 SAN FRANCISCO Oct. 31, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the third quarter 2024 on Thursday, November...

Alexander City Outlook, The (AL)
Quantexa News
10/31
Nektar to Announce Financial Results for the Third Quarter 2024 on Thursday, November 7, 2024, After Close of U.S.-Based Financial Markets By Nektar Therapeutics Oct 31, 2024 24 mins ago

SAN FRANCISCO Oct. 31, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the third quarter 2024 on Thursday, November 7, 2024 , after the close of U.S.-ba...

Cnhi News
Quantexa News
10/31
Nektar to Announce Financial Results for the Third Quarter 2024 on Thursday, November 7, 2024, After Close of U.S.-Based Financial Markets

SAN FRANCISCO, Oct. 31, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the third quarter 2024 on Thursday, November 7, 2024, after the close of U.S.-ba...

BioSpace
Quantexa News
11/01
Nektar Therapeutics (NKTR) to Release Earnings on Thursday

Nektar Therapeutics (NASDAQ:NKTR - Get Free Report) is scheduled to be announcing its earnings results after the market closes on Thursday, November 7th. Analysts expect the company to announce earnin...

MarketBeat.com
Quantexa News
11/01
Nektar Therapeutics (NKTR) to Release Earnings on Thursday

NASDAQ:NKTR – Get Free Report ) is scheduled to be announcing its earnings results after the market closes on Thursday, November 7th. Analysts expect the company to announce earnings of ($0.23) per sh...

Riverton Roll
Quantexa News
11/01
Nektar Therapeutics to Announce Financial Results for the Third Quarter 2024 on Thursday, November 7, 2024, After Close of U.S. Based Financial Markets

November 01, 2024 at 10:38 am EDT SAN FRANCISCO Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the third quarter 2024 on Thursday, November 7, 2024 , after the close of U....

MarketScreener
Quantexa News
11/01
Nektar Therapeutics (NKTR) to Release Quarterly Earnings on Thursday

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) is scheduled to release its earnings data after the market closes on Thursday, November 7th. Analysts expect Nektar Therapeutics to post earnings of...

Watchlistnews.com
Quantexa News
11/02
The Nektar Therapeutics (NASDAQ: NKTR) Stock Jumped -5.38% In A Single Month – Are There Any Hopes For A Gain?

During the last session, Nektar Therapeutics (NASDAQ:NKTR)'s traded shares were 0.84 million, with the beta value of the company hitting 0.61. At the end of the trading day, the stock's price was $1.2...

Marketingsentinel.com
Quantexa News
11/03
Analysts Set Nektar Therapeutics (NASDAQ:NKTR) PT at $2.33

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) has been assigned a consensus recommendation of “Hold” from the six brokerages that are presently covering the stock, MarketBeat Ratings reports. On...

Defense World
Quantexa News
11/03
Nektar Therapeutics (NASDAQ:NKTR) Receives $2.33 Average Price Target from Analysts

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) has earned an average recommendation of “Hold” from the six research firms that are presently covering the company, MarketBeat Ratings reports. One...

ETF Daily News
Quantexa News
11/03
Piper Sandler Starts Nektar Therapeutics (NKTR) at Overweight

November 4, 2024 12:30 AM EST Piper Sandler analyst Yasmeen Rahimi initiates coverage on Nektar Therapeutics (NASDAQ: NKTR) with a Overweight rating and a price target ... This is a premium only art...

StreetInsider
Quantexa News
11/04
Nektar initiated with an Overweight at Piper Sandler

Piper Sandler initiated coverage of Nektar (NKTR) with an Overweight rating and $7 price target The analyst believes Nektar’s lead asset rezpegaldesleukin has a differentiated IL-2Ralpha mechanaism of...

Tipranks
Quantexa News
11/04
Nektar Therapeutics (NKTR) to Sell Commercial PEGylation Reagent Manufacturing Business in Alabama

November 4, 2024 8:30 AM EST Nektar Therapeutics (Nasdaq: NKTR ), a global biotechnology company focused on the discovery and development of novel therapies to treat autoimmune disorders, today annou...

StreetInsider
Quantexa News
11/04
Nektar Therapeutics (NASDAQ:NKTR) Now Covered by Piper Sandler

Research analysts at Piper Sandler initiated coverage on shares of Nektar Therapeutics ( NASDAQ:NKTR – Get Free Report in a research note issued to investors on Monday, Benzinga reports. The firm set...

Baseball News Source
Quantexa News
11/04
Nektar Announces Definitive Agreement with Ampersand Capital Partners to Sell Its Commercial PEGylation Reagent Manufacturing Business in Alabama

News provided by Nektar Therapeutics Nov 04, 2024, 8:30 AM ET SAN FRANCISCO Nov. 4, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR), a global biotechnology company focused on the discovery...

LocalSYR
Quantexa News
11/04
Nektar to sell its Huntsville, Alabama facility to Ampersand Capital for $90M

Nektar (NKTR) Therapeutics announced that it has entered into a definitive agreement to sell its Huntsville, Alabama manufacturing facility and reagent supply business to Ampersand Capital Partners, a...

Tipranks
Quantexa News
11/04
Nektar To Sell Manufacturing Facility In Alabama, Reagent Supply Business To Ampersand

(RTTNews) - Nektar Therapeutics (NKTR), Monday announced a decision to sell its Alabama-based commercial-scale manufacturing facility and PEGylation reagent supply business to Ampersand Capital Partne...

Markets Businessinsider.com
Quantexa News
11/04
Nektar initiated with an Overweight at Piper Sandler

Piper Sandler initiated coverage of Nektar ( NKTR ) with an Overweight rating and $7 price target The analyst believes Nektar's lead asset rezpegaldesleukin has a differentiated IL-2Ralpha mechanaism...

Markets Businessinsider.com
Quantexa News
11/04
Nektar To Sell Manufacturing Facility In Alabama, Reagent Supply Business To Ampersand

Nektar Therapeutics (NKTR) announced on Monday its decision to divest its commercial-scale manufacturing facility in Alabama and its PEGylation reagent supply business. The assets will be sold to Ampe...

MT5 Forex Traders Portal
Quantexa News
11/04
Nektar pads wallet with $90M manufacturing plant sale to Ampersand

After a protracted rough patch—which has included layoffs, partnership terminations and lawsuits—San Francisco's Nektar Therapeutics is extending its cash runway with the sale of one of its two main f...

Fierce Pharma
Quantexa News
11/04
Nektar To Sell Manufacturing Facility In Alabama, Reagent Supply Business To Ampersand

Nektar Therapeutics (NKTR), Monday announced a decision to sell its Alabama-based commercial-scale manufacturing facility and PEGylation reagent supply to Ampersand Capital Partners for $90 million....

RTT News
Quantexa News
11/04
Nektar Therapeutics (NASDAQ: NKTR) Enters into Asset Purchase Agreement with Ampersand Capital Partners

On November 1, 2024, Nektar Therapeutics, a Delaware corporation, announced that it has entered into an Asset Purchase Agreement (APA) with an affiliate of Ampersand Management LLC d/b/a Ampersand Cap...

The Cerbat Gem
Quantexa News
11/05
Analysts Set Nektar Therapeutics (NASDAQ:NKTR) Price Target at $2.33

Shares of Nektar Therapeutics ( NASDAQ:NKTR – Get Free Report ) have earned an average recommendation of “Hold” from the seven brokerages that are currently covering the firm, MarketBeat.com reports....

PressOracle
Quantexa News
11/05
Nektar To Sell Manufacturing Facility In Alabama, Reagent Supply Business To Ampersand

(RTTNews) - Nektar Therapeutics (NKTR), Monday announced a decision to sell its Alabama-based commercial-scale manufacturing facility and PEGylation reagent supply business to Ampersand Capital Partne...

Finanzen - Austria
Quantexa News
11/05
Piper Sandler Issues Overweight Rating for Nektar Therapeutics (NKTR) Stock

Piper Sandler has recently initiated Nektar Therapeutics (NKTR) stock to Overweight rating, as announced on Today, according to Finviz . Earlier, on September 30, 2024, BTIG Research had resumed the s...

BOV News
Quantexa News
11/05
Nektar Therapeutics to sell Alabama facility to Ampersand

US-based Nektar Therapeutics has signed a definitive agreement to divest its Huntsville, Alabama manufacturing facility and associated reagent supply business to private equity firm Ampersand Capital...

Yahoo
Quantexa News
11/05
Nektar Therapeutics (NKTR) Set to Announce Earnings on Thursday

Nektar Therapeutics ( NASDAQ:NKTR – Get Free Report ) is scheduled to be posting its quarterly earnings results after the market closes on Thursday, November 7th. Analysts expect Nektar Therapeutics t...

Baseball News Source
Quantexa News
11/05
Nektar Therapeutics (NKTR) Set to Announce Earnings on Thursday

NASDAQ:NKTR – Get Free Report ) is scheduled to issue its quarterly earnings data after the market closes on Thursday, November 7th. Analysts expect the company to announce earnings of ($0.23) per sha...

Riverton Roll
Quantexa News
11/05
Nektar Therapeutics (NKTR) Set to Announce Earnings on Thursday

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) is set to post its quarterly earnings results after the market closes on Thursday, November 7th. Analysts expect Nektar Therapeutics to post earning...

Watchlistnews.com
Quantexa News
11/05
Ampersand's Acquisition of a Nektar's Manufacturing Facility and Reagent Supply Business

Sidley Austin is representing Nektar Therapeutics in the transaction, and Goodwin Procter is representing Ampersand Capital Partners.Ampersand has agreed to acquire Nektar's commercial-scale manufactu...

Global Legal Chronicle
Quantexa News
11/06
Nektar Therapeutics (NKTR) to Release Quarterly Earnings on Thursday

Nektar Therapeutics ( – ) is set to release its earnings data after the market closes on Thursday, November 7th. Analysts expect Nektar Therapeutics to post earnings of ($0.23) per share for the quart...

The Markets Daily
Quantexa News
11/06
Nektar Therapeutics (NKTR) Scheduled to Post Earnings on Thursday

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) will be releasing its earnings data after the market closes on Thursday, November 7th. Analysts expect Nektar Therapeutics to post earnings of ($0.2...

Dakota Financial News
Quantexa News
11/06
Nektar Therapeutics (NKTR) to Release Earnings on Thursday

Nektar Therapeutics ( NASDAQ:NKTR – Get Free Report ) is set to release its earnings data after the market closes on Thursday, November 7th. Analysts expect Nektar Therapeutics to post earnings of ($0...

Mayfield Recorder
Quantexa News
11/06
Nektar Therapeutics (NKTR) to Release Quarterly Earnings on Thursday

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) will be releasing its earnings data after the market closes on Thursday, November 7th. Analysts expect Nektar Therapeutics to post earnings of ($0.2...

Modern Readers
Quantexa News
11/07
Nektar Therapeutics (NASDAQ:NKTR) Receives $2.33 Consensus Price Target from Analysts

NASDAQ:NKTR – Get Free Report ) has received an average recommendation of “Hold” from the seven brokerages that are covering the company, Marketbeat.com reports. One research analyst has rated the sto...

The Cerbat Gem
Quantexa News
11/07
Nektar Therapeutics (NASDAQ:NKTR) Research Coverage Started at Piper Sandler

Piper Sandler started coverage on shares of Nektar Therapeutics ( NASDAQ:NKTR – Free Report in a report issued on Monday morning, MarketBeat Ratings reports. The firm issued an overweight rating and a...

Transcript Daily
Quantexa News
11/07
Nektar Therapeutics (NASDAQ:NKTR) Now Covered by Piper Sandler

Piper Sandler started coverage on shares of Nektar Therapeutics ( NASDAQ:NKTR – Free Report in a report released on Monday morning, MarketBeat reports. The brokerage issued an overweight rating and a...

Stock Observer
Quantexa News
11/07
Nektar Therapeutics (NASDAQ: NKTR) Enters into Asset Purchase Agreement with Ampersand Capital Partners Posted by on Nov 7th, 2024 The closing of the Transactions is anticipated to take place in the fourth quarter of 2024, subject to meeting customary clo

On November 1, 2024, Nektar Therapeutics, a Delaware corporation, announced that it has entered into an Asset Purchase Agreement (APA) with an affiliate of Ampersand Management LLC d/b/a Ampersand Cap...

Modern Readers
Quantexa News
11/07
Nektar presents late-breaking results from Phase 2 Study of NKTR-255 Nektar (NKTR) Therapeutics and collaborators at The University of Texas MD Anderson Cancer Center presented late-breaking results from...

Nektar (NKTR) Therapeutics and collaborators at The University of Texas MD Anderson Cancer Center presented late-breaking results from a Phase 2 study evaluating NKTR-255 for the treatment of radiatio...

Tipranks
Quantexa News
11/07
Nektar and Collaborators Present Late-breaking Results from Phase 2 Study of NKTR-255 for the Treatment of Radiation Induced Lymphopenia in Locally Advanced Non-Small Cell Lung Cancer Patients at Society for Immunotherapy of Cancer (SITC) Annual Meeting

Nektar Therapeutics and collaborators at The University of Texas MD Anderson Cancer Center today presented late-breaking results... ? NKTR-255 administered post completion of concurrent chemoradiatio...

Le Lézard (English)
Quantexa News
11/07
Nektar and Collaborators Present Late-breaking Results from Phase 2 Study of NKTR-255 for the Treatment of Radiation Induced Lymphopenia in Locally Advanced Non-Small Cell Lung Cancer Patients at ...

Werbung – Pharmacodynamic data show NKTR-255 increased NK cell proliferation and markers of NK cell activation – SAN FRANCISCO Nov. 7, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) and col...

finanzen.net
Quantexa News
11/07
Nektar and Collaborators Present Late-breaking Results from Phase 2 Study of NKTR-255 for the Treatment of Radiation Induced Lymphopenia in Locally Advanced Non-Small Cell Lung Cancer Patients at Society for Immunotherapy of Cancer (SITC) Annual Meeting

News provided by Nektar Therapeutics Nov 07, 2024, 10:15 AM ET SAN FRANCISCO Nov. 7, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) and collaborators at The University of Texas MD Anderson...

WATE
Quantexa News
11/07
Nektar Therapeutics (NKTR) and Collaborators Present Late-breaking Results from Phase 2 Study of NKTR-255

November 7, 2024 10:16 AM EST Nektar Therapeutics (Nasdaq: NKTR ) and collaborators at The University of Texas MD Anderson Cancer Center today presented late-breaking results from a Phase 2 study eva...

StreetInsider
Quantexa News
11/07
Nektar presents late-breaking results from Phase 2 Study of NKTR-255

Nektar ( NKTR ) Therapeutics and collaborators at The University of Texas MD Anderson Cancer Center presented late-breaking results from a Phase 2 study evaluating NKTR-255 for the treatment of radiat...

Markets Businessinsider.com
Quantexa News
11/07
Biologics CDMO Avid Bioservices to go private with $1.1B sale to Ampersand, GHO Capital

Just days after laying out $90 million to acquire Nektar Therapeutics' Alabama manufacturing plant, Ampersand Capital Partners is pulling out its life sciences checkbook once again. This week, biolog...

Fierce Pharma
Yahoo Finance News
11/07
Nektar Therapeutics Reports Third Quarter 2024 Financial Results

Nektar Therapeutics Reports Third Quarter 2024 Financial Results PR Newswire Thu, Nov 7, 2024, 1:15 PM 14 min read In This Article: NKTR +3.96% SAN FRANCISCO , Nov. 7, 2024 /PRNewswire/ -- Nektar Ther...

PR Newswire
Quantexa News
11/07
Nektar Therapeutics Reports Third Quarter 2024 Financial Results

News provided by SAN FRANCISCO Nov. 7, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR ) today reported financial results for the third quarter ended September 30, 2024 Cash and investments i...

PR Newswire
Quantexa News
11/07
Nektar Therapeutics Reports Third Quarter 2024 Financial Results

SAN FRANCISCO Nov. 7, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: ) today reported financial results for the third quarter ended September 30, 2024 © 2024 Barchart.com, Inc. All quote data is p...

sogotradedev.websol.barchart.com
Quantexa News
11/07
Nektar Therapeutics Reports Third Quarter 2024 Financial Results

Nektar Therapeutics Reports Third Quarter 2024 Financial Results PR Newswire SAN FRANCISCO, Nov. 7, 2024 SAN FRANCISCO, Nov. 7, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported f...

Canada StockWatch
Quantexa News
11/07
Nektar Therapeutics Reports Third Quarter 2024 Financial Results

SAN FRANCISCO Nov. 7, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the third quarter ended September 30, 2024 Cash and investments in marketable securi...

Stockhouse Newswire
Quantexa News
11/07
Nektar Therapeutics Reports Third Quarter 2024 Financial Results

Nektar Therapeutics Reports Third Quarter 2024 Financial Results PR Newswire SAN FRANCISCO, Nov. 7, 2024 SAN FRANCISCO Nov. 7, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported...

Central Charts EN
Quantexa News
11/07
Nektar Therapeutics Reports Third Quarter 2024 Financial Results

Werbung Cash and investments in marketable securities on September 30, 2024 were $249.0 million as compared to $329.4 million at December 31, 2023 . Nektar's cash and marketable securities are expect...

finanzen.net
Quantexa News
11/07
Nektar Therapeutics Reports Third Quarter 2024 Financial Results

SAN FRANCISCO Nov. 7, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the third quarter ended September 30, 2024 Cash and investments in marketable securi...

Yahoo! Finance News
Yahoo Finance News
11/07
Nektar: Q3 Earnings Snapshot

Nektar: Q3 Earnings Snapshot Associated Press Finance Thu, Nov 7, 2024, 4:36 PM 1 min read In This Article: NKTR +3.96% SAN FRANCISCO (AP) — SAN FRANCISCO (AP) — Nektar Therapeutics (NKTR) on Thursday...

Associated Press Finance
Quantexa News
11/07
Nektar Therapeutics Reports Third Quarter 2024 Financial Results

SAN FRANCISCO, Nov. 7, 2024 /PRNewswire/ -- Nektar Therapeutics NKTR today reported financial results for the third quarter ended September 30, 2024. Cash and investments in marketable securities on...

Benzinga
Quantexa News
11/07
Nektar Therapeutics Reports Third Quarter 2024 Financial Results

SAN FRANCISCO, Nov. 7, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the third quarter ended September 30, 2024. Cash and investments in marketable secu...

Associated Press News
Quantexa News
11/07
Nektar: Q3 Earnings Snapshot

November 07, 2024 at 04:37 pm EST SAN FRANCISCO (AP) — SAN FRANCISCO (AP) — Nektar Therapeutics (NKTR) on Thursday reported a loss of $37.1 million in its third quarter. On a per-share basis, the Sa...

MarketScreener
Quantexa News
11/07
Nektar reports Q3 EPS (18c), consensus (20c)

Reports Q3 revenue $24.1M, consensus $18.28M. Cash and investments in marketable securities on September 30, 2024 were $249M as compared to $329.4M at December 31, 2023. Nektar’s (NKTR) cash and marke...

Tipranks
Quantexa News
11/07
Nektar: Q3 Earnings Snapshot

SAN FRANCISCO (AP) — SAN FRANCISCO (AP) — Nektar Therapeutics (NKTR) on Thursday reported a loss of $37.1 million in its third quarter. On a per-share basis, the San Francisco-based company said it h...

Discovery News
Yahoo Finance News
11/07
Nektar Therapeutics (NKTR) Reports Q3 Loss, Tops Revenue Estimates

Nektar Therapeutics (NKTR) Reports Q3 Loss, Tops Revenue Estimates Zacks Equity Research Thu, Nov 7, 2024, 5:40 PM 3 min read In This Article: NKTR +3.96% Nektar Therapeutics (NKTR) came out with a qu...

Zacks
Quantexa News
11/07
Nektar Therapeutics Reports Third Quarter 2024 Financial Results By Nektar Therapeutics Nov 7, 2024 Nov 7, 2024 Updated 3 hrs ago

SAN FRANCISCO Nov. 7, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the third quarter ended September 30, 2024 Local Trending News Cash and investment...

WFMZ Allentown
Quantexa News
11/07
Nektar Therapeutics (NKTR) Reports Q3 Loss, Tops Revenue Estimates

3 min read Nektar Therapeutics (NKTR) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to loss of $0.19 per share a year ago. Th...

Yahoo Finanzas
Quantexa News
11/07
Nektar Therapeutics (NKTR) Q3 2024 Earnings Call Transcript

Nektar Therapeutics (NASDAQ:NKTR) Q3 2024 Earnings Conference Call November 7, 2024 5:00 PM ET Company Participants Vivian Wu - Associate Director, Investor Relations and Corporate Affairs Howard R...

Seeking Alpha
Yahoo Finance News
11/08
Nektar Therapeutics (NKTR) Q3 2024 Earnings Call Highlights: Strategic Moves and Financial Outlook

Nektar Therapeutics (NKTR) Q3 2024 Earnings Call Highlights: Strategic Moves and Financial Outlook GuruFocus News Thu, Nov 7, 2024, 11:30 PM 4 min read In This Article: NKTR +3.96% Revenue: $24.1 mill...

GuruFocus.com
Quantexa News
11/08
Nektar Therapeutics (NKTR) Q3 2024 Earnings Call Highlights: Strategic Moves and Financial Outlook

Revenue: $24.1 million for Q3 2024. Full Year Revenue Guidance: Expected between $90-95 million. Cash and Investments: $249 million at the end of Q3 2024. Net Loss: $37 million or $0.18 per share f...

Yahoo! Finance News
Quantexa News
11/08
Nektar Therapeutics (NASDAQ:NKTR) Coverage Initiated at Piper Sandler

Piper Sandler assumed coverage on shares of Nektar Therapeutics (NASDAQ:NKTR – Free Report) in a research note released on Monday, Marketbeat Ratings reports. The brokerage issued an overweight rating...

ETF Daily News
Quantexa News
11/08
Nektar Therapeutics (NASDAQ:NKTR) Earns Overweight Rating from Analysts at Piper Sandler

Piper Sandler assumed coverage on shares of Nektar Therapeutics ( NASDAQ:NKTR – Free Report in a research note released on Monday, Marketbeat reports. The brokerage issued an overweight rating and a $...

Defense World
Quantexa News
11/08
Nektar Therapeutics (NKTR) Q3 2024 Earnings Call Highlights: Strategic Moves and Financial Outlook

GuruFocus News 4 min read In This Article Revenue: $24.1 million for Q3 2024. Full Year Revenue Guidance: Expected between $90-95 million. Cash and Investments: $249 million at the end of Q3 2024...

Yahoo Finanzas
Quantexa News
11/08
Nektar Therapeutics Reports Stable Q3 Earnings for 2024

Nektar Therapeutics ( (NKTR) ) has released its Q3 earnings. Here is a breakdown of the information Nektar Therapeutics presented to its investors. Nektar Therapeutics is a clinical-stage biotechnolo...

Markets Businessinsider.com
Quantexa News
11/08
Nektar Therapeutics Reports Third Quarter 2024 Financial Results

SAN FRANCISCO - Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the third quarter ended September 30, 2024 . Cash and investments in marketable securities on September 30, 202...

MarketScreener
Quantexa News
11/08
Nektar and Collaborators Present Late-breaking Results from Phase 2 Study of NKTR-255 for the Treatment of Radiation Induced Lymphopenia in Locally Advanced Non-Small Cell Lung Cancer Patients

SAN FRANCISCO - Nektar Therapeutics (Nasdaq: NKTR) and collaborators at The University of Texas MD Anderson Cancer Center today presented late-breaking results from a Phase 2 study evaluating NKTR-255...

MarketScreener
Quantexa News
11/08
Nektar Q3 Loss Narrower Than Expected, Pipeline Development in Focus

Nektar Therapeutics NKTR Quick Quote NKTR Free Report ) incurred a loss per share of 18 cents in the third quarter of 2024, narrower than the Zacks Consensus Estimate of a loss of 23 cents. In the ye...

Zacks
Yahoo Finance News
11/08
Nektar Q3 Loss Narrower Than Expected, Pipeline Development in Focus

Nektar Q3 Loss Narrower Than Expected, Pipeline Development in Focus Zacks Equity Research Fri, Nov 8, 2024, 12:02 PM 4 min read In This Article: NKTR +3.96% NVS +0.41% Nektar Therapeutics NKTR incurr...

Zacks
Yahoo Finance News
11/18
Nektar Therapeutics Presents First Preclinical Data from Novel CSF-1 Program, NKTR-422, at 2024 American College of Rheumatology (ACR) Convergence

Nektar Therapeutics Presents First Preclinical Data from Novel CSF-1 Program, NKTR-422, at 2024 American College of Rheumatology (ACR) Convergence PR Newswire Mon, Nov 18, 2024, 2:30 PM 5 min read In...

PR Newswire
Quantexa News
11/19
Nektar Therapeutics (NASDAQ: NKTR) Could Soon Experience A Sharp Increase In Its Share Price.

In the last trading session, 1.39 million shares of the Nektar Therapeutics (NASDAQ:NKTR) were traded, and its beta was 0.57. Most recently the company's share price was $1.03, and it changed around -...

Marketingsentinel.com
Quantexa News
11/20
Nektar Therapeutics (NASDAQ:NKTR) CEO Sells $16,440.78 in Stock

Nektar Therapeutics ( NASDAQ:NKTR – Get Free Report ) CEO Howard W. Robin sold 16,278 shares of Nektar Therapeutics stock in a transaction on Tuesday, November 19th. The stock was sold at an average p...

Watchlistnews.com
Quantexa News
11/20
Howard W. Robin Sells 16,278 Shares of Nektar Therapeutics (NASDAQ:NKTR) Stock

NASDAQ:NKTR – Get Free Report ) CEO Howard W. Robin sold 16,278 shares of the stock in a transaction dated Tuesday, November 19th. The stock was sold at an average price of $1.01, for a total value of...

Riverton Roll
Quantexa News
11/21
Insider Sale: Chief R&D Officer of $NKTR (NKTR) Sells 7,785 Shares

Switch the Market flag Open the menu and switch the Market flag for targeted data from your country of choice. for targeted data from your country of choice....

Barchart.com
Quantexa News
11/21
Looking For A Top Momentum Stock? Why Nektar Therapeutics (NASDAQ: NKTR) Is A Great Pick

Nektar Therapeutics (NASDAQ:NKTR) shares, rose in value on Wednesday, November 20, with price down by -2.91% to the previous day's close as strong demand from buyers drove the stock to $1.00. Activel...

Stocksregister
Quantexa News
11/22
Howard W. Robin Sells 16,278 Shares of Nektar Therapeutics (NASDAQ:NKTR) Stock

Nektar Therapeutics ( NASDAQ:NKTR – Get Free Report ) CEO Howard W. Robin sold 16,278 shares of the company's stock in a transaction on Tuesday, November 19th. The shares were sold at an average price...

Baseball News Source
Quantexa News
11/22
Can Nektar Therapeutics (NASDAQ: NKTR) Still Be Considered A Loss When It's Up 91.15% YTD?

During the recent session, Nektar Therapeutics (NASDAQ:NKTR)'s traded shares were 0.84 million, with the beta value of the company hitting 0.56. At the last check today, the stock's price was $1.08, r...

Marketingsentinel.com
Quantexa News
11/23
Insider Selling: Nektar Therapeutics (NASDAQ:NKTR) CEO Sells 16,278 Shares of Stock

Nektar Therapeutics ( NASDAQ:NKTR – Get Free Report ) CEO Howard W. Robin sold 16,278 shares of the business's stock in a transaction on Tuesday, November 19th. The stock was sold at an average price...

Community Financial News
Quantexa News
11/24
GSA Capital Partners LLP Sells 716,698 Shares of Nektar Therapeutics (NASDAQ:NKTR)

GSA Capital Partners LLP lessened its stake in shares of Nektar Therapeutics (NASDAQ:NKTR – Free Report) by 77.0% during the third quarter, according to its most recent filing with the Securities & Ex...

Defense World
Quantexa News
11/25
Nektar Therapeutics (NASDAQ:NKTR) Given Consensus Rating of "Moderate Buy" by Brokerages

Nektar Therapeutics (NASDAQ:NKTR - Get Free Report) has received an average recommendation of "Moderate Buy" from the five analysts that are currently covering the stock, MarketBeat.com reports. Two a...

MarketBeat.com
Quantexa News
11/25
Nektar Therapeutics (NASDAQ:NKTR) Given Consensus Rating of “Moderate Buy” by Brokerages

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) has received an average recommendation of “Moderate Buy” from the five analysts that are currently covering the stock, MarketBeat.com reports. Two a...

Ticker Report
Quantexa News
11/25
Nektar Therapeutics (NASDAQ:NKTR) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Nektar Therapeutics ( NASDAQ:NKTR – Get Free Report ) has been assigned a consensus recommendation of “Moderate Buy” from the five ratings firms that are covering the firm, Marketbeat reports. Two ana...

PressOracle
Yahoo Finance Community
11/25
Comment

A Topic Dermatitis...

None
Yahoo Finance Community
11/25
Comment

Alopecia...

None
Quantexa News
11/28
Nektar Therapeutics (NASDAQ:NKTR) Receives $3.50 Consensus Target Price from Analysts

Shares of Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the five analysts that are covering the firm, Marketbeat reports. Two equi...

Defense World
Quantexa News
11/28
Connor Clark & Lunn Investment Management Ltd. Boosts Stock Holdings in Nektar Therapeutics (NASDAQ:NKTR)

Connor Clark & Lunn Investment Management Ltd. grew its position in shares of Nektar Therapeutics ( NASDAQ:NKTR – Free Report ) by 5.6% during the third quarter, according to its most recent filing wi...

PressOracle
Yahoo Finance Community
11/29
Comment

brutally cheap (athe) 1.20 to relase blockbuster phase 2 data within 2 month.....

None
Quantexa News
11/30
Nektar Therapeutics (NASDAQ:NKTR) Receives $3.50 Consensus PT from Brokerages

Shares of Nektar Therapeutics ( NASDAQ:NKTR – Get Free Report ) have been assigned a consensus rating of “Moderate Buy” from the five research firms that are currently covering the firm, MarketBeat.co...

American Banking News
Quantexa News
11/30
Brokerages Set Nektar Therapeutics (NASDAQ:NKTR) Target Price at $3.50

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) has earned a consensus rating of “Moderate Buy” from the five analysts that are presently covering the firm, MarketBeat reports. Two equities resear...

ETF Daily News
Quantexa News
12/02
Nektar Therapeutics (NASDAQ:NKTR) Receives Consensus Rating of “Moderate Buy” from Analysts

Nektar Therapeutics ( – ) has received a consensus rating of “Moderate Buy” from the five brokerages that are presently covering the company, reports. Two research analysts have rated the stock with a...

The Markets Daily
Quantexa News
12/02
Brokerages Set Nektar Therapeutics (NASDAQ:NKTR) PT at $3.50

Shares of Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the five ratings firms that are currently covering the company, Marke...

Modern Readers
Quantexa News
12/02
Ampersand Capital Partners Completes Acquisition of Nektar Therapeutics' PEG Reagent Manufacturing Business, Launching Newly Branded Gannet BioChem

BOSTON and HUNTSVILLE, Ala., Dec. 2, 2024 /PRNewswire/ -- Ampersand Capital Partners, a private equity firm specializing in growth equity investments in the life sciences and healthcare sectors, today...

Ticker Tech
Quantexa News
12/02
Ampersand Capital Partners Completes Acquisition of Nektar Therapeutics' PEG Reagent Manufacturing Business, Launching Newly Branded Gannet BioChem

BOSTON and HUNTSVILLE, Ala., Dec. 2, 2024 /PRNewswire/ -- Ampersand Capital Partners, a private equity firm specializing in growth equity investments in the life sciences and healthcare sectors, today...

Yahoo! Finance News
Quantexa News
12/02
Ampersand Capital Partners Completes Acquisition of Nektar Therapeutics' PEG Reagent Manufacturing Business, Launching Newly Branded Gannet BioChem

December 2, 2024 9:30 AM EST BOSTON and HUNTSVILLE, Ala. Dec. 2, 2024 /PRNewswire/ -- Ampersand Capital Partners, a private equity firm specializing in growth equity investments in the life sciences...

StreetInsider
Quantexa News
12/02
Ampersand Capital Partners Completes Acquisition of Nektar Therapeutics' PE

BOSTON and HUNTSVILLE, Ala. Dec. 2, 2024 /PRNewswire/ -- Ampersand Capital Partners, a private equity firm specializing in growth equity investments in the life sciences and healthcare sectors, today...

sogotradedev.websol.barchart.com
Quantexa News
12/02
Ampersand Capital Partners Completes Acquisition of Nektar Therapeutics' PEG Reagent Manufacturing Business, Launching Newly Branded Gannet BioChem

BOSTON and HUNTSVILLE, Ala. Dec. 2, 2024 /PRNewswire/ -- Ampersand Capital Partners, a private equity firm specializing in growth equity investments in the life sciences and healthcare sectors, today...

Le Lézard (English)
Quantexa News
12/02
Ampersand Capital Partners Completes Acquisition of Nektar Therapeutics' PEG Reagent Manufacturing Business, Launching Newly Branded Gannet BioChem

Werbung With over 30 years of expertise, Gannet BioChem is a proven specialty CDMO leader in developing, scaling, and manufacturing polyethylene glycol (PEG) reagents - critical components in advance...

finanzen.net
Quantexa News
12/02
Ampersand Capital Partners Completes Acquisition of Nektar Therapeutics' PEG Reagent Manufacturing Business, Launching Newly Branded Gannet BioChem PR Newswire Today at 3:30pm GMT+1

PR Newswire BOSTON and HUNTSVILLE, Ala., Dec. 2, 2024 BOSTON and HUNTSVILLE, Ala. Dec. 2, 2024 /PRNewswire/ -- Ampersand Capital Partners, a private equity firm specializing in growth equity investm...

Greenville Business Magazine
Quantexa News
12/02
Ampersand Capital Partners Completes Acquisition of Nektar Therapeutics' PEG Reagent Manufacturing Business, Launching Newly Branded Gannet BioChem PR Newswire Today at 3:30pm GMT+1

Ampersand Capital Partners Completes Acquisition of Nektar Therapeutics' PEG Reagent Manufacturing Business, Launching Newly Branded Gannet BioChem PR Newswire BOSTON and HUNTSVILLE, Ala., Dec. 2,...

Elizabethton Star (TN)
Quantexa News
12/02
Ampersand Capital Partners Completes Acquisition of Nektar Therapeutics' PEG Reagent Manufacturing Business, Launching Newly Branded Gannet BioChem

BOSTON and HUNTSVILLE, Ala., Dec. 2, 2024 /PRNewswire/ -- Ampersand Capital Partners, a private equity firm specializing in growth equity investments in the life sciences and healthcare sectors, today...

Bainbridge Post-Searchlight, The (GA)
Quantexa News
12/02
Ampersand Capital Partners Completes Acquisition of Nektar Therapeutics' PEG Reagent Manufacturing Business, Launching Newly Branded Gannet BioChem By Ampersand Capital Partners Dec 2, 2024 Dec 2, 2024 Updated 6 mins ago

BOSTON and HUNTSVILLE, Ala. Dec. 2, 2024 /PRNewswire/ -- Ampersand Capital Partners, a private equity firm specializing in growth equity investments in the life sciences and healthcare sectors, today...

WFMZ Allentown
Quantexa News
12/02
Ampersand Capital Partners Acquires Nektar Therapeutics' PEG Reagent Manufacturing Business

Launches newly rebranded Gannet BioChem. Ampersand Capital Partners, a private equity firm specializing in growth equity investments in the life sciences and healthcare sectors, has closed its acqui...

Contract Pharma
Quantexa News
12/02
Ampersand Completes Purchase of Nektar Therapeutics PEG Reagent Manufacturing Business

Ampersand Capital Partners , a private equity firm focused investments in the life sciences and healthcare sectors, has closed its previously announced acquisition of Nektar Therapeutics ‘ PEGylation...

Mergers & Acquisitions
Quantexa News
12/02
Ampersand Capital Partners Completes Acquisition of Nektar Therapeutics' PEG Reagent Manufacturing Business, Launching Newly Branded Gannet BioChem

BOSTON and HUNTSVILLE, Ala., Dec. 2, 2024 /PRNewswire/ -- Ampersand Capital Partners, a private equity firm specializing in growth equity investments in the life sciences and healthcare sectors, today...

Biotechgate
Yahoo Finance Community
12/02
Comment

I’ve been in since 2 weeks when I stumbled upon their Nature commun paper. If this drug is indeed Treg IL2R selective and the safety profile is favorable, then this is a game changer in immunology. Looks to me as if they have liquidity through 2026, I’m in til readout....

None
Quantexa News
12/03
Ampersand Management LLC completed the acquisition of Manufacturing Facility and Reagent Supply Business in Huntsville, Alabama of Nektar Therapeutics from Nektar Therapeutics.

Ampersand Management LLC entered into an Asset Purchase Agreement to acquire Manufacturing Facility and Reagent Supply Business in Huntsville, Alabama of Nektar Therapeutics from Nektar Therapeutics (...

MarketScreener
Yahoo Finance Community
12/03
Comment

Broad pipeline, but execution risks; speculative opportunity. MYNZ is still in my sights for strategic updates....

None
Yahoo Finance Community
12/03
Comment

Nktr 422 will be bought out by ABBIE. It's right up their alley. We can only hope the entire company as well. Pfe will pick up Nktr 358. We have 2 good compound that can be sold off. Nktr 422 go to phase 2 for max buy out price. HR and his team are now at 60 and dropping. Perfect for selling off....

None
Yahoo Finance Community
12/03
Comment

total junk stock...
Votes: 1 0

None
Quantexa News
12/04
Ampersand Capital acquires Nektar facility; Green Hill to divest Mission Cloud

Deal Wrap is updated as of 3 p.m. ET. – Ampersand Capital Partners purchased a manufacturing facility and reagent supply business in Alabama from San Francisco-headquartered Nektar Therapeutics. – G...

S&P Global
Yahoo Finance Community
12/06
Comment

dirt cheap cpix 1.15 - has multiple marketed drugs and imminent data readout........

None
Yahoo Finance Community
12/06
Comment

AMZN! I told you to sell NKTR to buy AMZN 5 years ago!!!NKTR is a FRAUD orchestrated by a Sexcretary-loving CEO and a dumb CSO!...

None
Yahoo Finance News
12/07
Nektar Therapeutics Announces NKTR-255 Following CD19-directed CAR-T Therapy Enhanced Complete Response Rates in Patients with Relapsed or Refractory Large B-cell Lymphoma at the 66th Annual ASH Meeting

Nektar Therapeutics Announces NKTR-255 Following CD19-directed CAR-T Therapy Enhanced Complete Response Rates in Patients with Relapsed or Refractory Large B-cell Lymphoma at the 66th Annual ASH Meeti...

PR Newswire
Quantexa News
12/07
Nektar Therapeutics Enhances CAR-T Efficacy with NKTR-255

Author Hannah Lewis Updated : 12-07-2024 12:09 PM Nektar Therapeutics Elevates CAR-T Therapy with NKTR-255 Nektar Therapeutics (Nasdaq: NKTR) has recently showcased remarkable findings from its Pha...

Investors Hangout
Yahoo Finance Community
12/07
Comment

255 Works...

None
Yahoo Finance Community
12/08
Comment

Who knows, maybe it will be up 43cents in the morning?...
Votes: 1 1

None
Yahoo Finance Community
12/09
Comment

No one believe the data. Nktr knows how to rig data....

None
Yahoo Finance Community
12/09
Comment

I feel sorry for the patients participating in the trial....
Votes: 2 1

None
Quantexa News
12/10
Intech Investment Management LLC Purchases Shares of 31,249 Nektar Therapeutics (NASDAQ:NKTR)

Intech Investment Management LLC acquired a new position in shares of Nektar Therapeutics (NASDAQ:NKTR – Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securitie...

Defense World
Quantexa News
12/10
Nektar initiated with a Buy at H.C. Wainwright

H.C. Wainwright analyst Arthur He initiated coverage of Nektar (NKTR) with a Buy rating and $6.50 price target Nektar is a clinical-stage biopharmaceutical company focused on developing innovative med...

Tipranks
Yahoo Finance News
12/10
HC Wainwright Initiates Nektar Therapeutics at Buy With $6.50 Price Target

PREMIUM HC Wainwright Initiates Nektar Therapeutics at Buy With $6.50 Price Target MT Newswires Tue, Dec 10, 2024, 4:26 AM In This Article: NKTR +0.99% Nektar Therapeutics (NKTR) has an average rating...

MT Newswires
Quantexa News
12/10
HC Wainwright Begins Coverage on Nektar Therapeutics (NASDAQ:NKTR)

Stock analysts at HC Wainwright initiated coverage on shares of Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) in a report issued on Tuesday,Briefing.com Automated Import reports. The brokerage s...

The Markets Daily
Quantexa News
12/10
Nektar Therapeutics (NASDAQ:NKTR) Coverage Initiated by Analysts at HC Wainwright

Equities researchers at HC Wainwright began coverage on shares of Nektar Therapeutics ( NASDAQ:NKTR – Get Free Report in a research report issued to clients and investors on Tuesday, Briefing.com Auto...

Stock Observer
Quantexa News
12/10
Nektar Therapeutics (NASDAQ:NKTR) Coverage Initiated by Analysts at HC Wainwright

Equities researchers at HC Wainwright began coverage on shares of Nektar Therapeutics (NASDAQ:NKTR - Get Free Report) in a research report issued to clients and investors on Tuesday,Briefing.com Autom...

MarketBeat.com
Quantexa News
12/10
Healthcare & Life Sciences Private Equity Deal Tracker: Ampersand Acquires Nektar Therapeutics' PEGylation

December 10, 2024 at 09:09 am EST Ampersand Capital Partners has announced its acquisition of Nektar Therapeutics' PEGylation reagent manufacturing business. The business, which will be branded Gann...

MarketScreener
Quantexa News
12/10
Nektar initiated with a Buy at H.C. Wainwright

H.C. Wainwright analyst Arthur He initiated coverage of Nektar ( NKTR ) with a Buy rating and $6.50 price target Nektar is a clinical-stage biopharmaceutical company focused on developing innovative m...

Markets Businessinsider.com
Quantexa News
12/11
Nektar Therapeutics (NKTR) Stock: A Closer Look at the Analyst Ratings

Additionally, the 36-month beta value for NKTR is 0.57. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 1 rating it as “overweight,” 3 rating it as “hold,” and 0 rating it...

Newsheater.com
Quantexa News
12/11
HC Wainwright Begins Coverage on Nektar Therapeutics (NASDAQ:NKTR)

HC Wainwright assumed coverage on shares of Nektar Therapeutics ( NASDAQ:NKTR – Free Report in a research report report published on Tuesday, Marketbeat.com reports. The brokerage issued a buy rating...

The Cerbat Gem
Quantexa News
12/11
Nektar Therapeutics (NASDAQ:NKTR) Now Covered by HC Wainwright

HC Wainwright initiated coverage on shares of Nektar Therapeutics ( NASDAQ:NKTR – Free Report in a report released on Tuesday, Marketbeat.com reports. The firm issued a buy rating and a $6.50 price ta...

Watchlistnews.com
Quantexa News
12/11
What is HC Wainwright's Estimate for NKTR Q1 Earnings?

Nektar Therapeutics ( NASDAQ:NKTR – Free Report ) – Research analysts at HC Wainwright issued their Q1 2025 earnings estimates for shares of Nektar Therapeutics in a note issued to investors on Tuesda...

Riverton Roll
Quantexa News
12/11
What is HC Wainwright's Estimate for NKTR Q1 Earnings?

Nektar Therapeutics (NASDAQ:NKTR - Free Report) - Research analysts at HC Wainwright issued their Q1 2025 earnings estimates for shares of Nektar Therapeutics in a note issued to investors on Tuesday,...

MarketBeat.com
Yahoo Finance Community
12/11
Comment

AMZN! I told you to sell NKTR to buy AMZN 5 years ago!!!NKTR is a FRAUD orchestrated by a Sexcretary-loving CEO and a dumb "YES MAN" CSO!...

None
Yahoo Finance Community
12/11
Comment

NKTR to $1.00 then to $0.00!...

None
Yahoo Finance Community
12/11
Comment

AMZN to $230, all time high!!!...

None
Quantexa News
12/12
Q1 Earnings Forecast for NKTR Issued By HC Wainwright

Nektar Therapeutics ( NASDAQ:NKTR – Free Report ) – Investment analysts at HC Wainwright issued their Q1 2025 earnings per share (EPS) estimates for Nektar Therapeutics in a note issued to investors o...

American Banking News
Quantexa News
12/12
Analysts Offer Predictions for NKTR Q1 Earnings

Get Nektar Therapeutics alerts: Nektar Therapeutics (NASDAQ:NKTR – Free Report) – Research analysts at HC Wainwright issued their Q1 2025 EPS estimates for Nektar Therapeutics in a research report is...

Defense World
Quantexa News
12/12
HC Wainwright Begins Coverage on Nektar Therapeutics (NASDAQ:NKTR)

Stock analysts at HC Wainwright started coverage on shares of Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) in a research note issued to investors on Tuesday, MarketBeat.com reports. The firm se...

Community Financial News
Quantexa News
12/12
Nektar Therapeutics (NASDAQ:NKTR) Earns Buy Rating from Analysts at HC Wainwright

Stock analysts at HC Wainwright started coverage on shares of Nektar Therapeutics ( NASDAQ:NKTR – Get Free Report in a research note issued on Tuesday, Marketbeat Ratings reports. The firm set a “buy”...

Thelincolnianonline
Quantexa News
12/12
Research Analysts Issue Forecasts for NKTR FY2024 Earnings

Nektar Therapeutics (NASDAQ:NKTR - Free Report) - Analysts at HC Wainwright issued their FY2024 earnings per share estimates for Nektar Therapeutics in a report issued on Tuesday, December 10th. HC Wa...

MarketBeat.com
Quantexa News
12/12
Ewing Sarcoma Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Medication, Therapies, Patient Pool, Prevalence and Companies DelveInsight

December 12 Ewing Sarcoma Companies are Gradalis, Eisai, Salarius Pharmaceuticals, Tyme, Jazz Pharmaceuticals, Pfizer, Eli Lilly and Company, Cellectar Biosciences, Inc., Valent Technologies, LLC, Su...

Jefferson City Headlines
Quantexa News
12/12
What is HC Wainwright's Forecast for NKTR FY2024 Earnings?

Nektar Therapeutics ( NASDAQ:NKTR – Free Report ) – Investment analysts at HC Wainwright issued their FY2024 earnings per share (EPS) estimates for shares of Nektar Therapeutics in a research report i...

Mayfield Recorder
Yahoo Finance Community
12/12
Comment

Wainright has 6.50 target...

None
Yahoo Finance Community
12/12
Comment

At a 1.00 pps, low risk....

None
Quantexa News
12/12
Research Analysts Issue Forecasts for NKTR FY2024 Earnings

Nektar Therapeutics (NASDAQ:NKTR – Free Report) – Analysts at HC Wainwright issued their FY2024 earnings per share estimates for Nektar Therapeutics in a report issued on Tuesday, December 10th. HC Wa...

Modern Readers
Quantexa News
12/12
Comparing Aravive (NASDAQ:ARAV) & Nektar Therapeutics (NASDAQ:NKTR)

Aravive ( NASDAQ:ARAV – Get Free Report ) and Nektar Therapeutics ( NASDAQ:NKTR – Get Free Report ) are both small-cap medical companies, but which is the superior stock? We will compare the two busin...

Riverton Roll
Quantexa News
12/13
Equities Analysts Set Expectations for NKTR FY2024 Earnings

Get Nektar Therapeutics alerts: Nektar Therapeutics (NASDAQ:NKTR – Free Report) – Stock analysts at HC Wainwright issued their FY2024 earnings per share (EPS) estimates for Nektar Therapeutics in a r...

Defense World
Quantexa News
12/13
Research Analysts Offer Predictions for NKTR FY2024 Earnings

Nektar Therapeutics ( NASDAQ:NKTR – Free Report ) – Research analysts at HC Wainwright issued their FY2024 earnings per share estimates for shares of Nektar Therapeutics in a research note issued to i...

American Banking News
Quantexa News
12/13
Analysts Issue Forecasts for NKTR Q1 Earnings

Nektar Therapeutics (NASDAQ:NKTR – Free Report) – Analysts at HC Wainwright issued their Q1 2025 earnings per share (EPS) estimates for shares of Nektar Therapeutics in a research note issued to inves...

ETF Daily News
Quantexa News
12/13
What is HC Wainwright's Forecast for NKTR Q1 Earnings?

Nektar Therapeutics (NASDAQ:NKTR – Free Report) – Equities researchers at HC Wainwright issued their Q1 2025 earnings per share (EPS) estimates for shares of Nektar Therapeutics in a research note iss...

Ticker Report
Quantexa News
12/13
Nektar Therapeutics (NASDAQ:NKTR) Earns Buy Rating from Analysts at HC Wainwright

HC Wainwright initiated coverage on shares of Nektar Therapeutics ( NASDAQ:NKTR – Free Report in a research note issued to investors on Tuesday, MarketBeat reports. The firm issued a buy rating and a...

Riverton Roll
Quantexa News
12/14
Research Analysts Offer Predictions for NKTR FY2024 Earnings

Nektar Therapeutics (NASDAQ:NKTR – Free Report) – Research analysts at HC Wainwright issued their FY2024 earnings per share (EPS) estimates for Nektar Therapeutics in a report released on Tuesday, Dec...

ETF Daily News
Quantexa News
12/14
What is HC Wainwright's Forecast for NKTR FY2024 Earnings?

Nektar Therapeutics (NASDAQ:NKTR – Free Report) – Analysts at HC Wainwright issued their FY2024 earnings per share (EPS) estimates for shares of Nektar Therapeutics in a research note issued to invest...

Ticker Report
Yahoo Finance Community
12/14
Comment

Fraud!...

None
Quantexa News
12/15
Nektar Therapeutics (NASDAQ:NKTR) & Aravive (NASDAQ:ARAV) Financial Comparison

Aravive ( NASDAQ:ARAV – Get Free Report ) and Nektar Therapeutics ( NASDAQ:NKTR – Get Free Report ) are both medical companies, but which is the better business? We will contrast the two businesses ba...

Defense World
Yahoo Finance Community
12/15
Comment

Data Cherry picking = great early data but dismal pivotal data. 2026 bk!...

None
Yahoo Finance Community
12/15
Comment

HR’s first-class propaganda for his greed!...

None
Quantexa News
12/16
BNP Paribas Financial Markets Grows Stock Position in Nektar Therapeutics (NASDAQ:NKTR)

BNP Paribas Financial Markets lifted its position in Nektar Therapeutics (NASDAQ:NKTR – Free Report) by 1,877.2% in the 3rd quarter, according to the company in its most recent disclosure with the Sec...

Defense World
Yahoo Finance Community
12/16
Comment

NVDA!!! HAHAHAHAHA...
Votes: 1 2

None
Yahoo Finance Community
12/16
Comment

Lobo, bought at $20, sold at $5, follows realkllownnn around like a little puppy...
Votes: 1 1

None
Quantexa News
12/17
Nektar Therapeutics (NASDAQ:NKTR) Shares Sold by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. reduced its stake in shares of Nektar Therapeutics (NASDAQ:NKTR – Free Report) by 2.3% in the 3rd quarter, according to its most recent 13F filing with the Se...

Defense World
Quantexa News
12/17
The Manufacturers Life Insurance Company Makes New $86,000 Investment in Nektar Therapeutics (NASDAQ:NKTR)

The Manufacturers Life Insurance Company bought a new position in shares of Nektar Therapeutics (NASDAQ:NKTR – Free Report) during the 3rd quarter, according to its most recent Form 13F filing with th...

Defense World
Quantexa News
12/17
The Manufacturers Life Insurance Company Invests $86,000 in Nektar Therapeutics (NASDAQ:NKTR)

The Manufacturers Life Insurance Company bought a new stake in Nektar Therapeutics ( NASDAQ:NKTR – Free Report ) in the third quarter, Holdings Channel.com reports. The institutional investor bought 6...

American Banking News
Quantexa News
12/17
Contrasting Aravive (NASDAQ:ARAV) and Nektar Therapeutics (NASDAQ:NKTR)

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) and Aravive (NASDAQ:ARAV – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companie...

ETF Daily News
Quantexa News
12/19
Nektar Therapeutics (NASDAQ:NKTR) Shares Purchased by Fmr LLC

Fmr LLC boosted its holdings in Nektar Therapeutics (NASDAQ:NKTR – Free Report) by 403.2% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 386,656 shares of the bi...

Ticker Report
Quantexa News
12/19
Contrasting Nektar Therapeutics (NASDAQ:NKTR) and Aravive (NASDAQ:ARAV)

Nektar Therapeutics ( NASDAQ:NKTR – Get Free Report ) and Aravive ( NASDAQ:ARAV – Get Free Report ) are both small-cap medical companies, but which is the better stock? We will contrast the two compan...

Transcript Daily
Quantexa News
12/19
Nektar Therapeutics (NKTR) Shares Down Despite Recent Market Volatility

Nektar Therapeutics (NASDAQ: NKTR)'s stock price has decreased by -9.30 compared to its previous closing price of 1.02. However, the company has seen a -9.30% decrease in its stock price over the last...

Newsheater.com
Quantexa News
12/19
Nektar Therapeutics (NKTR) poses a Brand-New Opportunity for Investors with beta value of 0.57

Nektar Therapeutics (NASDAQ: NKTR) flaunted slowness of -9.30% at $0.93, before settling in for the price of $1.02 at the close. Taking a more long-term approach, NKTR posted a 52-week range of $0.46-...

Newsdaemon.com
Quantexa News
12/19
Nektar Therapeutics (NASDAQ:NKTR) CEO Howard W. Robin Sells 46,995 Shares

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) CEO Howard W. Robin sold 46,995 shares of Nektar Therapeutics stock in a transaction dated Tuesday, December 17th. The stock was sold at an average...

Modern Readers
Quantexa News
12/20
Insider Selling: Nektar Therapeutics (NASDAQ:NKTR) CEO Sells 46,995 Shares of Stock

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) CEO Howard W. Robin sold 46,995 shares of the business’s stock in a transaction on Tuesday, December 17th. The shares were sold at an average price...

The Markets Daily
Yahoo Finance Community
12/20
Comment

CCL and NVDA!!!!...

None
Yahoo Finance Community
12/20
Comment

NKTR to BK in 2026 thanks to the MOST DEEPLY secretarries-loving, nepotistic, greedy, pompous and incompetent and GLIB CEO!...

None
Quantexa News
12/20
Nektar Therapeutics (NASDAQ:NKTR) CEO Howard W. Robin Sells 46,995 Shares

Nektar Therapeutics ( NASDAQ:NKTR – Get Free Report ) CEO Howard W. Robin sold 46,995 shares of the stock in a transaction on Tuesday, December 17th. The stock was sold at an average price of $1.01, f...

Stock Observer
Yahoo Finance Community
12/20
Comment

Sell NKTR to buy QQQ! Pass QQQ generation to generation. Then some day your descendant will fully recover your losses!...

None
Yahoo Finance Community
12/20
Comment

I sold GODADDY too early! But I made a small fortune. Any stock is better than NKTR!...

None
Yahoo Finance Community
12/20
Comment

Did HR and his son share the same secretaries? Just asking!...

None
Quantexa News
12/20
Nektar Therapeutics (NASDAQ:NKTR) Insider Sells $48,048.10 in Stock

Nektar Therapeutics ( NASDAQ:NKTR – Get Free Report ) insider Jonathan Zalevsky sold 51,115 shares of the firm's stock in a transaction that occurred on Thursday, December 19th. The shares were sold a...

Transcript Daily
Quantexa News
12/21
Wellington Management Group LLP Purchases New Position in Nektar Therapeutics (NASDAQ:NKTR)

Wellington Management Group LLP bought a new stake in Nektar Therapeutics ( NASDAQ:NKTR – Free Report ) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchang...

American Banking News
Quantexa News
12/21
Insider Selling: Nektar Therapeutics (NASDAQ:NKTR) CEO Sells 46,995 Shares of Stock

Nektar Therapeutics ( NASDAQ:NKTR – Get Free Report ) CEO Howard W. Robin sold 46,995 shares of Nektar Therapeutics stock in a transaction dated Tuesday, December 17th. The shares were sold at an aver...

Watchlistnews.com
Quantexa News
12/21
Nektar Therapeutics (NASDAQ:NKTR) Insider Jonathan Zalevsky Sells 51,115 Shares

NASDAQ:NKTR – Get Free Report ) insider Jonathan Zalevsky sold 51,115 shares of the firm's stock in a transaction on Thursday, December 19th. The shares were sold at an average price of $0.94, for a t...

Riverton Roll
Quantexa News
12/22
Insider Selling: Nektar Therapeutics (NASDAQ:NKTR) CEO Sells $47,464.95 in Stock

Nektar Therapeutics ( NASDAQ:NKTR – Get Free Report ) CEO Howard W. Robin sold 46,995 shares of the firm's stock in a transaction dated Tuesday, December 17th. The stock was sold at an average price o...

Thelincolnianonline
Quantexa News
12/22
Insider Selling: Nektar Therapeutics (NASDAQ:NKTR) Insider Sells 51,115 Shares of Stock

Nektar Therapeutics ( NASDAQ:NKTR – Get Free Report ) insider Jonathan Zalevsky sold 51,115 shares of Nektar Therapeutics stock in a transaction on Thursday, December 19th. The shares were sold at an...

Community Financial News
Quantexa News
12/22
Howard W. Robin Sells 46,995 Shares of Nektar Therapeutics (NASDAQ:NKTR) Stock

Nektar Therapeutics ( NASDAQ:NKTR – Get Free Report ) CEO Howard W. Robin sold 46,995 shares of Nektar Therapeutics stock in a transaction that occurred on Tuesday, December 17th. The shares were sold...

Dispatch Tribunal
Quantexa News
12/23
Analysts Set Nektar Therapeutics (NASDAQ:NKTR) Price Target at $4.10

Shares of Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) have earned an average recommendation of “Moderate Buy” from the six ratings firms that are currently covering the company, MarketBeat Rat...

Ticker Report
Yahoo Finance Community
12/23
Comment

NVDA UP 3.69% and NKTR DOWN 2.99%!Fuzzyball is a dummeeeeeeeeeee. No surprise!!!!...

None
Yahoo Finance Community
12/23
Comment

NKTR to BK in 2026 thanks to the MOST DEEPLY secretarries-loving, nepotistic, greedy, pompous, incompetent and GLIB short CEO!...
Votes: 1 1

None
Yahoo Finance Community
12/24
Comment

anyone really believe this thing traded 315k shares today. it only moved once that I can see...

None
Quantexa News
12/25
Nektar Therapeutics (NASDAQ:NKTR) Receives $4.10 Consensus Target Price from Brokerages

Shares of Nektar Therapeutics ( NASDAQ:NKTR – Get Free Report ) have been assigned a consensus rating of “Moderate Buy” from the six brokerages that are presently covering the firm, Marketbeat.com rep...

American Banking News
Yahoo Finance Community
12/25
Comment

In one year and 3 Quarters, NKTR will be gone! But Howard will be laughing all the way to the bank with his former secretaries....

None
Quantexa News
12/26
Nektar Therapeutics (NASDAQ:NKTR) Insider Mark Andrew Wilson Sells 33,402 Shares

Nektar Therapeutics (NASDAQ:NKTR - Get Free Report) insider Mark Andrew Wilson sold 33,402 shares of the firm's stock in a transaction that occurred on Monday, December 23rd. The shares were sold at a...

MarketBeat.com
Quantexa News
12/26
Insider Selling: Nektar Therapeutics (NASDAQ:NKTR) Insider Sells 33,402 Shares of Stock

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) insider Mark Andrew Wilson sold 33,402 shares of the firm’s stock in a transaction that occurred on Monday, December 23rd. The stock was sold at an...

Daily Political
Quantexa News
12/27
Nektar Therapeutics (NASDAQ:NKTR) Receives $4.10 Average Price Target from Analysts

Nektar Therapeutics ( NASDAQ:NKTR – Get Free Report ) has been given an average rating of “Moderate Buy” by the six analysts that are currently covering the firm, MarketBeat Ratings reports. Two analy...

Dispatch Tribunal
Quantexa News
12/27
Nektar Therapeutics (NASDAQ:NKTR) Insider Sells $30,061.80 in Stock

Nektar Therapeutics ( NASDAQ:NKTR – Get Free Report ) insider Mark Andrew Wilson sold 33,402 shares of Nektar Therapeutics stock in a transaction dated Monday, December 23rd. The stock was sold at an...

American Banking News
Quantexa News
12/27
Nektar Therapeutics (NKTR) Stock: A Closer Look at the Analyst Ratings

Additionally, the 36-month beta value for NKTR is 0.57. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 2 rating it as “overweight,” 3 rating it as “hold,” and 0 rating it...

Newsheater.com
Quantexa News
12/28
Mark Andrew Wilson Sells 33,402 Shares of Nektar Therapeutics (NASDAQ:NKTR) Stock

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) insider Mark Andrew Wilson sold 33,402 shares of the company’s stock in a transaction dated Monday, December 23rd. The stock was sold at an average...

Ticker Report
Quantexa News
12/29
Nektar Therapeutics (NASDAQ:NKTR) Insider Sells $30,061.80 in Stock

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) insider Mark Andrew Wilson sold 33,402 shares of the firm’s stock in a transaction that occurred on Monday, December 23rd. The stock was sold at an...

Community Financial News
Quantexa News
12/29
Insider Selling: Nektar Therapeutics (NASDAQ:NKTR) Insider Sells $30,061.80 in Stock

Nektar Therapeutics ( NASDAQ:NKTR – Get Free Report ) insider Mark Andrew Wilson sold 33,402 shares of the business's stock in a transaction that occurred on Monday, December 23rd. The shares were sol...

Baseball News Source
Yahoo Finance Community
12/31
Comment

SMGO 55% off. Next year, NKTR will be on sale like SGMO. The following year, BK! Finally the process of burning investors' cash will be over. But great for Howard and his lovers!...

None
Quantexa News
01/03
Nektar Therapeutics (NASDAQ:NKTR) Shares Acquired by Barclays PLC

Barclays PLC increased its holdings in shares of Nektar Therapeutics ( NASDAQ:NKTR – Free Report ) by 96.1% in the third quarter, according to the company in its most recent filing with the SEC. The i...

American Banking News
Quantexa News
01/03
Nektar Therapeutics (NKTR) Shares Rise Despite Market Challenges

The stock of Nektar Therapeutics (NASDAQ: NKTR) has increased by 17.59 when compared to last closing price of 0.96.Despite this, the company has seen a gain of 18.80% in its stock price over the last...

Newsheater.com
Quantexa News
01/04
Institutional investors have a lot riding on Nektar Therapeutics (NASDAQ:NKTR) with 68% ownership

Given the large stake in the stock by institutions, Nektar Therapeutics' stock price might be vulnerable to their trading decisions The top 11 shareholders own 52% of the company Every investor in...

Yahoo Finance
Quantexa News
01/04
Yahoo Finance

Given the large stake in the stock by institutions, Nektar Therapeutics' stock price might be vulnerable to their trading decisions The top 11 shareholders own 52% of the company Insiders have been...

Yahoo Finanzas
Yahoo Finance Community
01/04
Comment

$1.1 penny stock. Howard Robin’s fake biotech stock. Now almost no revenue, fake experimental compounds which will surely flop in phase 2 or 3, fat checks for HR and his accessories. The year of 2026 will be there sooner than you think. The year of bankruptcy!...

None
Yahoo Finance Community
01/04
Comment

Some maaauuuuraaaans here are soooo joyful this penny stock was up 14 cents for nothing….. unbelievable....

None
Yahoo Finance Community
01/05
Comment

Cash runway seems to me to be enough for now. I am not worried about the results of rezpeg being a fluke, looks too consistent. Cancer add on looked promising. If they had a trustworthy management, this stock would likely be at 2 or 3$, but management is super important in the end. Still think we have good potential here for the price....
Votes: 2 0

None
Quantexa News
01/07
Why Nektar Therapeutics (NKTR) Is Among the Best Penny Stocks to Invest In According to Media?

We recently compiled a list of the 12 Best Penny Stocks to Invest in According to the Media. In this article, we are going to take a look at where Nektar Therapeutics (NASDAQ:NKTR) stands against othe...

Yahoo
Quantexa News
01/07
Why Nektar Therapeutics (NKTR) Is Among the Best Penny Stocks to Invest In According to Media?

We recently compiled a list of the 12 Best Penny Stocks to Invest in According to the Media . In this article, we are going to take a look at where Nektar Therapeutics (NASDAQ:NKTR) stands against oth...

Insider Monkey Blog
Quantexa News
01/07
B.Riley Starts Nektar Therapeutics (NKTR) at Buy

January 7, 2025 11:35 PM EST B.Riley analyst Mayank Mamtani initiates coverage on Nektar Therapeutics (NASDAQ: NKTR) with a Buy rating and a price target of ... This is a premium only article. To co...

StreetInsider
Quantexa News
01/07
Nektar initiated with a Buy at B. Riley

B. Riley initiated coverage of Nektar ( NKTR ) with a Buy rating and $4 price target Stay Ahead of the Market: Discover outperforming stocks and invest smarter with Top Smart Score Stocks Filter,...

Markets Businessinsider.com
Quantexa News
01/07
Nektar Therapeutics (NKTR) Gets a Buy from B.Riley Financial

Nektar Therapeutics ( NKTR – Research Report ) received a Buy rating and a $4.00 price target from B.Riley Financial analyst Mayank Mamtani yesterday. The company's shares closed yesterday at $1.19....

Markets Businessinsider.com
Quantexa News
01/08
B. Riley Securities Initiates Coverage On Nektar Therapeutics with Buy Rating, Announces Price Target of $4 B. Riley Securities analyst Mayank Mamtani initiates coverage on Nektar Therapeutics (NASDAQ:NKTR) with a Buy rating and announces Price Target of

Never miss a trade again with the fastest news alerts in the world! This headline only article is a sample of real-time intelligence Benzinga Pro traders use to win in the markets everyday. Want the...

Benzinga
Quantexa News
01/08
Nektar Therapeutics (NASDAQ:NKTR) Coverage Initiated at B. Riley

B. Riley assumed coverage on shares of Nektar Therapeutics ( NASDAQ:NKTR – Get Free Report in a research note issued to investors on Wednesday, MarketBeat.com reports. The brokerage set a “buy” rating...

Baseball News Source
Quantexa News
01/08
B. Riley Begins Coverage on Nektar Therapeutics (NASDAQ:NKTR)

B. Riley started coverage on shares of Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) in a note issued to investors on Wednesday, Marketbeat.com reports. The brokerage set a “buy” rating and a $4...

Community Financial News
Quantexa News
01/08
Nektar initiated with a Buy at B. Riley

B. Riley last night initiated coverage of Nektar ( NKTR ) with a Buy rating and $4 price target The firm views Nektar's most advanced T regulatory cell targeting candidate, Rezpeg, as on the path to “...

Markets Businessinsider.com
Quantexa News
01/08
Nektar Therapeutics (NASDAQ:NKTR) Coverage Initiated at B. Riley

B. Riley assumed coverage on shares of Nektar Therapeutics (NASDAQ:NKTR - Get Free Report) in a research note issued to investors on Wednesday, MarketBeat.com reports. The brokerage set a "buy" rating...

MarketBeat.com
Quantexa News
01/09
Nektar Therapeutics (NASDAQ:NKTR) Raised to “Strong-Buy” at B. Riley

Nektar Therapeutics ( NASDAQ:NKTR – Get Free Report was upgraded by research analysts at B. Riley to a “strong-buy” rating in a research note issued on Tuesday, Zacks.com reports. A number of other a...

Mayfield Recorder
Quantexa News
01/09
Nektar Therapeutics (NASDAQ:NKTR) Stock Rating Upgraded by B. Riley

Nektar Therapeutics (NASDAQ:NKTR - Get Free Report) was upgraded by equities research analysts at B. Riley to a "strong-buy" rating in a research note issued to investors on Tuesday,Zacks.com reports....

MarketBeat.com
Quantexa News
01/09
Nektar Therapeutics (NASDAQ:NKTR) Stock Rating Upgraded by B. Riley

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) was upgraded by equities research analysts at B. Riley to a “strong-buy” rating in a research note issued to investors on Tuesday,Zacks.com reports....

Modern Readers
Quantexa News
01/09
What is Zacks Research's Estimate for NKTR FY2024 Earnings?

Nektar Therapeutics (NASDAQ:NKTR - Free Report) - Zacks Research lifted their FY2024 EPS estimates for Nektar Therapeutics in a research report issued on Monday, January 6th. Zacks Research analyst K....

MarketBeat.com
Quantexa News
01/09
Nektar Therapeutics (NASDAQ:NKTR) Upgraded to “Strong-Buy” at B. Riley

Nektar Therapeutics ( NASDAQ:NKTR – Get Free Report was upgraded by analysts at B. Riley to a “strong-buy” rating in a research report issued to clients and investors on Tuesday, Zacks.com reports. S...

Baseball News Source
Quantexa News
01/09
B. Riley Upgrades Nektar Therapeutics (NASDAQ:NKTR) to Strong-Buy

was upgraded by analysts at B. Riley to a “strong-buy” rating in a report issued on Tuesday, Zacks.com reports. Other research analysts have also issued research reports about the company. BTIG Resea...

The Cerbat Gem
Quantexa News
01/09
What is Zacks Research’s Estimate for NKTR FY2024 Earnings?

Nektar Therapeutics (NASDAQ:NKTR – Free Report) – Zacks Research lifted their FY2024 EPS estimates for Nektar Therapeutics in a research report issued on Monday, January 6th. Zacks Research analyst K....

Dispatch Tribunal
Quantexa News
01/09
Nektar Therapeutics (NASDAQ:NKTR) Upgraded by B. Riley to “Strong-Buy” Rating

B. Riley upgraded shares of Nektar Therapeutics ( NASDAQ:NKTR – Free Report to a strong-buy rating in a report issued on Tuesday morning, Zacks.com reports. A number of other equities research analys...

Riverton Roll
Quantexa News
01/09
Nektar Therapeutics (NASDAQ:NKTR) Upgraded to Strong-Buy at B. Riley

B. Riley upgraded shares of Nektar Therapeutics ( NASDAQ:NKTR – Free Report to a strong-buy rating in a report issued on Tuesday morning, Zacks.com reports. NKTR has been the subject of several other...

PressOracle
Quantexa News
01/10
Zacks Research Has Positive Outlook of NKTR FY2024 Earnings

Get Nektar Therapeutics alerts: Nektar Therapeutics ( NASDAQ:NKTR – Free Report ) – Research analysts at Zacks Research lifted their FY2024 earnings estimates for shares of Nektar Therapeutics in a r...

Defense World
Quantexa News
01/10
Nektar Therapeutics (NASDAQ:NKTR) Upgraded at B. Riley

B. Riley upgraded shares of Nektar Therapeutics ( NASDAQ:NKTR – Free Report to a strong-buy rating in a report released on Tuesday morning, Zacks.com reports. Get Nektar Therapeutics alerts: Severa...

Defense World
Quantexa News
01/10
Nektar Therapeutics (NASDAQ:NKTR) Rating Increased to Strong-Buy at B. Riley

B. Riley upgraded shares of Nektar Therapeutics ( NASDAQ:NKTR – Free Report to a strong-buy rating in a research note published on Tuesday morning, Zacks.com reports. NKTR has been the subject of sev...

American Banking News
Quantexa News
01/10
B. Riley Begins Coverage on Nektar Therapeutics (NASDAQ:NKTR)

Equities researchers at B. Riley assumed coverage on shares of Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) in a research note issued on Wednesday, Marketbeat Ratings reports. The firm set a “b...

ETF Daily News
Quantexa News
01/10
What is B. Riley's Forecast for NKTR FY2024 Earnings?

Nektar Therapeutics (NASDAQ:NKTR – Free Report) – Research analysts at B. Riley issued their FY2024 earnings per share (EPS) estimates for Nektar Therapeutics in a note issued to investors on Tuesday,...

Modern Readers
Quantexa News
01/10
Nektar Therapeutics Announces Completion of Target Enrollment in REZOLVE-AD Phase 2b Clinical Trial of Rezpegaldesleukin in Patients with Moderate-to-Severe Atopic Dermatitis SAN FRANCISCO, Jan. 10, 2025 /PRNewswire/ -- Nektar Therapeutics (NASDAQ:NKTR) t

SAN FRANCISCO, Jan. 10, 2025 /PRNewswire/ -- Nektar Therapeutics NKTR today announced the company has completed target enrollment in its REZOLVE-AD Phase 2b study of rezpegaldesleukin in patients with...

Benzinga
Quantexa News
01/10
Nektar Therapeutics Announces Completion of Target Enrollment in REZOLVE-AD Phase 2b Clinical Trial of Rezpegaldesleukin in Patients with Moderate-to-Severe Atopic Dermatitis

News provided by SAN FRANCISCO Jan. 10, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR ) today announced the company has completed target enrollment in its REZOLVE-AD Phase 2b study of rezpeg...

PR Newswire
Quantexa News
01/10
Nektar Therapeutics Announces Completion of Target Enrollment in REZOLVE-AD Phase 2b Clinical Trial of Rezpegaldesleukin in Patients with Moderate-to-Severe Atopic Dermatitis

SAN FRANCISCO, Jan. 10, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced the company has completed target enrollment in its REZOLVE-AD Phase 2b study of rezpegaldesleukin in pat...

Associated Press News
Quantexa News
01/10
Nektar Therapeutics Announces Completion of Target Enrollment in REZOLVE-AD Phase 2b Clinical Trial of Rezpegaldesleukin in Patients with Moderate-to-Severe Atopic Dermatitis

PR Newswire SAN FRANCISCO, Jan. 10, 2025 SAN FRANCISCO Jan. 10, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced the company has completed target enrollment in its REZOLVE-AD...

Central Charts EN
Quantexa News
01/10
Nektar Therapeutics' Phase 2b Trial Enrollment Completes for AD

Author Dominic Sanders Updated : 01-10-2025 07:10 AM Nektar Therapeutics Achieves Milestone in Atopic Dermatitis Trial Nektar Therapeutics (NASDAQ: NKTR) has reached a significant milestone by comp...

Investors Hangout
Quantexa News
01/10
Nektar Therapeutics Announces Completion of Target Enrollment in REZOLVE-AD Phase 2b Clinical Trial of Rezpegaldesleukin in Patients with Moderate-to-Severe Atopic Dermatitis

Rezpegaldesleukin is a first-in-class interleukin-2 receptor (IL-2R) agonist that proliferates and activates regulatory T cells (Tregs) with promising dose-dependent clinical activity in multiple skin...

finanzen.net
Quantexa News
01/10
Nektar Therapeutics Announces Completion of Target Enrollment in REZOLVE-AD Phase 2b Clinical Trial of Rezpegaldesleukin in Patients with Moderate-to-Severe Atopic Dermatitis PR Newswire Today at 1:00pm GMT+1

Nektar Therapeutics Announces Completion of Target Enrollment in REZOLVE-AD Phase 2b Clinical Trial of Rezpegaldesleukin in Patients with Moderate-to-Severe Atopic Dermatitis PR Newswire SAN FRANCISC...

La Grange Daily News (La Grange, GA)
Quantexa News
01/10
Nektar Therapeutics Reaches Key Milestone in AD Trial Success

Author Hannah Lewis Updated : 01-10-2025 07:43 AM Nektar Therapeutics Achieves Enrollment Target for Clinical Trial Nektar Therapeutics (NASDAQ: NKTR), a forward-thinking clinical-stage company, ha...

Investors Hangout
Quantexa News
01/10
Nektar Therapeutics (NKTR) competes target enrollment in its REZOLVE-AD Phase 2b study

Nektar Therapeutics (Nasdaq: NKTR ) today announced the company has completed target enrollment in its REZOLVE-AD Phase 2b study of rezpegaldesleukin in patients with moderate-to-severe atopic dermati...

StreetInsider
Yahoo Finance Community
01/10
Comment

HR announces trial participant enrollment complete after a year for rezpeg skin cream phase 2b trial and the stock drops 10%. When the announcement comes that the skin cream fails in phase 3, which is a given, it’ll drop to a few pennies and it’ll be game over just like RKB has predicted....

None
Yahoo Finance Community
01/10
Comment

Another trial phase 2b, or more accurately described as an expedited drain of company resources for the enrichment of you know you. SEC needs to investigate this train wreck....

None
Yahoo Finance Community
01/10
Comment

Time for more stock options, “we have a phase 2 trial”. Let’s all congratulate HR....

None
Quantexa News
01/10
Nektar Therapeutics (NKTR) Gets a Buy from Piper Sandler

Piper Sandler analyst Yasmeen Rahimi maintained a Buy rating on Nektar Therapeutics ( NKTR – Research Report ) today and set a price target of $7.00. The company's shares closed last Wednesday at $1.1...

Markets Businessinsider.com
Quantexa News
01/10
Nektar completes enrollment in REZOLVE-AD Phase 2b study of rezpegaldesleukin

Nektar ( NKTR ) Therapeutics announced the company has completed target enrollment in its REZOLVE-AD Phase 2b study of rezpegaldesleukin in patients with moderate-to-severe atopic dermatitis. “We are...

Markets Businessinsider.com
Quantexa News
01/11
FY2024 Earnings Estimate for NKTR Issued By B. Riley

Nektar Therapeutics (NASDAQ:NKTR – Free Report) – B. Riley issued their FY2024 earnings estimates for Nektar Therapeutics in a research note issued to investors on Tuesday, January 7th. B. Riley analy...

Ticker Report
Quantexa News
01/11
Zacks Research Has Bullish Estimate for NKTR FY2024 Earnings

Nektar Therapeutics (NASDAQ:NKTR – Free Report) – Analysts at Zacks Research upped their FY2024 EPS estimates for Nektar Therapeutics in a report issued on Monday, January 6th. Zacks Research analyst...

ETF Daily News
Quantexa News
01/11
Nektar Therapeutics (NASDAQ:NKTR) Coverage Initiated by Analysts at B. Riley

B. Riley assumed coverage on shares of Nektar Therapeutics ( NASDAQ:NKTR – Free Report in a report published on Wednesday, Marketbeat reports. The brokerage issued a buy rating and a $4.00 price targe...

Riverton Roll
Quantexa News
01/11
Nektar Therapeutics (NASDAQ:NKTR) Research Coverage Started at B. Riley

B. Riley assumed coverage on shares of Nektar Therapeutics (NASDAQ:NKTR – Free Report) in a research note issued to investors on Wednesday, Marketbeat Ratings reports. The brokerage issued a buy ratin...

Ticker Report
Quantexa News
01/11
Buy Rating for Nektar Therapeutics: Promising Clinical Trial Strategy and Efficacy of Rezpeg

Nektar Therapeutics ( NKTR – Research Report ), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Julian Harrison from BTIG reiterated a Buy rating on the stock...

Markets Businessinsider.com
Quantexa News
01/12
What is B. Riley’s Forecast for NKTR FY2024 Earnings?

Nektar Therapeutics (NASDAQ:NKTR – Free Report) – Analysts at B. Riley issued their FY2024 earnings estimates for Nektar Therapeutics in a research report issued to clients and investors on Tuesday, J...

ETF Daily News
Quantexa News
01/13
Nektar Therapeutics completes target enrollment in REZOLVE-AD phase 2b trial of rezpegaldesleukin in patients with moderate-to-severe atopic dermatitis

Nektar Therapeutics, a clinical-stage biotechnology company, announced the company has completed target enrollment in its REZOLVE-AD phase 2b study of rezpegaldesleukin in patients with moderate-to-se...

Pharmabiz.com (India)
Quantexa News
01/13
HC Wainwright Reiterates Buy Rating for Nektar Therapeutics (NASDAQ:NKTR)

Nektar Therapeutics ( NASDAQ:NKTR – Get Free Report ‘s stock had its “buy” rating reissued by stock analysts at HC Wainwright in a report issued on Monday, Benzinga reports. They presently have a $6.5...

Mayfield Recorder
Quantexa News
01/13
Nektar Therapeutics: Promising Drug Pipeline and Strategic Expansion Drive Buy Rating

Analyst Arthur He CFA of H.C. Wainwright maintained a Buy rating on Nektar Therapeutics ( NKTR – Research Report ), retaining the price target of $6.50. Stay Ahead of the Market: Discover outperfor...

Markets Businessinsider.com
Quantexa News
01/14
HC Wainwright Reaffirms Buy Rating for Nektar Therapeutics (NASDAQ:NKTR)

HC Wainwright restated their buy rating on shares of Nektar Therapeutics (NASDAQ:NKTR – Free Report) in a research report report published on Monday morning,Benzinga reports. They currently have a $6....

ETF Daily News
Quantexa News
01/14
Nektar Therapeutics (NASDAQ:NKTR) Given Buy Rating at HC Wainwright

HC Wainwright reissued their buy rating on shares of Nektar Therapeutics (NASDAQ:NKTR – Free Report) in a research note released on Monday morning,Benzinga reports. The firm currently has a $6.50 pric...

Defense World
Quantexa News
01/14
Nektar Therapeutics (NASDAQ:NKTR) Receives Average Recommendation of "Moderate Buy" from Brokerages

Nektar Therapeutics (NASDAQ:NKTR - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the seven brokerages that are currently covering the company, MarketBeat.com rep...

MarketBeat.com
Yahoo Finance Community
01/14
Comment

Nktr investors are losers. Howard and his son who has left NKTR are the winners of NKTR. Sad....

None
Quantexa News
01/14
Nektar Therapeutics (NKTR)'s latest performance is not what we had anticipated

Nektar Therapeutics (NASDAQ: NKTR) on Monday, plunged -6.67% from the previous trading day, before settling in for the closing price of $1.03. Within the past 52 weeks, NKTR's price has moved between...

Newsdaemon.com
Yahoo Finance Community
01/14
Comment

IWM UP > 1%, but this fraud down! NKTR towards $0.50 not $2.0. Imploding!...

None
Yahoo Finance Community
01/14
Comment

NKTR pumpers, keep buying the shares until they are worth 1 cent or 0 cents....

None
Quantexa News
01/15
Nektar Therapeutics' (NKTR) “Buy” Rating Reaffirmed at HC Wainwright

Nektar Therapeutics ( NASDAQ:NKTR – Get Free Report ‘s stock had its “buy” rating reissued by analysts at HC Wainwright in a research note issued on Monday, Benzinga reports. They presently have a $6....

American Banking News
Quantexa News
01/15
HC Wainwright Reiterates Buy Rating for Nektar Therapeutics (NASDAQ:NKTR)

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report)‘s stock had its “buy” rating reaffirmed by analysts at HC Wainwright in a research report issued to clients and investors on Monday,Benzinga reports...

Ticker Report
Yahoo Finance Community
01/15
Comment

"Deepening Response", "First in class", "Tremendous," "Working closely with the FDA," "It is working, but we will focus on oncology," blah blah blah...... all lies for stock options.........BK in 2026!...
Votes: 3 0

None
Yahoo Finance Community
01/15
Comment

WFC! Sell your 780 shares of NKTR to buy one share of WFC to recover your 99% loss in NKTR "investment" (aka fraud) in 100 years!...

None
Yahoo Finance Community
01/15
Comment

HC Wainwright & Co. reiterates BUY on Nektar with TP of 6.5 cents....

None
Quantexa News
01/16
HC Wainwright Reiterates Buy Rating for Nektar Therapeutics (NASDAQ:NKTR)

HC Wainwright reissued their buy rating on shares of Nektar Therapeutics (NASDAQ:NKTR – Free Report) in a research note issued to investors on Monday,Benzinga reports. They currently have a $6.50 pric...

Daily Political
Quantexa News
01/17
Analysts Set Nektar Therapeutics (NASDAQ:NKTR) Price Target at $4.08

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the seven research firms that are covering the stock, Marketbeat.com reports. Two res...

Defense World
Yahoo Finance Community
01/17
Comment

NKTR has cure-all technologies, which are, of course, great technologies up to phase 2. Bankruptcy in 2026 following disastrous REZPEG!...

None
Yahoo Finance Community
01/17
Comment

"Deepening Response", "First in class", "Tremendous," "Working closely with the FDA," "It is working, but we will focus on oncology," "We use AI to expedite drug discovery," blah blah blah...... endless shameless lies for greed (stock options).........BK in 2026!...
Votes: 3 0

None
Quantexa News
01/18
Barclays PLC Purchases 175,596 Shares of Nektar Therapeutics (NASDAQ:NKTR)

Barclays PLC raised its stake in Nektar Therapeutics (NASDAQ:NKTR – Free Report) by 96.1% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission...

Defense World
Quantexa News
01/19
Nektar Therapeutics (NASDAQ:NKTR) Given Average Rating of “Moderate Buy” by Analysts

Shares of Nektar Therapeutics ( NASDAQ:NKTR – Get Free Report ) have been given a consensus rating of “Moderate Buy” by the seven brokerages that are covering the stock, MarketBeat Ratings reports. Tw...

American Banking News
Quantexa News
01/21
Nektar Therapeutics (NASDAQ: NKTR) Stock Could Reward Investors With A Loss Of -2596.63%

In today's recent session, 0.49 million shares of the Nektar Therapeutics (NASDAQ:NKTR) have been traded, and its beta is 0.59. Most recently the company's share price was $0.89, and it changed around...

Marketingsentinel.com
Quantexa News
01/22
Analysts Are Bullish on These Healthcare Stocks: Monopar Therapeutics Inc (MNPR), Nektar Therapeutics (NKTR)

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Monopar Therapeutics Inc ( MNPR – Research Report ) and Nektar Therapeutics ( NKTR – Research Report ) wi...

Markets Businessinsider.com
Yahoo Finance Community
01/23
Comment

representing the sttopppid and delusiiionall mauroon brigade, i'm proud to say we continue to buy more at these levels!!!!...

None
Yahoo Finance Community
01/23
Comment

"I am buying more of this worthless stock because it is cheaper" What a mau....ran! What a liar who claims to buy this stock with NO money!!!...

None
Yahoo Finance Community
01/23
Comment

Palantir (PLTR)! I bought @12.3!!!...

None
Yahoo Finance Community
01/24
Comment

NKTR is UP! Maybe the Chinese Health Authority has approved a phase 1 trial for NKTR-214 in China. Hahaha....CB (aka Fuzzybawl leaking Howard's bawls) at the time was really excited about the China trial....

None
Quantexa News
01/26
HB Wealth Management LLC Raises Holdings in Nektar Therapeutics (NASDAQ:NKTR)

HB Wealth Management LLC grew its stake in Nektar Therapeutics (NASDAQ:NKTR – Free Report) by 44.0% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 64,100 shares of t...

ETF Daily News
Yahoo Finance Community
01/27
Comment

5 Days Ago, RealKllownn said:"NVDA is soaring thanks to Stargate!"How's that working out?Certainly a ddummmmm and stoopppid maroon!!!...
Votes: 1 0

None
Yahoo Finance Community
01/28
Comment

NVDA!!!! I added back 14,500 shares at the bloodbath yesterday....
Votes: 1 1

None
Yahoo Finance Community
01/28
Comment

NKTR to ZERO in 2026!!! Finally the HR SCAM will be over!...
Votes: 1 1

None
Yahoo Finance Community
01/28
Comment

RealKllownn claims to have bought 14,500 yesterday...probably at the LOD $116.70! he's such a genius!not a sttttooooopiid and deluuusionnnall liar!...
Votes: 1 3

None
Yahoo Finance Community
01/28
Comment

HAHAHAHAHAHHAHA NVDA...
Votes: 1 3

None
Yahoo Finance Community
01/28
Comment

I haven’t read any $2 predictions lately from the 800 share owner/pumper cristoediatt. Failed prediction after failed prediction, just like HR....
Votes: 2 1

None
Yahoo Finance Community
01/28
Comment

CCL flying to the moon while NKTR is crashing to the earth........
Votes: 2 1

None
Yahoo Finance Community
01/28
Comment

If you’re long, get out, next stop 50 cents....
Votes: 2 1

None
Yahoo Finance Community
01/28
Comment

NKTR fraud/scam is ending soon........

None
Yahoo Finance Community
01/28
Comment

NVDA!!!! Recovering strong!!!! Unlike this scam!!!...
Votes: 2 1

None
Yahoo Finance Community
01/28
Comment

AMZN to a ALL TIME HIGH, >$240!!!!!! I told you "sell NKTR to buy AMZN" many years ago!...
Votes: 1 1

None
Yahoo Finance Community
01/28
Comment

A poor Steve who bought more of this scam stock shares! Dum.and.Dummer! Just like Klaus, Fuzzyball, "Howard!" guy!...
Votes: 2 1

None
Yahoo Finance Community
01/28
Comment

Wow! Looks like Lobo (who bought NKTR @ $20 and sold at $5) is back here cuddling his buddy RealKllownn. Such precious moments that one can only find on the internet!...

None
Yahoo Finance Community
01/28
Comment

NKTR DOWN 4% and NVDA UP 8.8%!!!!!The former to ZERO in 2026!The latter to $100 following 1 to 5 splits 3 to 5 years later!...

None
Quantexa News
01/29
An In-Depth Look At The Nektar Therapeutics (NKTR) Stock

Nektar Therapeutics (NASDAQ:NKTR) has a beta value of 0.59 and has seen 1.11 million shares traded in the last trading session. The company, currently valued at $154.94M, closed the last trade at $0.8...

Marketingsentinel.com
Yahoo Finance Community
01/29
Comment

Cristo Q, the bid is 70 cents, maybe you and your boyfriend should buy more of this trash pile....
Votes: 1 0

None
Quantexa News
01/30
Nektar Therapeutics (NKTR) Shares Down Despite Recent Market Volatility

Nektar Therapeutics (NASDAQ: NKTR)'s stock price has plunge by -0.35relation to previous closing price of 0.84. Nevertheless, the company has seen a -8.81% plunge in its stock price over the last five...

Newsheater.com
Yahoo Finance Community
01/30
Comment

50 cents is coming...........sad.........

None
Quantexa News
01/30
The 12-Month Price Target For Nektar Therapeutics (NASDAQ:NKTR) Is Now 24.

In last trading session, Nektar Therapeutics (NASDAQ:NKTR) saw 1.66 million shares changing hands with its beta currently measuring 0.58. Company's recent per share price level of $0.84 trading at $0....

Marketingsentinel.com
Yahoo Finance Community
01/30
Comment

CCL flying....... NKTR crashing........ They are great at putting fake drugs on clinical trials!!!...

None
Yahoo Finance Community
01/30
Comment

I used to own NKTR a few years ago and it caught my eye a few months ago when it went past a dollar. I lost track of it and yesterday saw it was under a dollar again. I visited their website and noted the pipeline had some phase two drugs in clinical trials and quite a few others in earlier phases. Here's my logic regarding why I invest in such stocks. Since it is very time consuming and making past clinical trials also very costly, a non performing biotech could be on the cusp of a successful product. A biotech could go from disappointment to failure and r/s to r/s disappointing investors. As long as they are working hard and necessary to raise funds causing dilution to existing shareholders with potential drugs, I am ok. Of course, they could also shut down with nothing for us shareholders. God willing, …...
Votes: 1 2

None
Yahoo Finance Community
01/31
Comment

Nktr 181 ‘mu’-opioid painkiller roundly and soundly rejected by the FDA a couple years ago. Vertex Pharm ‘non’-opioid painkiller approved by FDA overwhelmingly. Stock up 35 points...
Votes: 2 1

None
Yahoo Finance Community
01/31
Comment

VRTX!!!!...
Votes: 2 1

None
Yahoo Finance Community
01/31
Comment

Cristo Q, when will it hit $2.00 as you’ve been pumping? Sad that some might believe those pumps only to lose it all....
Votes: 2 0

None
Yahoo Finance Community
01/31
Comment

NVDA!!!! TRUMP!!! Jensen Huang!!!...
Votes: 2 1

None
Quantexa News
02/03
Zacks Research Issues Optimistic Forecast for NKTR Earnings

Get Nektar Therapeutics alerts: Nektar Therapeutics (NASDAQ:NKTR – Free Report) – Zacks Research raised their Q1 2025 earnings per share (EPS) estimates for Nektar Therapeutics in a note issued to in...

Defense World
Yahoo Finance News
02/03
Zacks Industry Outlook Highlights Corcept, Amneal, Dyne, Nektar and Cardiol

Zacks Industry Outlook Highlights Corcept, Amneal, Dyne, Nektar and Cardiol Zacks Equity Research Mon, Feb 3, 2025, 11:09 AM 10 min read In This Article: DYN -2.46% ^GSPC -0.76% NKTR -2.22% CORT -0.55...

Zacks
Yahoo Finance Community
02/03
Comment

Your NVDA trade seems to be working out exceptionally well kllownnn! my guess is Lobo bought at $140 but he'll soon be selling at $80...
Votes: 1 2

None
Yahoo Finance Community
02/03
Comment

PLTR!!!!!!!! Great Earnings! Up 20% in after hour!!!!...
Votes: 2 0

None
Yahoo Finance Community
02/03
Comment

Cristo Q, you said it would be 2 bucks by now? Maybe you should double your holdings and add 800 more shares at 80 cents,...
Votes: 2 0

None
Quantexa News
02/04
Q1 EPS Forecast for Nektar Therapeutics Increased by Analyst

Nektar Therapeutics ( NASDAQ:NKTR – Free Report ) – Zacks Research increased their Q1 2025 earnings per share estimates for shares of Nektar Therapeutics in a report issued on Wednesday, January 29th....

American Banking News
Quantexa News
02/04
Q1 EPS Forecast for Nektar Therapeutics Raised by Analyst

Nektar Therapeutics (NASDAQ:NKTR – Free Report) – Equities researchers at Zacks Research raised their Q1 2025 EPS estimates for shares of Nektar Therapeutics in a research report issued on Wednesday,...

Ticker Report
Yahoo Finance Community
02/04
Comment

PLTR and NVDA!!!!...
Votes: 1 1

None
Yahoo Finance Community
02/04
Comment

Only fools buy more shares of NKTR which has NO fundamentals, Exceptionally WORST track records, Tremendously Corrupt and Mendacious greedy CEO and incapable scientists. They lose more money.... SAD!...
Votes: 1 1

None
Quantexa News
02/05
Zacks Research Issues Optimistic Forecast for NKTR Earnings

Nektar Therapeutics ( NASDAQ:NKTR – Free Report ) – Zacks Research increased their Q1 2025 earnings per share (EPS) estimates for Nektar Therapeutics in a note issued to investors on Wednesday, Januar...

Transcript Daily
Quantexa News
02/05
Zacks Research Issues Optimistic Estimate for NKTR Earnings

Nektar Therapeutics ( NASDAQ:NKTR – Free Report ) – Investment analysts at Zacks Research boosted their Q1 2025 earnings per share (EPS) estimates for shares of Nektar Therapeutics in a research note...

Stock Observer
Quantexa News
02/05
Let's Jump Into The Nektar Therapeutics (NASDAQ: NKTR) Stock Forecast

In the last trading session, 1.6 million Nektar Therapeutics (NASDAQ:NKTR) shares changed hands as the company's beta touched 0.66. With the company's per share price at $0.78 changed hands at -$0.03...

Marketingsentinel.com
Yahoo Finance Community
02/05
Comment

NVDA!!!!...

None
Yahoo Finance Community
02/05
Comment

Mary is stepping down because she is sick and tired of XYZ........

None
Yahoo Finance Community
02/05
Comment

Only fools buy more shares of NKTR which has NO fundamentals, Exceptionally WORST track records, Tremendously Corrupt and Mendacious greedy CEO and incapable scientists. They burn more money.... SAD!...
Votes: 2 1

None
Yahoo Finance Community
02/05
Comment

Only fools like CB (aka Fuzzyball), Klaus, Gladpick, Steve etc. add more shares just because they are cheaper...... SAD!...

None
Yahoo Finance Community
02/05
Comment

Soaring RBLX is the polar opposite of crashing NKTR!!!...

None
Quantexa News
02/05
Investors finally get a glimpse of Nektar Therapeutics (NKTR) volume hitting the figure of 1.6 million.

On Tuesday, Nektar Therapeutics (NASDAQ: NKTR) opened lower -3.72% from the last session, before settling in for the closing price of $0.81. Price fluctuations for NKTR have ranged from $0.54 to $1.93...

Newsdaemon.com
Yahoo Finance Community
02/05
Comment

stock price is 76 cents, with $1.33/share in cash...O.K....

None
Quantexa News
02/06
Nektar Therapeutics Sees Unusually High Options Volume (NASDAQ:NKTR)

Nektar Therapeutics (NASDAQ:NKTR - Get Free Report) was the target of unusually large options trading on Wednesday. Investors bought 7,673 call options on the stock. This is an increase of 3,045% comp...

MarketBeat.com
Yahoo Finance Community
02/06
Comment

It seems to me that all smart people have left the crashing company......... BK!!!!...

None
Yahoo Finance Community
02/06
Comment

NVDA!!!!! You cannot possibly compare (fake company) NKTR with (the most prosperous company in the universe) NVDA! Only CB does that. Insanely dum and getting dummer....

None
Yahoo Finance Community
02/06
Comment

50 cents are coming........NOT 200 cents though an insanely dum CB claimed 200 cents time and again! BK in 2026!!!...

None
Quantexa News
02/07
Nektar Therapeutics Sees Unusually High Options Volume (NASDAQ:NKTR)

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) was the target of some unusual options trading on Wednesday. Investors purchased 7,673 call options on the company. This represents an increase of 3...

Ticker Report
Yahoo Finance Community
02/07
Comment

Wow, this stock is just flaming out. Incredible...

None
Yahoo Finance Community
02/07
Comment

Hopefully 50 cents this month so that a tremendously dum liar CB may buy several millions of this fraudulent company shares in her paper trading account...

None
Yahoo Finance Community
02/07
Comment

I hear all smart scientists have left this to be bankrupt company. No hope. My target price is 2 cents. That’s my two cents!...

None
Yahoo Finance News
02/07
Down -38.51% in 4 Weeks, Here's Why Nektar (NKTR) Looks Ripe for a Turnaround

Down -38.51% in 4 Weeks, Here's Why Nektar (NKTR) Looks Ripe for a Turnaround Zacks Equity Research Fri, Feb 7, 2025, 6:35 AM 2 min read In This Article: NKTR -3.57% Nektar Therapeutics (NKTR) has bee...

Zacks
Yahoo Finance Community
02/07
Comment

The shorts are in full and total control of this stock right now. Everyday its the same thing....

None
Yahoo Finance Community
02/07
Comment

Possible gap closure bounce at .6710 although the volume was not there, still bought some for a trade. OBV and RSI is very low. For those that are holding this stock in cash accounts, you may want to consider lending your stock to pickup additional revenue, your broker needs your permission for cash accounts (margin accounts allows your broker to lend your stock). If you are fundamental investor you shouldn't be concerned about daily trading activity (ie. short term trends)....

None
Yahoo Finance Community
02/09
Comment

Where’s Cristo Q? What no pumping the last several days? Someone should stop by his mommy’s basement and do a self health check on him or her or whatever it is. Pumpers only pump when it moves higher, when it drops they always disappear like Cristo did when he was posting under his prior CB id several years ago....
Votes: 2 1

None
Yahoo Finance Community
02/09
Comment

For those who might be new here:Lobo = an investor who was verrrry bullish, bought this at $20 only to sell several months later at $5. told everyone who was a bear that they were very dum. now that the stock is below $1, he somehow feels vindicated, despite having lost 75%!!!! Realllkllowwnn = used to work at NKTR and was fired. Probably because of the very strong mennnnntalll illlnesss that is constantly on display here...
Votes: 1 1

None
Yahoo Finance News
02/10
Nektar Therapeutics Receives Fast Track Designation for Rezpegaldesleukin for the Treatment of Moderate-to-Severe Atopic Dermatitis

Nektar Therapeutics Receives Fast Track Designation for Rezpegaldesleukin for the Treatment of Moderate-to-Severe Atopic Dermatitis PR Newswire Mon, Feb 10, 2025, 6:00 AM 8 min read In This Article: N...

PR Newswire
Quantexa News
02/10
Nektar Therapeutics Receives Fast Track Designation for Rezpegaldesleukin for the Treatment of Moderate-to-Severe Atopic Dermatitis

SAN FRANCISCO, Feb. 10, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for rezpegaldesleuki...

MarketScreener
Quantexa News
02/10
Nektar Therapeutics (NKTR) Receives Fast Track Designation for Rezpegaldesleukin

February 10, 2025 7:01 AM EST Nektar Therapeutics (Nasdaq: NKTR ) today announced that the U.S. Food and Drug Administration FDA ) has granted Fast Track designation for rezpegaldesleukin for the tre...

StreetInsider
Quantexa News
02/10
Nektar Therapeutics Receives Fast Track Designation for Rezpegaldesleukin for the Treatment of Moderate-to-Severe Atopic Dermatitis

Nektar Therapeutics Receives Fast Track Designation for Rezpegaldesleukin for the Treatment of Moderate-to-Severe Atopic Dermatitis PR Newswire SAN FRANCISCO, Feb. 10, 2025 SAN FRANCISCO, Feb. 10, 20...

Canada StockWatch
Quantexa News
02/10
Nektar Therapeutics Receives Fast Track Designation for Rezpegaldesleukin for the Treatment of Moderate-to-Severe Atopic Dermatitis

SAN FRANCISCO, Feb. 10, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for rezpegaldesleuki...

Associated Press News
Quantexa News
02/10
Nektar Therapeutics Receives Fast Track Designation for Rezpegaldesleukin for the Treatment of Moderate-to-Severe Atopic Dermatitis

SAN FRANCISCO, Feb. 10, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for rezpegaldesleuki...

Yahoo! Finance News
Quantexa News
02/10
Nektar receives FDA Fast Track Designation for rezpegaldesleukin

Nektar ( NKTR ) Therapeutics announced that the U.S. FDA has granted Fast Track designation for rezpegaldesleukin for the treatment of adult and pediatric patients 12 years of age and older with moder...

Markets Businessinsider.com
Quantexa News
02/10
Nektar Therapeutics Gets Fast Track Designation For Rezpegaldesleukin In Atopic Dermatitis; Stock Up

Nektar Therapeutics ( NKTR ) Monday said that the U.S. Food and Drug Administration or FDA has granted Fast Track designation for its drug candidate rezpegaldesleukin for the treatment of atopic derma...

RTT News
Yahoo Finance News
02/10
Nektar Says FDA Grants Fast-Track Designation to Atopic Dermatitis Treatment

PREMIUM Nektar Says FDA Grants Fast-Track Designation to Atopic Dermatitis Treatment MT Newswires Mon, Feb 10, 2025, 6:57 AM In This Article: NKTR +3.55% Nektar Therapeutics (NKTR) said Monday the US...

MT Newswires
Quantexa News
02/10
Nektar Says FDA Grants Fast-Track Designation to Atopic Dermatitis Treatment

Nektar Therapeutics is a clinical-stage biotechnology company. It is focused on developing treatments that address the underlying immunological dysfunction in autoimmune and chronic inflammatory disea...

MarketScreener
Quantexa News
02/10
NKTR (Nektar Therapeutics) dropped -3.57 at the last close: Is This Today's Most Popular Stock?

On Friday, Nektar Therapeutics (NASDAQ: NKTR) was -3.57% drop from the session before settling in for the closing price of $0.70. A 52-week range for NKTR has been $0.63 – $1.93. Here's Your FREE Rep...

Newsdaemon.com
Quantexa News
02/10
Nektar Therapeutics Receives Fast Track Designation for Rezpegaldesleukin for the Treatment of Moderate-to-Severe Atopic Dermatitis

SAN FRANCISCO, Feb. 10, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for rezpegaldesleuki...

BioSpace
Quantexa News
02/10
FDA grants rezpegaldesleukin fast track to treat moderate, severe atopic dermatitis

The investigational biologic targets the interleukin-2 receptor complex in the body in order to stimulate proliferation of inhibitory immune cells. Rezpegaldesleukin (Rezpeg; Nektar Therapeutics) has...

Contemporary Pediatrics
Quantexa News
02/10
Rezpegaldesleukin Receives Fast Track Designation for Moderate to Severe AD

Image credit: © Tada Images - stock.adobe.com Nektar Therapeutics recently announced that the FDA granted fast track designation to rezpegaldesleukin for the treatment of adult and pediatric patients...

Dermatology Times
Quantexa News
02/11
Nektar Therapeutics (NKTR) Stock: Tracking the Weekly Performance

The stock of Nektar Therapeutics (NKTR) has seen a -13.33% decrease in the past week, with a -38.50% drop in the past month, and a -49.56% decrease in the past quarter. The volatility ratio for the we...

Newsheater.com
Quantexa News
02/11
Brokerages Set Nektar Therapeutics (NASDAQ:NKTR) Price Target at $4.08

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) has received an average recommendation of “Moderate Buy” from the seven analysts that are currently covering the company, Marketbeat reports. Two eq...

Defense World
Quantexa News
02/11
Analysts Set Nektar Therapeutics (NASDAQ:NKTR) Price Target at $4.08

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) has been assigned an average rating of “Moderate Buy” from the seven brokerages that are currently covering the company, Marketbeat reports. Two inv...

ETF Daily News
Quantexa News
02/11
US FDA grants fast track designation to Nektar Therapeutics’ rezpegaldesleukin to treat moderate-to-severe atopic dermatitis

Nektar Therapeutics, a clinical-stage biotechnology company, announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for rezpegaldesleukin for the treatment of adul...

Pharmabiz.com (India)
Quantexa News
02/11
FDA Grants Rezpegaldesleukin Fast Track Designation for Treatment of Children, Adults With Atopic Dermatitis

Rezpegaldesleukin (Rezpeg; Nektar Therapeutics) has received fast track designation from the FDA for the treatment of adult and pediatric patients 12 years and older with moderate-to-severe atopic der...

Pharmacy Times
Yahoo Finance Community
02/11
Comment

Don't try to catch a falling knife! This company is doomed to close down....
Votes: 1 1

None
Yahoo Finance Community
02/12
Comment

Chase seems a little sore this morning. Is it because his $2 dream has crashed to 60 cents, or maybe because Cristo Q and him changed it up last night with Cristo Q becoming the pitcher and Chase the catcher?...
Votes: 2 2

None
Yahoo Finance Community
02/12
Comment

I am buying 100,000 shares @0.5 to sell them @0.55 for QUICK 10% profits. NKTR is GOOD for day trading. hahahaha.........
Votes: 1 1

None
Reddit
02/12
My penny stock portfolio :)

Hey everyone, Wanted to share my current penny stock holdings - partly to get some insights, but also to discuss thoughts and maybe find others riding the same wave. Today’s red day makes for some gr...

r/pennystocks
Reddit
02/12
My penny stock portfolio :)

Hey everyone, Wanted to share my current penny stock holdings - partly to get some insights, but also to discuss thoughts and maybe find others riding the same wave. Today’s red day makes for some gr...

r/pennystocks
Yahoo Finance Community
02/12
Comment

Chase is crushing lobo and the kllowwnn today. It's great to see...
Votes: 2 1

None
Yahoo Finance Community
02/12
Comment

HOOD!...

None
Yahoo Finance Community
02/12
Comment

Chase talking about undoing belts and using his hand, or getting on his knees to do the dirty, or checking his buddy’s pubies for lunch. Maybe that’s another id for Cristo, both post the same dirt....

None
Yahoo Finance Community
02/13
Comment

IT'S ALIVE ! Stand back...give it some air !...
Votes: 4 1

None
Yahoo Finance Community
02/13
Comment

the silence of the lambs...
Votes: 1 1

None
Yahoo Finance Community
02/13
Comment

loboner is a sad panda...
Votes: 1 1

None
Yahoo Finance Community
02/13
Comment

Decent volume....Hmmm......isleepwell......

None
Yahoo Finance Community
02/13
Comment

load up IRD $1 - has two phase 3 readouts in Q1 and Q2 =500%++ opp.....
Votes: 1 3

None
Yahoo Finance Community
02/13
Comment

Great time to dump this fake stock! Eventually BK!...

None
Yahoo Finance Community
02/13
Comment

I bought a bunch more at .66 cents. Wish I had gotten more though....
Votes: 1 1

None
Yahoo Finance Community
02/13
Comment

Definitely at this price and with the recent announcement NKTR is worth a small investment. A kicker to this is maybe this will spur on LLY to make an offer to settle their prior collaboration differences. Could double or more in price at anytime in the future or the downside is a full loss at .90 which after a tax loss harvest is .68....
Votes: 2 0

None
Yahoo Finance Community
02/13
Comment

A Topic Dermatitis...
Votes: 1 0

None
Yahoo Finance Community
02/14
Comment

$1.50 today???...isleepwell......
Votes: 1 0

None
Yahoo Finance Community
02/14
Comment

Going to give it a run!!!...isleepwell.......
Votes: 1 0

None
Yahoo Finance Community
02/14
Comment

hobo how we doin today pal...
Votes: 1 0

None
Yahoo Finance Community
02/14
Comment

Left side is ready...how is it on the right????...isleepwell......
Votes: 1 0

None
Yahoo Finance Community
02/14
Comment

Right side is ready.......isleepwell......
Votes: 1 0

None
Yahoo Finance Community
02/14
Comment

We are a Go!!!...isleepwell......
Votes: 1 0

None
Yahoo Finance Community
02/14
Comment

First squad...on this count...engage this target...Tower...on this Julian Day: Authenticate Sierra, Sierra......isleepwell......
Votes: 1 0

None
Yahoo Finance Community
02/14
Comment

This range is Wet!!!I say again...this range is Wet!!!...isleepwell......
Votes: 1 0

None
Yahoo Finance Community
02/14
Comment

First Squad...Engage ......isleepwell......
Votes: 1 0

None
Yahoo Finance Community
02/14
Comment

schlomo how we doin today pal?...

None
Yahoo Finance Community
02/14
Comment

Outstanding First Squad...now...step away from the firing line... Second Squad...advance to the firing line......isleepwell......

None
Yahoo Finance Community
02/14
Comment

Second Squad...Fire...Fire for Effect........isleepwell......

None
Yahoo Finance Community
02/14
Comment

Bravo 62 Report to the Commander....Second Squad...Well done!!!Move away from the firing line......isleepwell......

None
Yahoo Finance Community
02/14
Comment

Tower...this Range...is now Dry!!! ...isleepwell......

None
Yahoo Finance Community
02/14
Comment

In her hair...SheWore a yellow ribbon...She woreit for her soldier Who was FarFar...Away!!!And,if you asked herwhy she wore it...She Wore it for Her soldier...Who was Far...Far...Far...Away!!!Far Away...Far Away...She Wore it for Her Soldier...Who was Far...Far...Away......isleepwell......

None
Yahoo Finance Community
02/14
Comment

Yo...left...Yo...left...Yo...Left..Right......isleepwell......

None
Yahoo Finance Community
02/14
Comment

We are...Bravo Company...And..We're gonna...Lead the Way!!Lead the Way!!!Lead the Way!!! ...isleepwell......

None
Yahoo Finance Community
02/14
Comment

Bravo, Echo...Encore......isleepwell......

None
Yahoo Finance Community
02/14
Comment

Let it Blow...Let it Blow...Let the four Winds Blow...From the East to the West...Moon Puzzle...You're the Best......isleepwell......

None
Yahoo Finance Community
02/14
Comment

a little late trying to buy in today at .90, maybe next week I'll try again if it comes back down. Its a reasonable gamble and with this company thats exactly what it is ......gambling....
Votes: 1 0

None
Quantexa News
02/14
Nektar's Jonathan Zalevsky, PhD, Dives Into Rezpegaldesleukin Fast Track Designation for Atopic Dermatitis

Nektar Therapeutics recently announced that the FDA granted Fast Track designation to its investigational drug rezpegaldesleukin (Rezpeg) for the treatment of atopic dermatitis (AD).1 Read more from...

Dermatology Times
Quantexa News
02/15
Nektar Therapeutics (NASDAQ:NKTR) Short Interest Up 22.0% in January

Nektar Therapeutics ( NASDAQ:NKTR – Get Free Report ) was the target of a significant growth in short interest in January. As of January 31st, there was short interest totalling 5,760,000 shares, a gr...

PressOracle
Yahoo Finance Community
02/15
Comment

klllowwwnnn? loboner? where you guys at?...

None
Quantexa News
02/15
Why Nektar Therapeutics's (NKTR) Stock Is Up 10.18%

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Nektar Therapeutics before investing. In this article, we go over a few key elem...

The American Association of Individual Investors
Quantexa News
02/15
Nektar Therapeutics Receives Fast Track Designation for Rezpegaldesleukin for the Treatment of Moderate-to-Severe Atopic Dermatitis

SAN FRANCISCO, Feb. 10, 2025 /PRNewswire/ -- Nektar Therapeutics NKTR today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for rezpegaldesleukin for the...

Benzinga
Quantexa News
02/16
Nektar Therapeutics (NASDAQ:NKTR) Short Interest Up 22.0% in January

Nektar Therapeutics (NASDAQ:NKTR - Get Free Report) was the target of a significant growth in short interest in January. As of January 31st, there was short interest totalling 5,760,000 shares, a grow...

MarketBeat.com
Quantexa News
02/17
B.Riley Financial Sticks to Their Buy Rating for Nektar Therapeutics (NKTR)

B.Riley Financial analyst Mayank Mamtani reiterated a Buy rating on Nektar Therapeutics ( NKTR – Research Report ) on February 14 and set a price target of $4.00. The company's shares closed last Frid...

Markets Businessinsider.com
Quantexa News
02/17
Rezpegaldesleukin gets FDA fast track designation for atopic dermatitis

The FDA has granted a fast track designation to rezpegaldesleukin for treating patients aged 12 years and older with moderate to severe atopic dermatitis that topical therapies have not adequately con...

Cardiology Today
Yahoo Finance Community
02/18
Comment

Before anyone buys into this 'Fake' Stock, Look at it's history of trying to release drugs.It's brutal. Do not touch with a barge pole unless you like losing money.Shorties out there probably love this pile of junk....
Votes: 1 2

None
Reddit
02/18
NEKTAR Therapeutics. High risk / High reward

# 1. Introduction & Company Overview Nektar Therapeutics is a research-driven biopharmaceutical company whose core competency lies in polymer conjugate chemistry. By modifying the pharmacological...

r/pennystocks
Reddit
02/18
NEKTAR Therapeutics. High risk / High reward

# 1. Introduction & Company Overview Nektar Therapeutics is a research-driven biopharmaceutical company whose core competency lies in polymer conjugate chemistry. By modifying the pharmacological...

r/pennystocks
Yahoo Finance Community
02/19
Comment

Any insider buys at these levels? Hmmmmmmmm……...

None
Quantexa News
02/20
Here are the top Institutional holders of Nektar Therapeutics (NKTR) shares

Nektar Therapeutics (NASDAQ: NKTR) is 7.53% higher on its value in year-to-date trading and has touched a low of $0.63 and a high of $1.93 in the current 52-week trading range. The question becomes, w...

Newsrts.com
Quantexa News
02/21
Analysts Say That Nektar Therapeutics (NASDAQ:NKTR) Is Likely To Make It To 24 In 12 Months

In last trading session, Nektar Therapeutics (NASDAQ:NKTR) saw 1.65 million shares changing hands with its beta currently measuring 0.67. Company's recent per share price level of $0.96 trading at -$0...

Marketingsentinel.com
Yahoo Finance Community
02/21
Comment

2025 Business plan...
Votes: 1 0

None
Quantexa News
02/21
Nektar Therapeutics (NASDAQ:NKTR) Insider Jonathan Zalevsky Sells 10,300 Shares

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) insider Jonathan Zalevsky sold 10,300 shares of the business’s stock in a transaction that occurred on Wednesday, February 19th. The shares were sol...

Ticker Report
Quantexa News
02/21
Nektar Therapeutics (NASDAQ:NKTR) Insider Jonathan Zalevsky Sells 10,300 Shares

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) insider Jonathan Zalevsky sold 10,300 shares of the firm’s stock in a transaction dated Wednesday, February 19th. The stock was sold at an average p...

Daily Political
Quantexa News
02/22
Nektar Therapeutics (NASDAQ:NKTR) CEO Howard W. Robin Sells 23,774 Shares

Nektar Therapeutics ( NASDAQ:NKTR – Get Free Report ) CEO Howard W. Robin sold 23,774 shares of the company's stock in a transaction on Wednesday, February 19th. The shares were sold at an average pri...

Stock Observer
Quantexa News
02/22
Nektar Therapeutics (NASDAQ:NKTR) CEO Howard W. Robin Sells 23,774 Shares

Nektar Therapeutics ( – ) CEO Howard W. Robin sold 23,774 shares of the firm's stock in a transaction that occurred on Wednesday, February 19th. The stock was sold at an average price of $1.01, for a...

The Markets Daily
Quantexa News
02/22
Nektar Therapeutics (NASDAQ:NKTR) Insider Jonathan Zalevsky Sells 10,300 Shares of Stock

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) insider Jonathan Zalevsky sold 10,300 shares of Nektar Therapeutics stock in a transaction that occurred on Wednesday, February 19th. The stock was...

Modern Readers
Quantexa News
02/22
Nektar Therapeutics (NASDAQ:NKTR) Insider Jonathan Zalevsky Sells 10,300 Shares

Nektar Therapeutics ( NASDAQ:NKTR – Get Free Report ) insider Jonathan Zalevsky sold 10,300 shares of the stock in a transaction that occurred on Wednesday, February 19th. The shares were sold at an a...

PressOracle
Quantexa News
02/22
Nektar Therapeutics (NASDAQ:NKTR) Insider Jonathan Zalevsky Sells 10,300 Shares

Nektar Therapeutics (NASDAQ:NKTR - Get Free Report) insider Jonathan Zalevsky sold 10,300 shares of the firm's stock in a transaction dated Wednesday, February 19th. The stock was sold at an average p...

MarketBeat.com
Quantexa News
02/24
Insider Selling: Nektar Therapeutics (NASDAQ:NKTR) CEO Sells $24,011.74 in Stock

Nektar Therapeutics ( NASDAQ:NKTR – Get Free Report ) CEO Howard W. Robin sold 23,774 shares of the company's stock in a transaction dated Wednesday, February 19th. The stock was sold at an average pr...

Baseball News Source
Quantexa News
02/24
Howard W. Robin Sells 23,774 Shares of Nektar Therapeutics (NASDAQ:NKTR) Stock

Nektar Therapeutics ( NASDAQ:NKTR – Get Free Report ) CEO Howard W. Robin sold 23,774 shares of the company's stock in a transaction on Wednesday, February 19th. The stock was sold at an average price...

Community Financial News
Quantexa News
02/24
Insider Selling: Nektar Therapeutics (NASDAQ:NKTR) Insider Sells 10,300 Shares of Stock

Nektar Therapeutics ( NASDAQ:NKTR – Get Free Report ) insider Jonathan Zalevsky sold 10,300 shares of the business's stock in a transaction dated Wednesday, February 19th. The shares were sold at an a...

Watchlistnews.com
Quantexa News
02/24
Nektar Therapeutics (NKTR) to Release Earnings on Monday

NASDAQ:NKTR – Get Free Report ) is expected to be releasing its earnings data before the market opens on Monday, March 3rd. Analysts expect Nektar Therapeutics to post earnings of ($0.18) per share an...

The Cerbat Gem
Quantexa News
02/24
Nektar Therapeutics (NKTR) to Release Earnings on Monday

Nektar Therapeutics ( NASDAQ:NKTR – Get Free Report ) will likely be releasing its earnings data before the market opens on Monday, March 3rd. Analysts expect Nektar Therapeutics to post earnings of (...

Watchlistnews.com
Quantexa News
02/24
Nektar Announces Clinical Trial Agreement to Evaluate Rezpegaldesleukin in Patients with New Onset Type 1 Diabetes Mellitus

News provided by -- TrialNet to conduct the Phase 2 randomized, placebo-controlled clinical study -- SAN FRANCISCO and NEW YORK Feb. 24, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR ) and...

PR Newswire
Quantexa News
02/24
Nektar Announces Clinical Trial Agreement to Evaluate Rezpegaldesleukin in

-- TrialNet to conduct the Phase 2 randomized, placebo-controlled clinical study -- SAN FRANCISCO and NEW YORK Feb. 24, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: ) and TrialNet, an internatio...

sogotradedev.websol.barchart.com
Quantexa News
02/24
Nektar Announces Clinical Trial Agreement to Evaluate Rezpegaldesleukin in Patients with New Onset Type 1 Diabetes Mellitus

February 24, 2025 at 07:01 am EST -- TrialNet to conduct the Phase 2 randomized, placebo-controlled clinical study -- SAN FRANCISCO and NEW YORK Feb. 24, 2025 /PRNewswire/ -- Nektar Therapeutics (Na...

MarketScreener
Quantexa News
02/24
Nektar Announces Clinical Trial Agreement to Evaluate Rezpegaldesleukin in Patients with New Onset Type 1 Diabetes Mellitus -- TrialNet to conduct the Phase 2 randomized, placebo-controlled clinical study -- SAN FRANCISCO and NEW YORK, Feb. 24, 2025 /PRNe

-- TrialNet to conduct the Phase 2 randomized, placebo-controlled clinical study -- SAN FRANCISCO and NEW YORK, Feb. 24, 2025 /PRNewswire/ -- Nektar Therapeutics NKTR and TrialNet, an international c...

Benzinga
Quantexa News
02/24
Nektar announces clinical trial agreement to evaluate Rezpegaldesleukin Nektar (NKTR) Therapeutics announced a new collaboration agreement to evaluate Nektar’s rezpegaldesleukin in patients with new onset stage...

Nektar (NKTR) Therapeutics announced a new collaboration agreement to evaluate Nektar’s rezpegaldesleukin in patients with new onset stage 3 type 1 diabetes mellitus. Rezpegaldesleukin is a novel agon...

Tipranks
Quantexa News
02/24
Nektar Therapeutics' Promising Trial for Type 1 Diabetes Treatment

Nektar Therapeutics Collaborates on a New Clinical Trial Nektar Therapeutics has taken a significant step forward in diabetes research with an exciting collaboration agreement with TrialNet. This par...

Investors Hangout
Quantexa News
02/24
Nektar Announces Clinical Trial Agreement to Evaluate Rezpegaldesleukin in Patients with New Onset Type 1 Diabetes Mellitus PR Newswire Today at 1:00pm GMT+1

PR Newswire SAN FRANCISCO and NEW YORK, Feb. 24, 2025 -- TrialNet to conduct the Phase 2 randomized, placebo-controlled clinical study -- SAN FRANCISCO and NEW YORK Feb. 24, 2025 /PRNewswire/ -- Ne...

Greenville Business Magazine
Quantexa News
02/24
Nektar Announces Clinical Trial Agreement to Evaluate Rezpegaldesleukin in Patients with New Onset Type 1 Diabetes Mellitus

-- TrialNet to conduct the Phase 2 randomized, placebo-controlled clinical study -- SAN FRANCISCO and NEW YORK, Feb. 24, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) and TrialNet, an inter...

Associated Press News
Quantexa News
02/24
Nektar Announces Clinical Trial Agreement to Evaluate Rezpegaldesleukin in Patients with New Onset Type 1 Diabetes Mellitus

SAN FRANCISCO and NEW YORK Feb. 24, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) and TrialNet, an international clinical trial network at the forefront of diabetes research, today announced...

finanzen.net
Quantexa News
02/24
Nektar Therapeutics Engages in Innovative Diabetes Trial

Collaboration Between Nektar Therapeutics and TrialNet Nektar Therapeutics NKTR and TrialNet have teamed up to initiate a groundbreaking Phase 2 clinical trial. This study aims to investigate the eff...

Investors Hangout
Quantexa News
02/24
Nektar Announces Clinical Trial Agreement to Evaluate Rezpegaldesleukin in Patients with New Onset Type 1 Diabetes Mellitus

-- TrialNet to conduct the Phase 2 randomized, placebo-controlled clinical study -- SAN FRANCISCO and NEW YORK, Feb. 24, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) and TrialNet, an inter...

Yahoo! Finance News
Quantexa News
02/24
Nektar announces clinical trial agreement to evaluate Rezpegaldesleukin

Nektar ( NKTR ) Therapeutics announced a new collaboration agreement to evaluate Nektar's rezpegaldesleukin in patients with new onset stage 3 type 1 diabetes mellitus. Rezpegaldesleukin is a novel ag...

Markets Businessinsider.com
Quantexa News
02/24
Nektar Announces Clinical Trial Agreement to Evaluate Rezpegaldesleukin in Patients with New Onset Type 1 Diabetes Mellitus

Nektar Therapeutics and TrialNet announced a new collaboration agreement to evaluate Nektar's rezpegaldesleukin in patients with new onset stage 3 type 1 diabetes mellitus (T1D). Rezpegaldesleukin is...

MarketScreener
Quantexa News
02/24
Nektar Announces Clinical Trial Agreement To Evaluate Rezpegaldesleukin

Nektar Therapeutics is a clinical-stage biotechnology company. It is focused on developing treatments that address the underlying immunological dysfunction in autoimmune and chronic inflammatory disea...

MarketScreener
Quantexa News
02/24
Nektar Announces Clinical Trial Agreement To Evaluate Rezpegaldesleukin In Patients With New Onset Type 1 Diabetes Mellitus

-- TrialNet to conduct the Phase 2 randomized, placebo-controlled clinical study -- SAN FRANCISCO and NEW YORK, Feb. 24, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR ) and TrialNet, an inte...

MENAFN
Quantexa News
02/24
Piper Sandler Reiterates Overweight Rating on Nektar Therapeutics (NKTR)

February 24, 2025 11:29 PM EST Piper Sandler analyst Yasmeen Rahimi reiterated an Overweight rating and $7.00 price target on Nektar Therapeutics (NASDAQ: NKTR)The analyst comments ... This is a pre...

StreetInsider
Quantexa News
02/25
Nektar Therapeutics (NKTR) Announces Clinical Trial Agreement to Evaluate Rezpegaldesleukin in Patients with New Onset Type 1 Diabetes Mellitus

TrialNet to conduct the Phase 2 randomized, placebo-controlled clinical study -- SAN FRANCISCO and NEW YORK Feb. 24, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR ) and TrialNet, an internat...

StreetInsider
Quantexa News
02/25
Nektar Therapeutics Advances Diabetes Research with New Clinical Trial Agreement for Rezpegaldesleukin

San Francisco, CA – Nektar Therapeutics (Nasdaq: NKTR) announced on February 24, 2025, that it has entered into a clinical trial agreement with TrialNet, an international clinical trial network known...

Community Financial News
Quantexa News
02/25
H.C. Wainwright Reiterates Buy Rating on Nektar Therapeutics (NKTR)

February 25, 2025 6:52 AM EST H.C. Wainwright analyst Arthur He reiterated a Buy rating and $6.50 price target on Nektar Therapeutics (NASDAQ: NKTR).The analyst commented ... This is a premium only...

StreetInsider
Quantexa News
02/25
Nektar announces clinical trial agreement to evaluate rezpegaldesleukin in patients with new onset type 1 diabetes mellitus

Nektar Therapeutics and TrialNet, an international clinical trial network at the forefront of diabetes research, announced a new collaboration agreement to evaluate Nektar's rezpegaldesleukin in patie...

Pharmabiz.com (India)
Quantexa News
02/25
Nektar Therapeutics (NASDAQ:NKTR) Given "Buy" Rating at HC Wainwright

Nektar Therapeutics (NASDAQ:NKTR - Get Free Report)'s stock had its "buy" rating reaffirmed by stock analysts at HC Wainwright in a research note issued on Tuesday,Benzinga reports. They currently hav...

MarketBeat.com
Quantexa News
02/25
Analysts Have Conflicting Sentiments on These Healthcare Companies: Fresenius Medical Care (FMS), Herbalife (HLF) and Nektar Therapeutics (NKTR)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Fresenius Medical Care ( FMS – Research Report ), Herbalife ( HLF – Research Report ) and Nektar Therapeutics ( NKTR –...

Markets Businessinsider.com
Quantexa News
02/25
William Blair Reaffirms Their Hold Rating on Nektar Therapeutics (NKTR)

In a report released today, Andy Hsieh from William Blair maintained a Hold rating on Nektar Therapeutics ( NKTR – Research Report ). The company's shares closed yesterday at $0.85. Discover the Best...

Markets Businessinsider.com
Quantexa News
02/25
William Blair Reaffirms "Market Perform" Rating for Nektar Therapeutics (NASDAQ:NKTR)

Nektar Therapeutics (NASDAQ:NKTR - Get Free Report)'s stock had its "market perform" rating reiterated by equities researchers at William Blair in a research note issued on Tuesday,RTT News reports....

MarketBeat.com
Quantexa News
02/26
Nektar Therapeutics (NASDAQ:NKTR) Given “Buy” Rating at HC Wainwright

HC Wainwright restated their buy rating on shares of Nektar Therapeutics ( NASDAQ:NKTR – Free Report in a report issued on Tuesday morning, Benzinga reports. HC Wainwright currently has a $6.50 target...

American Banking News
Quantexa News
02/26
Nektar Therapeutics’ (NKTR) “Market Perform” Rating Reaffirmed at William Blair

William Blair reiterated their market perform rating on shares of Nektar Therapeutics (NASDAQ:NKTR – Free Report) in a report issued on Tuesday,RTT News reports. Other research analysts have also iss...

ETF Daily News
Quantexa News
02/26
Nektar Therapeutics Announces Completion of Target Enrollment in REZOLVE-AA Phase 2b Clinical Trial of Rezpegaldesleukin in Patients with Severe-to-Very Severe Alopecia Areata

News provided by SAN FRANCISCO Feb. 26, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR ) today announced the company has completed target enrollment in its REZOLVE-AA Phase 2b study of rezpeg...

PR Newswire
Quantexa News
02/26
NEKTAR THERAPEUTICS Nektar Therapeutics Announces Completion of Target Enrollment in REZOLVE-AA Phase 2b Clinical Trial of Rezpegaldesleukin in Patients with Severe-to-Very Severe Alopecia Areata

February 26, 2025 at 07:01 am EST SAN FRANCISCO Feb. 26, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced the company has completed target enrollment in its REZOLVE-AA Phase 2b...

MarketScreener
Quantexa News
02/26
Nektar Therapeutics Announces Completion of Target Enrollment in REZOLVE-AA Phase 2b Clinical Trial of Rezpegaldesleukin in Patients with Severe-to-Very Severe Alopecia Areata

SAN FRANCISCO Feb. 26, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced the company has completed target enrollment in its REZOLVE-AA Phase 2b study of rezpegaldesleukin in pati...

Stockhouse Newswire
Quantexa News
02/26
Nektar Therapeutics Nektar Therapeutics Announces Completion of Target Enrollment in REZOLVE-AA Phase 2b Clinical Trial of Rezpegaldesleukin in Patients with Severe-to-Very Severe Alopecia Areata (PR Newswire)

Nektar Therapeutics Announces Completion of Target Enrollment in REZOLVE-AA Phase 2b Clinical Trial of Rezpegaldesleukin in Patients with Severe-to-Very Severe Alopecia Areata PR Newswire SAN FRANC...

Avanza
Quantexa News
02/26
Nektar Therapeutics Receives Fast Track Designation for Rezpegaldesleukin for the Treatment of Moderate-to-Severe Atopic Dermatitis

SAN FRANCISCO Feb. 10, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for rezpegaldesleukin...

Latin Business Today
Quantexa News
02/26
Nektar Therapeutics Announces Completion of Target Enrollment in REZOLVE-AA Phase 2b Clinical Trial of Rezpegaldesleukin in Patients with Severe-to-Very Severe Alopecia Areata

Rezpegaldesleukin is an investigational biologic therapy that targets the interleukin-2 receptor complex in the body in order to stimulate proliferation of inhibitory immune cells known as regulatory...

finanzen.net
Quantexa News
02/26
Nektar Therapeutics Announces Completion of Target Enrollment in REZOLVE-AA Phase 2b Clinical Trial of Rezpegaldesleukin in Patients with Severe-to-Very Severe Alopecia Areata

SAN FRANCISCO Feb. 26, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced the company has completed target enrollment in its REZOLVE-AA Phase 2b study of rezpegaldesleukin in pati...

Yahoo! Finance News
Quantexa News
02/26
Nektar Therapeutics Announces Completion of Target Enrollment in REZOLVE-AA Phase 2b Clinical Trial of Rezpegaldesleukin in Patients with Severe-to-Very Severe Alopecia Areata

SAN FRANCISCO, Feb. 26, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced the company has completed target enrollment in its REZOLVE-AA Phase 2b study of rezpegaldesleukin in pat...

Associated Press News
Quantexa News
02/26
Nektar Therapeutics (NKTR) Announces Completion of Target Enrollment in REZOLVE-AA Phase 2b Clinical Trial of Rezpegaldesleukin

Nektar Therapeutics (Nasdaq: NKTR ) today announced the company has completed target enrollment in its REZOLVE-AA Phase 2b study of rezpegaldesleukin in patients with severe-to-very-severe alopecia ar...

StreetInsider
Quantexa News
02/26
Nektar Therapeutics Announces Completion of Target Enrollment in REZOLVE-AA Phase 2b Clinical Trial of Rezpegaldesleukin in Patients with Severe-to-Very Severe Alopecia Areata

Nektar Therapeutics Announces Completion of Target Enrollment in REZOLVE-AA Phase 2b Clinical Trial of Rezpegaldesleukin in Patients with Severe-to-Very Severe Alopecia Areata SAN FRANCISCO Feb. 26,...

Crwe World
Quantexa News
02/26
Nektar completes enrollment in REZOLVE-AA Phase 2b trial of rezpegaldesleukin

Nektar ( NKTR ) Therapeutics announced the company has completed target enrollment in its REZOLVE-AA Phase 2b study of rezpegaldesleukin in patients with severe-to-very-severe alopecia areata. Rezpega...

Markets Businessinsider.com
Quantexa News
02/26
Nektar completes enrollment in REZOLVE-AA Phase 2b trial of rezpegaldesleukin Nektar (NKTR) Therapeutics announced the company has completed target enrollment in its REZOLVE-AA Phase 2b study of rezpegaldesleukin...

Nektar (NKTR) Therapeutics announced the company has completed target enrollment in its REZOLVE-AA Phase 2b study of rezpegaldesleukin in patients with severe-to-very-severe alopecia areata. Rezpegald...

Tipranks
Quantexa News
02/26
Nektar Therapeutics Announces Completion of Target Enrollment in REZOLVE-AA Phase 2b Clinical Trial of Rezpegaldesleukin in Patients with Severe-to-Very Severe Alopecia Areata SAN FRANCISCO, Feb. 26, 2025 /PRNewswire/ -- Nektar Therapeutics (NASDAQ:NKTR)

SAN FRANCISCO, Feb. 26, 2025 /PRNewswire/ -- Nektar Therapeutics NKTR today announced the company has completed target enrollment in its REZOLVE-AA Phase 2b study of rezpegaldesleukin in patients with...

Benzinga
Quantexa News
02/26
Nektar Therapeutics Announces Completion of Target Enrollment in REZOLVE-AA Phase 2b Clinical Trial of Rezpegaldesleukin in Patients with Severe-to-Very Severe Alopecia Areata

Nektar Therapeutics Announces Completion of Target Enrollment in REZOLVE-AA Phase 2 b Clinical Trial of Rezpegaldesleukin in Patients with Severe-to-Very...

Morningstar
Quantexa News
02/27
Nektar Therapeutics (NASDAQ:NKTR) Earns Market Perform Rating from William Blair

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report)‘s stock had its “market perform” rating reissued by equities research analysts at William Blair in a research note issued to investors on Tuesday,RT...

Defense World
Quantexa News
02/27
Nektar Therapeutics' (NKTR) “Buy” Rating Reiterated at HC Wainwright

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at HC Wainwright in a research note issued on Tuesday,Benzinga reports. They present...

Ticker Report
Yahoo Finance News
02/27
Nektar completes enrolment in trial of rezpegaldesleukin for alopecia areata

Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Nektar completes enrolment in trial of rezpegaldesleukin for alopecia areata The trial enrolled subjects who had not...

Clinical Trials Arena
Quantexa News
02/28
Nektar Therapeutics' (NKTR) “Market Perform” Rating Reiterated at William Blair

William Blair reaffirmed their market perform rating on shares of Nektar Therapeutics ( NASDAQ:NKTR – Free Report in a research report report published on Tuesday, RTT News reports. Several other equ...

Baseball News Source
Quantexa News
02/28
Nektar Therapeutics' (NKTR) Buy Rating Reiterated at HC Wainwright

HC Wainwright restated their buy rating on shares of Nektar Therapeutics ( NASDAQ:NKTR – Free Report in a research note issued to investors on Tuesday morning, Benzinga reports. They currently have a...

Thelincolnianonline
Quantexa News
02/28
Nektar Therapeutics (NASDAQ:NKTR) Receives “Market Perform” Rating from William Blair

William Blair restated their market perform rating on shares of Nektar Therapeutics ( NASDAQ:NKTR – Free Report in a research report released on Tuesday, RTT News reports. NKTR has been the topic of...

Community Financial News
Quantexa News
02/28
Analysts Conflicted on These Healthcare Names: Lemaitre Vascular (LMAT), Catalyst Pharma (CPRX) and Nektar Therapeutics (NKTR)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Lemaitre Vascular ( LMAT – Research Report ), Catalyst Pharma ( CPRX – Research Report ) and Nektar The...

Markets Businessinsider.com
Quantexa News
02/28
Should Nektar Therapeutics (NASDAQ: NKTR) Rally After -141.25% Drop From High?

Nektar Therapeutics (NASDAQ:NKTR)'s traded shares stood at 1.31 million during the last session, with the company's beta value hitting 0.67. At the close of trading, the stock's price was $0.80, to im...

Marketingsentinel.com
Quantexa News
03/01
Nektar Therapeutics (NKTR) Expected to Announce Earnings on Monday

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) is expected to post its quarterly earnings results before the market opens on Monday, March 3rd. Analysts expect Nektar Therapeutics to post earning...

Defense World
Quantexa News
03/02
Nektar Therapeutics (NKTR) Projected to Post Quarterly Earnings on Monday

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) will likely be posting its quarterly earnings results before the market opens on Monday, March 3rd. Analysts expect Nektar Therapeutics to post earn...

ETF Daily News
Quantexa News
03/03
Could Nektar Therapeutics (NASDAQ: NKTR) Deliver Exceptional Returns?

In the last trading session, 1.16 million shares of the Nektar Therapeutics (NASDAQ:NKTR) were traded, and its beta was 0.66. Most recently the company's share price was $0.84, and it changed around $...

Marketingsentinel.com
Yahoo Finance News
03/05
Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2024 on Wednesday, March 12, 2025, After Close of U.S.-Based Financial Markets

Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2024 on Wednesday, March 12, 2025, After...

PR Newswire
Quantexa News
03/05
Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2024 on Wednesday, March 12, 2025, After Close of U.S.-Based Financial Markets

News provided by SAN FRANCISCO March 5, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR ) will announce its financial results for the fourth quarter and year-ended December 31, 2024 on Wednesd...

PR Newswire
Quantexa News
03/05
Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2024 on Wednesday, March 12, 2025, After Close of U.S.-Based Financial Markets

Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2024 on Wednesday, March 12, 2025, After Close of U.S.-Based Financial Markets PR Newswire SAN FRANCISCO, March 5, 2025 SAN...

Canada StockWatch
Quantexa News
03/05
Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2024 on Wednesday, March 12, 2025, After Close of U.S.-Based Financial Markets

SAN FRANCISCO March 5, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the fourth quarter and year-ended December 31, 2024 on Wednesday, March 12, 202...

Advanced Financial Network
Quantexa News
03/05
Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended

SAN FRANCISCO March 5, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: ) will announce its financial results for the fourth quarter and year-ended December 31, 2024 on Wednesday, March 12, 2025 , af...

sogotradedev.websol.barchart.com
Quantexa News
03/05
Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2024 on Wednesday, March 12, 2025, After Close of U.S.-Based Financial Markets

SAN FRANCISCO, March 5, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the fourth quarter and year-ended December 31, 2024 on Wednesday, March 12, 2025...

Associated Press News
Quantexa News
03/05
Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2024 on Wednesday, March 12, 2025, After Close of U.S.-Based Financial Markets

Nektar Therapeutics will announce its financial results for the fourth quarter and year-ended December 31, 2024 on Wednesday, March 12, 2025, after the close of U.S.-based financial markets. Howard Ro...

Le Lézard (English)
Quantexa News
03/05
Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2024 on Wednesday, March 12, 2025, After Close of U.S.-Based Financial Markets

Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2024 on Wednesday, March 12, 2025, After Close of U.S.-Based Financial Markets PR Newswire SAN FRANCISCO, March 5, 2025...

Elizabethton Star (TN)
Quantexa News
03/05
Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2024 on Wednesday, March 12, 2025, After Close of U.S.-Based Financial Markets

PR Newswire SAN FRANCISCO, March 5, 2025 SAN FRANCISCO March 5, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the fourth quarter and year-ended Dece...

Ironton Tribune, The (Ohio)
Quantexa News
03/05
Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2024 on Wednesday, March 12, 2025, After Close of U.S.-Based...

PR Newswire Today at 12:00am GMT+1 Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2024 on Wednesday, March 12, 2025, After Close of U.S.-Based Financial Markets PR Newsw...

Wetumpka Herald, The (AL)
Quantexa News
03/05
Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2024 on Wednesday, March 12, 2025, After Close of U.S.-Based Financial Markets

PR Newswire SAN FRANCISCO, March 5, 2025 SAN FRANCISCO March 5, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the fourth quarter and year-ended Dece...

Central Charts EN
Quantexa News
03/05
Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2024 on Wednesday, March 12, 2025, After Close of U.S.-Based Financial Markets

05/03/2025 11:00pm PR Newswire (US) Wednesday 5 March 2025 SAN FRANCISCO March 5, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the fourth quarter...

Advanced Financial Network
Quantexa News
03/05
Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2024 on Wednesday, March 12, 2025, After Close of U.S.-Based Financial Markets

Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2024 on Wednesday, March 12, 2025, After Close of U.S.-Based Financial Markets SAN FRANCISCO March 5, 2025 /PRNewswire/ -- N...

Crwe World
Quantexa News
03/05
Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2024 on Wednesday, March 12, 2025, After Close of U.S.-Based Financial Markets PR Newswire Today at 12:00am GMT+1

Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2024 on Wednesday, March 12, 2025, After Close of U.S.-Based Financial Markets PR Newswire SAN FRANCISCO, March 5, 2025 SAN...

La Grange Daily News (La Grange, GA)
Quantexa News
03/05
Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2024 on Wednesday, March 12, 2025, After Close of U.S.-Based Financial Markets

March 5, 2025 6:00 PM EST SAN FRANCISCO March 5, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR ) will announce its financial results for the fourth quarter and year-ended December 31, 2024 o...

StreetInsider
Quantexa News
03/05
Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2024 on Wednesday, March 12, 2025, After Close of U.S.-Based Financial Markets

SAN FRANCISCO March 5, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the fourth quarter and year-ended December 31, 2024 on Wednesday, March 12, 2025...

Investing.com India
Quantexa News
03/05
Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2024 on Wednesday, March 12, 2025, After Close of U.S.-Based Financial Markets

SAN FRANCISCO, March 5, 2025 /PRNewswire/ -- Nektar Therapeutics NKTR will announce its financial results for the fourth quarter and year-ended December 31, 2024 on Wednesday, March 12, 2025, after th...

Benzinga
Quantexa News
03/05
Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2024 on Wednesday, March 12, 2025, After Close of U.S.-Based Financial Markets

We and our partnersstore and/or access information on a device, such as cookies and process personal data, such as unique identifiers and standard information sent by a device for personalised adverti...

News Blaze
Quantexa News
03/05
Nektar Therapeutics Reports Upcoming Financial Results for 2024

Nektar Therapeutics Upcoming Financial Results Announcement Nektar Therapeutics (Nasdaq: NKTR) is gearing up to announce its financial results for the final quarter and the entire year, marking the c...

Investors Hangout
Quantexa News
03/05
Nektar Therapeutics Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2024 on Wednesday, March 12, 2025, After Close of U.S.-Based Financial Markets (PR Newswire)

Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2024 on Wednesday, March 12, 2025, After Close of U.S.-Based Financial Markets PR Newswire SAN FRANCISCO, March 5, 2025...

Avanza
Quantexa News
03/05
Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2024 on Wednesday, March 12, 2025, After Close of U.S.-Based Financial Markets

News provided by Nektar Therapeutics Mar 05, 2025, 6:00 PM ET SAN FRANCISCO March 5, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the fourth quart...

8News Now
Quantexa News
03/05
Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2024 on Wednesday, March 12, 2025, After Close of U.S.-Based Financial Markets

SAN FRANCISCO March 5, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the fourth quarter and year-ended December 31, 2024 on Wednesday, March 12, 2025...

Yahoo! Finance News
Quantexa News
03/05
NEKTAR THERAPEUTICS Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2024 on Wednesday, March 12, 2025, After Close of U.S.-Based Financial Markets

March 05, 2025 at 06:01 pm EST SAN FRANCISCO March 5, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the fourth quarter and year-ended December 31, 20...

MarketScreener
Quantexa News
03/05
Nektar To Announce Financial Results For The Fourth Quarter And Year-Ended 2024 On Wednesday, March 12, 2025, After Close Of U.S.-Based Financial Markets

SAN FRANCISCO, March 5, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR ) will announce its results for the fourth quarter and year-ended December 31, 2024 on Wednesday, March 12, 2025, after t...

MENAFN
Quantexa News
03/08
Analysts Set Nektar Therapeutics (NASDAQ:NKTR) PT at $4.08

Nektar Therapeutics ( NASDAQ:NKTR – Get Free Report ) has received an average rating of “Buy” from the six ratings firms that are covering the firm, Marketbeat.com reports. One analyst has rated the s...

American Banking News
Quantexa News
03/08
Nektar Therapeutics (NASDAQ:NKTR) Receives $4.08 Consensus PT from Brokerages

Shares of Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) have been assigned an average recommendation of “Buy” from the six analysts that are presently covering the company, Marketbeat.com report...

Defense World
Quantexa News
03/08
Nektar Therapeutics (NASDAQ: NKTR): Blank Check For Growth?

Nektar Therapeutics (NASDAQ:NKTR) shares, rose in value on Friday, March 07, with the stock price up by 1.95% to the previous day's close as strong demand from buyers drove the stock to $0.88. Active...

Stocksregister
Quantexa News
03/11
Nektar Therapeutics (NKTR) with a beta value of 0.60 appears to be a promising investment opportunity.

A new trading day began on Monday, with Nektar Therapeutics (NASDAQ: NKTR) stock price down -6.61% from the previous day of trading, before settling in for the closing price of $0.88. NKTR's price has...

Newsdaemon.com
Quantexa News
03/12
Nektar Therapeutics Q4 24 Earnings Conference Call At 5:00 PM ET

Nektar Therapeutics ( NKTR ) will host a conference call at 5:00 PM ET on March 12, 2025, to discuss Q4 24 earnings results. To access the live webcast, log on to https://ir.nektar.com/events-and-pre...

RTT News
Yahoo Finance News
03/12
Nektar Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results

Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Nektar Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results PR Newswire Wed, Mar 12, 2025, 3:15...

PR Newswire
Quantexa News
03/12
Nektar Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results

SAN FRANCISCO March 12, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR ) today reported financial results for the fourth quarter ended December 31, 2024 Cash and investments in marketable sec...

PR Newswire
Quantexa News
03/12
Nektar Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results

SAN FRANCISCO March 12, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR ) today reported financial results for the fourth quarter ended December 31, 2024 Cash and investments in marketable sec...

Ticker Tech
Quantexa News
03/12
Nektar Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Res

SAN FRANCISCO March 12, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: ) today reported financial results for the fourth quarter ended December 31, 2024 This article contains syndicated content. W...

sogotradedev.websol.barchart.com
Quantexa News
03/12
Nektar Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results

Cash and investments in marketable securities on December 31, 2024 were $269.1 million as compared to $329.4 million at December 31, 2023 . Nektar's cash and marketable securities are expected to supp...

finanzen.net
Quantexa News
03/12
Nektar Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results

PR Newswire Today at 9:15pm GMT+1 PR Newswire SAN FRANCISCO, March 12, 2025 SAN FRANCISCO March 12, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the...

Chester County Press (Oxford, PA)
Quantexa News
03/12
Nektar Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results

PR Newswire Today at 9:15pm GMT+1 Nektar Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results PR Newswire SAN FRANCISCO, March 12, 2025 SAN FRANCISCO March 12, 2025 /PRNewswi...

Wetumpka Herald, The (AL)
Quantexa News
03/12
Nektar Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results

SAN FRANCISCO, March 12, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the fourth quarter ended December 31, 2024. Cash and investments in marketable sec...

The Coastland Times
Quantexa News
03/12
Nektar Therapeutics Unveils Year-End Financial Results Insights

Nektar Therapeutics Report Reveals Financial Performance Nektar Therapeutics (NASDAQ: NKTR) has announced its financial results for the fourth quarter and full year, shedding light on its economic po...

Investors Hangout
Quantexa News
03/12
Nektar Therapeutics Q4 Earnings Summary

Our website uses cookies for analytics, advertising and to improve our site. By using our site you agree to our use of cookies. To find out more, including how to change your settings, see our Cookie...

RTT News
Quantexa News
03/12
Nektar Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results

Nektar Therapeutics today reported financial results for the fourth quarter ended December 31, 2024. Cash and investments in... SAN FRANCISCO March 12, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasda...

Le Lézard (English)
Quantexa News
03/12
Nektar Therapeutics Reveals Q4 2024 Financial Insights

Nektar Therapeutics Financial Results Overview Nektar Therapeutics (NASDAQ: NKTR) has made significant strides in its financial performance for the fourth quarter of 2024. The company reported a reve...

Investors Hangout
Quantexa News
03/12
Nektar Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results

SAN FRANCISCO, March 12, 2025 /PRNewswire/ -- Nektar Therapeutics NKTR today reported financial results for the fourth quarter ended December 31, 2024. Cash and investments in marketable securities o...

Benzinga
Quantexa News
03/12
Nektar Therapeutics shares rise on Q4 earnings beat

SAN FRANCISCO - Nektar Therapeutics (NASDAQ: NKTR ) reported better-than-expected fourth quarter earnings, sending shares up 2.5% in after-hours trading on Tuesday. The biopharmaceutical company post...

Investing.com India
Quantexa News
03/12
Nektar Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results

SAN FRANCISCO March 12, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the fourth quarter ended December 31, 2024 (PRNewsfoto/Nektar Therapeutics) Cash...

Yahoo! Finance News
Yahoo Finance News
03/12
Assertio (ASRT) Reports Q4 Loss, Tops Revenue Estimates

Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Assertio (ASRT) Reports Q4 Loss, Tops Revenue Estimates Zacks Equity Research Wed, Mar 12, 2025, 5:20 PM 3 min read...

Zacks
Quantexa News
03/12
Nektar Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results

SAN FRANCISCO March 12, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the fourth quarter ended December 31, 2024 Cash and investments in marketable secu...

Investing.com India
Yahoo Finance News
03/12
Nektar: Q4 Earnings Snapshot

Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Nektar: Q4 Earnings Snapshot Associated Press Finance Wed, Mar 12, 2025, 6:12 PM 1 min read In This Article: NKTR +0...

Associated Press Finance
Quantexa News
03/12
NEKTAR THERAPEUTICS Nektar: Q4 Earnings Snapshot

March 12, 2025 at 06:13 pm EDT SAN FRANCISCO (AP) — SAN FRANCISCO (AP) — Nektar Therapeutics (NKTR) on Wednesday reported fourth-quarter earnings of $7.3 million The San Francisco -based company sai...

MarketScreener
Quantexa News
03/12
Nektar Therapeutics (NASDAQ:NKTR) Issues Quarterly Earnings Results

Nektar Therapeutics ( NASDAQ:NKTR – Get Free Report ) announced its earnings results on Wednesday. The biopharmaceutical company reported $0.15 earnings per share (EPS) for the quarter, beating the co...

Transcript Daily
Quantexa News
03/12
Nektar: Q4 Earnings Snapshot

SAN FRANCISCO (AP) — SAN FRANCISCO (AP) — Nektar Therapeutics (NKTR) on Wednesday reported fourth-quarter earnings of $7.3 million. The San Francisco-based company said it had net income of 3 cents p...

Discovery News
Quantexa News
03/12
Nektar: Q4 Earnings Snapshot

Associated Press Finance 1 min read In this article SAN FRANCISCO (AP) — SAN FRANCISCO (AP) — Nektar Therapeutics (NKTR) on Wednesday reported fourth-quarter earnings of $7.3 million. The San Fran...

Yahoo Singapore Finance
Yahoo Finance News
03/12
Nektar Therapeutics (NKTR) Q4 Earnings Beat Estimates

Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Nektar Therapeutics (NKTR) Q4 Earnings Beat Estimates Zacks Equity Research Wed, Mar 12, 2025, 4:00 PM 3 min read In...

Zacks
Quantexa News
03/12
Nektar Therapeutics (NASDAQ:NKTR) Releases Earnings Results, Beats Expectations By $0.33 EPS

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) released its quarterly earnings results on Wednesday. The biopharmaceutical company reported $0.15 EPS for the quarter, topping the consensus estima...

Daily Political
Quantexa News
03/12
Nektar Therapeutics (NKTR) Q4 2024 Earnings Call Transcript

Nektar Therapeutics (NASDAQ:NKTR) Q4 2024 Earnings Conference Call March 12, 2025 5:00 PM ET Company Participants Vivian Wu - Investor Relations Howard Robin - President & Chief Executive Officer...

Seeking Alpha
Quantexa News
03/12
Nektar Therapeutics (NKTR) Q4 2024 Earnings Call Transcript

SA Transcripts Nektar Therapeutics ( NASDAQ: NKTR ) Q4 2024 Earnings Conference Call March 12, 2025 5:00 PM ET Company Participants Vivian Wu - Investor Relations Howard Robin - President & Chief...

Seeking Alpha
Yahoo Finance News
03/12
Nektar (NKTR) Reports Q4 Earnings: What Key Metrics Have to Say

Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Nektar (NKTR) Reports Q4 Earnings: What Key Metrics Have to Say Zacks Equity Research Wed, Mar 12, 2025, 6:30 PM 2 m...

Zacks
Quantexa News
03/12
Nektar Therapeutics Q4 Earnings Summary

(RTTNews) - Below are the earnings highlights for Nektar Therapeutics (NKTR): Earnings: $7.26 million in Q4 vs. -$42.08 million in the same period last year. EPS: $0.03 in Q4 vs. -$0.22 in the same...

Finanzen.ch
Quantexa News
03/12
Nektar (NKTR) Reports Q4 Earnings: What Key Metrics Have to Say

For the quarter ended December 2024, Nektar Therapeutics (NKTR) reported revenue of $29.18 million, up 22.1% over the same period last year. EPS came in at $0.15, compared to -$0.22 in the year-ago qu...

Yahoo! Finance News
Quantexa News
03/12
Nektar (NKTR) Reports Q4 Earnings: What Key Metrics Have to Say

Nektar Therapeutics (NKTR) reported $29.18 million in revenue for the quarter ended December 2024, representing a year-over-year increase of 22.1%. EPS of -$0.15 for the same period compares to -$0.22...

Yahoo! Finance News
Quantexa News
03/12
Nektar Therapeutics (NKTR) Tops Q4 EPS by 19c

Nektar Therapeutics (NASDAQ: NKTR ) reported Q4 EPS of $0.03, $0.19 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $29.2 million versus the consensus estimate of $29.8...

StreetInsider
Yahoo Finance News
03/13
Nektar Therapeutics (NKTR) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Financial ...

Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Nektar Therapeutics (NKTR) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Financial ... GuruFocus News Th...

GuruFocus.com
Quantexa News
03/13
Nektar Therapeutics Announces Completion of Target Enrollment in REZOLVE-AA Phase 2b Clinical Trial of Rezpegaldesleukin in Patients with Severe-to-Very Severe Alopecia Areata

SAN FRANCISCO Feb. 26, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced the company has completed target enrollment in its REZOLVE-AA Phase 2b study of rezpegaldesleukin in pati...

Latin Business Today
Quantexa News
03/13
William Blair Sticks to Their Hold Rating for Nektar Therapeutics (NKTR)

William Blair analyst Andy Hsieh reiterated a Hold rating on Nektar Therapeutics ( NKTR – Research Report ) today. The company's shares closed yesterday at $0.82. Light Up your Portfolio with Spark:...

Markets Businessinsider.com
Quantexa News
03/13
Nektar Therapeutics (NKTR) Gets a Buy from Piper Sandler

In a report released today, Yasmeen Rahimi from Piper Sandler maintained a Buy rating on Nektar Therapeutics ( NKTR – Research Report ), with a price target of . The company's shares closed yesterday...

Markets Businessinsider.com
Yahoo Finance News
03/13
Q4 2024 Nektar Therapeutics Earnings Call

Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Q4 2024 Nektar Therapeutics Earnings Call Thomson Reuters StreetEvents Thu, Mar 13, 2025, 10:06 AM 39 min read In Th...

Thomson Reuters StreetEvents
Yahoo Finance News
03/13
Nektar Q4 Loss Wider Than Expected, Pipeline in Focus, Stock Up

Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Nektar Q4 Loss Wider Than Expected, Pipeline in Focus, Stock Up Zacks Equity Research Thu, Mar 13, 2025, 12:15 PM 5...

Zacks
Quantexa News
03/13
Nektar Therapeutics (NASDAQ:NKTR) Earns Market Perform Rating from William Blair

Nektar Therapeutics ( NASDAQ:NKTR – Get Free Report ‘s stock had its “market perform” rating reaffirmed by equities research analysts at William Blair in a research note issued on Thursday, RTT News r...

Thelincolnianonline
Quantexa News
03/13
Nektar Q4 Loss Wider Than Expected, Pipeline in Focus, Stock Up

Nektar Therapeutics NKTR Quick Quote NKTR Free Report ) incurred an adjusted loss per share of 15 cents in the fourth quarter of 2024, wider than the Zacks Consensus Estimate of a loss of 13 cents. In...

Zacks
Quantexa News
03/13
Nektar Therapeutics (NASDAQ:NKTR) Releases Earnings Results, Beats Expectations By $0.33 EPS

Nektar Therapeutics (NASDAQ:NKTR - Get Free Report) released its quarterly earnings results on Wednesday. The biopharmaceutical company reported $0.15 EPS for the quarter, topping the consensus estima...

MarketBeat.com
Quantexa News
03/13
Nektar upgraded to Outperform at Oppenheimer ahead of rezpeg readout in June

Oppenheimer upgraded Nektar ( NKTR ) to Outperform from Perform with a $6 price target The firm is refreshing its model ahead of the company's rezpegaldesleukin in atopic dermatitis – AD – Phase 2B re...

Markets Businessinsider.com
Quantexa News
03/13
Nektar upgraded to Outperform from Perform at Oppenheimer

Oppenheimer upgraded Nektar ( NKTR ) to Outperform from Perform with a $6 price target Light Up your Portfolio with Spark: Easily identify stocks' risks and opportunities. Discover stocks' market...

Markets Businessinsider.com
Quantexa News
03/13
Nektar upgraded to Outperform at Oppenheimer ahead of rezpeg readout in June

Oppenheimer upgraded Nektar (NKTR) to Outperform from Perform with a $6 price target The firm is refreshing its model ahead of the company’s rezpegaldesleukin in atopic dermatitis – AD – Phase 2B read...

Tipranks
Quantexa News
03/14
Oppenheimer Upgrades Nektar Therapeutics (NKTR) to Outperform

March 14, 2025 1:55 AM EDT Oppenheimer analyst Jay Olson upgraded Nektar Therapeutics (NASDAQ: NKTR) from Perform to Outperform with a price target of $6.00.The analyst ... This is a premium only ar...

StreetInsider

© 2025 - PennyLoupe LLC. Austin, TX.

DJDT

Versions

Package Name Version
Django 5.0.3
Python 3.11.8
coverage Coverage 7.4.4
debug_toolbar Debug Toolbar 4.3.0
django_extensions Django Extensions 3.2.3
grappelli Grappelli 3.0.8

Time

Resource usage

Resource Value
User CPU time 295.566 msec
System CPU time 12.161 msec
Total CPU time 307.727 msec
Elapsed time 719.982 msec
Context switches 21 voluntary, 3 involuntary

Browser timing

Timing attribute Timeline Milliseconds since navigation start (+length)

Settings from app.settings

Setting Value
ABSOLUTE_URL_OVERRIDES {}
ADMINS []
ALLOWED_HOSTS ['*']
ALPACA_API '********************'
APPEND_SLASH True
AUTH0_CLIENT_ID None
AUTH0_CLIENT_SECRET '********************'
AUTH0_DOMAIN None
AUTHENTICATION_BACKENDS ['django.contrib.auth.backends.ModelBackend']
AUTH_PASSWORD_VALIDATORS '********************'
AUTH_USER_MODEL 'auth.User'
BASE_DIR PosixPath('/mnt/disks/pennyloupe_disk/pennyloupe')
CACHES {'default': {'BACKEND': 'django.core.cache.backends.filebased.FileBasedCache', 'LOCATION': '/var/tmp/django_cache'}}
CACHE_MIDDLEWARE_ALIAS 'default'
CACHE_MIDDLEWARE_KEY_PREFIX '********************'
CACHE_MIDDLEWARE_SECONDS 600
CELERY_BROKER_URL 'redis://localhost:6379'
CELERY_RESULT_BACKEND 'redis://localhost:6379'
CSRF_COOKIE_AGE 31449600
CSRF_COOKIE_DOMAIN None
CSRF_COOKIE_HTTPONLY False
CSRF_COOKIE_NAME 'csrftoken'
CSRF_COOKIE_PATH '/'
CSRF_COOKIE_SAMESITE 'Lax'
CSRF_COOKIE_SECURE False
CSRF_FAILURE_VIEW 'django.views.csrf.csrf_failure'
CSRF_HEADER_NAME 'HTTP_X_CSRFTOKEN'
CSRF_TRUSTED_ORIGINS []
CSRF_USE_SESSIONS False
DATABASES {'default': {'ATOMIC_REQUESTS': False, 'AUTOCOMMIT': True, 'CONN_HEALTH_CHECKS': True, 'CONN_MAX_AGE': 600, 'ENGINE': 'django.db.backends.postgresql', 'HOST': '34.125.28.12', 'NAME': 'pennyloupe', 'OPTIONS': {'sslmode': 'require'}, 'PASSWORD': '********************', 'PORT': 5432, 'TEST': {'CHARSET': None, 'COLLATION': None, 'MIGRATE': True, 'MIRROR': None, 'NAME': None}, 'TIME_ZONE': None, 'USER': 'pennyloupe'}}
DATABASE_ROUTERS []
DATA_UPLOAD_MAX_MEMORY_SIZE 2621440
DATA_UPLOAD_MAX_NUMBER_FIELDS 1000
DATA_UPLOAD_MAX_NUMBER_FILES 100
DATETIME_FORMAT 'N j, Y, P'
DATETIME_INPUT_FORMATS ['%Y-%m-%d %H:%M:%S', '%Y-%m-%d %H:%M:%S.%f', '%Y-%m-%d %H:%M', '%m/%d/%Y %H:%M:%S', '%m/%d/%Y %H:%M:%S.%f', '%m/%d/%Y %H:%M', '%m/%d/%y %H:%M:%S', '%m/%d/%y %H:%M:%S.%f', '%m/%d/%y %H:%M']
DATE_FORMAT 'N j, Y'
DATE_INPUT_FORMATS ['%Y-%m-%d', '%m/%d/%Y', '%m/%d/%y', '%b %d %Y', '%b %d, %Y', '%d %b %Y', '%d %b, %Y', '%B %d %Y', '%B %d, %Y', '%d %B %Y', '%d %B, %Y']
DEBUG True
DEBUG_PROPAGATE_EXCEPTIONS False
DEBUG_TOOLBAR_CONFIG {'SHOW_TOOLBAR_CALLBACK': <function <lambda> at 0x7ff664cdbec0>}
DECIMAL_SEPARATOR '.'
DEFAULT_AUTO_FIELD 'django.db.models.BigAutoField'
DEFAULT_CHARSET 'utf-8'
DEFAULT_EXCEPTION_REPORTER 'django.views.debug.ExceptionReporter'
DEFAULT_EXCEPTION_REPORTER_FILTER 'django.views.debug.SafeExceptionReporterFilter'
DEFAULT_FILE_STORAGE 'django.core.files.storage.FileSystemStorage'
DEFAULT_FROM_EMAIL 'webmaster@localhost'
DEFAULT_INDEX_TABLESPACE ''
DEFAULT_TABLESPACE ''
DISALLOWED_USER_AGENTS []
EMAIL_BACKEND 'django.core.mail.backends.smtp.EmailBackend'
EMAIL_HOST 'localhost'
EMAIL_HOST_PASSWORD '********************'
EMAIL_HOST_USER ''
EMAIL_PORT 25
EMAIL_SSL_CERTFILE None
EMAIL_SSL_KEYFILE '********************'
EMAIL_SUBJECT_PREFIX '[Django] '
EMAIL_TIMEOUT None
EMAIL_USE_LOCALTIME False
EMAIL_USE_SSL False
EMAIL_USE_TLS False
FIELD_ENCRYPTION_KEY '********************'
FILE_UPLOAD_DIRECTORY_PERMISSIONS None
FILE_UPLOAD_HANDLERS ['django.core.files.uploadhandler.MemoryFileUploadHandler', 'django.core.files.uploadhandler.TemporaryFileUploadHandler']
FILE_UPLOAD_MAX_MEMORY_SIZE 2621440
FILE_UPLOAD_PERMISSIONS 420
FILE_UPLOAD_TEMP_DIR None
FIRST_DAY_OF_WEEK 0
FIXTURE_DIRS []
FORCE_SCRIPT_NAME None
FORMAT_MODULE_PATH None
FORMS_URLFIELD_ASSUME_HTTPS False
FORM_RENDERER 'django.forms.renderers.DjangoTemplates'
GRAPPELLI_ADMIN_TITLE 'Penny Loupe'
GRAPPELLI_AUTOCOMPLETE_SEARCH_FIELDS {'auth': {'user': ('id__iexact', 'username__icontains')}}
IGNORABLE_404_URLS []
INSTALLED_APPS ['coverage', 'grappelli', 'django.contrib.admin', 'django.contrib.auth', 'django.contrib.contenttypes', 'django.contrib.humanize', 'django.contrib.messages', 'django.contrib.postgres', 'django.contrib.sessions', 'django.contrib.staticfiles', 'django_htmx', 'app.core.apps.CoreConfig', 'django_extensions', 'debug_toolbar']
INTERNAL_IPS ['127.0.0.1']
LANGUAGES [('en', 'English')]
LANGUAGES_BIDI ['he', 'ar', 'ar-dz', 'ckb', 'fa', 'ug', 'ur']
LANGUAGE_CODE 'en-us'
LANGUAGE_COOKIE_AGE None
LANGUAGE_COOKIE_DOMAIN None
LANGUAGE_COOKIE_HTTPONLY False
LANGUAGE_COOKIE_NAME 'django_language'
LANGUAGE_COOKIE_PATH '/'
LANGUAGE_COOKIE_SAMESITE None
LANGUAGE_COOKIE_SECURE False
LOCALE_PATHS []
LOGGING {}
LOGGING_CONFIG 'logging.config.dictConfig'
LOGIN_REDIRECT_URL '/accounts/profile/'
LOGIN_URL '/accounts/login/'
LOGOUT_REDIRECT_URL None
MANAGERS []
MEDIA_ROOT PosixPath('/mnt/disks/pennyloupe_disk/pennyloupe/media')
MEDIA_URL '/media/'
MESSAGE_STORAGE 'django.contrib.messages.storage.fallback.FallbackStorage'
MIDDLEWARE ['django.middleware.security.SecurityMiddleware', 'whitenoise.middleware.WhiteNoiseMiddleware', 'django.contrib.sessions.middleware.SessionMiddleware', 'django.middleware.cache.UpdateCacheMiddleware', 'django.middleware.common.CommonMiddleware', 'django.middleware.csrf.CsrfViewMiddleware', 'django.contrib.auth.middleware.AuthenticationMiddleware', 'django.contrib.messages.middleware.MessageMiddleware', 'django.middleware.clickjacking.XFrameOptionsMiddleware', 'django_htmx.middleware.HtmxMiddleware', 'debug_toolbar.middleware.DebugToolbarMiddleware']
MIGRATION_MODULES {}
MONTH_DAY_FORMAT 'F j'
NUMBER_GROUPING 0
OPENAI_API_KEY '********************'
PASSWORD_HASHERS '********************'
PASSWORD_RESET_TIMEOUT '********************'
POLYGON_API_KEY '********************'
PREPEND_WWW False
QT_API_KEY '********************'
QT_APP_ID '13d3cbab'
QT_PASSWORD '********************'
QT_USERNAME 'kevin+dev3@pennyloupe.com'
ROOT_URLCONF 'app.urls'
SCRAPER_API_KEY '********************'
SECRET_KEY '********************'
SECRET_KEY_FALLBACKS '********************'
SECURE_CONTENT_TYPE_NOSNIFF True
SECURE_CROSS_ORIGIN_OPENER_POLICY 'same-origin'
SECURE_HSTS_INCLUDE_SUBDOMAINS False
SECURE_HSTS_PRELOAD False
SECURE_HSTS_SECONDS 0
SECURE_PROXY_SSL_HEADER None
SECURE_REDIRECT_EXEMPT []
SECURE_REFERRER_POLICY 'same-origin'
SECURE_SSL_HOST None
SECURE_SSL_REDIRECT False
SERVER_EMAIL 'root@localhost'
SESSION_CACHE_ALIAS 'default'
SESSION_COOKIE_AGE 1209600
SESSION_COOKIE_DOMAIN None
SESSION_COOKIE_HTTPONLY True
SESSION_COOKIE_NAME 'sessionid'
SESSION_COOKIE_PATH '/'
SESSION_COOKIE_SAMESITE 'Lax'
SESSION_COOKIE_SECURE False
SESSION_ENGINE 'django.contrib.sessions.backends.db'
SESSION_EXPIRE_AT_BROWSER_CLOSE False
SESSION_FILE_PATH None
SESSION_SAVE_EVERY_REQUEST False
SESSION_SERIALIZER 'django.contrib.sessions.serializers.JSONSerializer'
SETTINGS_MODULE 'app.settings'
SHORT_DATETIME_FORMAT 'm/d/Y P'
SHORT_DATE_FORMAT 'm/d/Y'
SIGNING_BACKEND 'django.core.signing.TimestampSigner'
SILENCED_SYSTEM_CHECKS []
SQL_FILES_DIR '/mnt/disks/pennyloupe_disk/pennyloupe/app/core/sql'
STATICFILES_DIRS []
STATICFILES_FINDERS ['django.contrib.staticfiles.finders.FileSystemFinder', 'django.contrib.staticfiles.finders.AppDirectoriesFinder']
STATICFILES_STORAGE 'django.contrib.staticfiles.storage.StaticFilesStorage'
STATIC_ROOT PosixPath('/mnt/disks/pennyloupe_disk/pennyloupe/static')
STATIC_URL '/static/'
STORAGES {'default': {'BACKEND': 'django.core.files.storage.FileSystemStorage'}, 'staticfiles': {'BACKEND': 'django.contrib.staticfiles.storage.StaticFilesStorage'}}
TEMPLATES [{'APP_DIRS': True, 'BACKEND': 'django.template.backends.django.DjangoTemplates', 'DIRS': ['templates'], 'OPTIONS': {'context_processors': ['django.template.context_processors.debug', 'django.template.context_processors.request', 'django.contrib.auth.context_processors.auth', 'django.contrib.messages.context_processors.messages']}}]
TEST_NON_SERIALIZED_APPS []
TEST_RUNNER 'django.test.runner.DiscoverRunner'
THOUSAND_SEPARATOR ','
TIME_FORMAT 'P'
TIME_INPUT_FORMATS ['%H:%M:%S', '%H:%M:%S.%f', '%H:%M']
TIME_ZONE 'UTC'
USE_I18N True
USE_THOUSAND_SEPARATOR False
USE_TZ True
USE_X_FORWARDED_HOST False
USE_X_FORWARDED_PORT False
WSGI_APPLICATION 'app.wsgi.application'
X_FRAME_OPTIONS 'DENY'
YEAR_MONTH_FORMAT 'F Y'

Headers

Request headers

Key Value
Accept */*
Accept-Encoding gzip, br, zstd, deflate
Cookie => see Request panel
Host pennyloupe.com
User-Agent Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)

Response headers

Key Value
Content-Type text/html; charset=utf-8

WSGI environ

Since the WSGI environ inherits the environment of the server, only a significant subset is shown below.

Key Value
CONTENT_LENGTH
CONTENT_TYPE
PATH_INFO /ticker/NKTR/content
QUERY_STRING date_from=2024-09-15&date_to=2025-03-14
REMOTE_ADDR 18.191.209.202
REQUEST_METHOD GET
SCRIPT_NAME
SERVER_NAME pennyloupe.com
SERVER_PORT 443
SERVER_PROTOCOL HTTP/1.1

Request

View information

View function Arguments Keyword arguments URL name
app.core.views.app.ticker_content () {'ticker': 'NKTR'} ticker_content

Cookies

Variable Value
'csrftoken' 'xTrhW9sVOQ14mbedtjKROm6zq9Tn3DAm'

No session data

GET data

Variable Value
'date_from' '2024-09-15'
'date_to' '2025-03-14'

No POST data

SQL queries from 1 connection

  • default 411.67 ms (4 queries )
Query Timeline Time (ms) Action
SELECT "pl_symbol_report_summary"."report_date",
       "pl_symbol_report_summary"."items_count",
       "pl_symbol_report_summary"."items_positive_count",
       "pl_symbol_report_summary"."items_negative_count",
       "pl_symbol_report_summary"."items_neutral_count",
       "pl_symbol_report_summary"."sentiment_avg_positive",
       "pl_symbol_report_summary"."sentiment_avg_negative",
       "pl_symbol_report_summary"."sentiment_avg_neutral",
       "pl_symbol_report_summary"."sentiment_avg"
  FROM "pl_symbol_report_summary"
 WHERE ("pl_symbol_report_summary"."report_date" BETWEEN '2024-09-15'::date AND '2025-03-14'::date AND "pl_symbol_report_summary"."ticker" = 'NKTR')
 ORDER BY "pl_symbol_report_summary"."report_date" ASCSELECT ••• FROM "pl_symbol_report_summary" WHERE ("pl_symbol_report_summary"."report_date" BETWEEN '2024-09-15'::date AND '2025-03-14'::date AND "pl_symbol_report_summary"."ticker" = 'NKTR') ORDER BY "pl_symbol_report_summary"."report_date" ASC
 372.79

Connection: default

Transaction status: Idle

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/whitenoise/middleware.py in __call__(124)
  return self.get_response(request)

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django_htmx/middleware.py in __call__(43)
  return self.get_response(request)

/mnt/disks/pennyloupe_disk/pennyloupe/app/core/views/app.py in ticker_content(1352)
  for srs in symbol_report_summary:
SELECT "pl_data_source"."created_dt",
       "pl_data_source"."updated_dt",
       "pl_data_source"."status_id",
       "pl_data_source"."id",
       "pl_data_source"."name",
       "pl_data_source"."type",
       "pl_data_source"."url",
       "pl_data_source"."description",
       "pl_data_source"."weight",
       "pl_data_source"."class_name",
       "pl_data_source"."class_params_json"
  FROM "pl_data_source"
 WHERE "pl_data_source"."status_id" = 10
 ORDER BY "pl_data_source"."name" ASCSELECT ••• FROM "pl_data_source" WHERE "pl_data_source"."status_id" = 10 ORDER BY "pl_data_source"."name" ASC
 0.96

Connection: default

Transaction status: Idle

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/whitenoise/middleware.py in __call__(124)
  return self.get_response(request)

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django_htmx/middleware.py in __call__(43)
  return self.get_response(request)

/mnt/disks/pennyloupe_disk/pennyloupe/app/core/views/app.py in ticker_content(1398)
  return render(request, "ticker_content.html", context)

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/shortcuts.py in render(25)
  content = loader.render_to_string(template_name, context, request, using=using)

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/template/loader.py in render_to_string(62)
  return template.render(context, request)

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/template/backends/django.py in render(61)
  return self.template.render(context)

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/template/base.py in render(171)
  return self._render(context)

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/test/utils.py in instrumented_test_render(111)
  return self.nodelist.render(context)

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/template/base.py in render(1000)
  return SafeString("".join([node.render_annotated(context) for node in self]))

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/template/base.py in <listcomp>(1000)
  return SafeString("".join([node.render_annotated(context) for node in self]))

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/template/base.py in render_annotated(961)
  return self.render(context)

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/template/loader_tags.py in render(159)
  return compiled_parent._render(context)

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/test/utils.py in instrumented_test_render(111)
  return self.nodelist.render(context)

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/template/base.py in render(1000)
  return SafeString("".join([node.render_annotated(context) for node in self]))

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/template/base.py in <listcomp>(1000)
  return SafeString("".join([node.render_annotated(context) for node in self]))

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/template/base.py in render_annotated(961)
  return self.render(context)

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/template/loader_tags.py in render(65)
  result = block.nodelist.render(context)

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/template/base.py in render(1000)
  return SafeString("".join([node.render_annotated(context) for node in self]))

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/template/base.py in <listcomp>(1000)
  return SafeString("".join([node.render_annotated(context) for node in self]))

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/template/base.py in render_annotated(961)
  return self.render(context)

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/template/defaulttags.py in render(198)
  len_values = len(values)
21 <input placeholder="To Date" type="text" class="uk-input uk-form-small" name="date_to" id="date_to" value="{{ date_to }}" uk-datepicker="format:'YYYY-MM-DD'"/>
22 <select class="uk-select uk-form-small" name="data_source_id">
23 <option value="">Data Source...</option>
24 {% for ds in data_sources %}
25 {% if ds.id|slugify == data_source_id %}
26 <option value="{{ ds.id }}" selected>{{ ds.name }}</option>
27 {% else %}
28 <option value="{{ ds.id }}">{{ ds.name }}</option>

/mnt/disks/pennyloupe_disk/pennyloupe/app/core/templates/ticker_content.html
SELECT DISTINCT "pl_content"."published_by"
  FROM "pl_content"
 WHERE (("pl_content"."publish_dt" AT TIME ZONE 'America/Chicago')::date >= '2024-09-15'::date AND ("pl_content"."publish_dt" AT TIME ZONE 'America/Chicago')::date <= '2025-03-14'::date AND "pl_content"."status_id" = 10 AND "pl_content"."ticker" = 'NKTR')
 ORDER BY "pl_content"."published_by" ASCSELECT ••• FROM "pl_content" WHERE (("pl_content"."publish_dt" AT TIME ZONE 'America/Chicago')::date >= '2024-09-15'::date AND ("pl_content"."publish_dt" AT TIME ZONE 'America/Chicago')::date <= '2025-03-14'::date AND "pl_content"."status_id" = 10 AND "pl_content"."ticker" = 'NKTR') ORDER BY "pl_content"."published_by" ASC
 6.29

Connection: default

Transaction status: Idle

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/whitenoise/middleware.py in __call__(124)
  return self.get_response(request)

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django_htmx/middleware.py in __call__(43)
  return self.get_response(request)

/mnt/disks/pennyloupe_disk/pennyloupe/app/core/views/app.py in ticker_content(1398)
  return render(request, "ticker_content.html", context)

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/shortcuts.py in render(25)
  content = loader.render_to_string(template_name, context, request, using=using)

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/template/loader.py in render_to_string(62)
  return template.render(context, request)

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/template/backends/django.py in render(61)
  return self.template.render(context)

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/template/base.py in render(171)
  return self._render(context)

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/test/utils.py in instrumented_test_render(111)
  return self.nodelist.render(context)

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/template/base.py in render(1000)
  return SafeString("".join([node.render_annotated(context) for node in self]))

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/template/base.py in <listcomp>(1000)
  return SafeString("".join([node.render_annotated(context) for node in self]))

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/template/base.py in render_annotated(961)
  return self.render(context)

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/template/loader_tags.py in render(159)
  return compiled_parent._render(context)

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/test/utils.py in instrumented_test_render(111)
  return self.nodelist.render(context)

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/template/base.py in render(1000)
  return SafeString("".join([node.render_annotated(context) for node in self]))

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/template/base.py in <listcomp>(1000)
  return SafeString("".join([node.render_annotated(context) for node in self]))

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/template/base.py in render_annotated(961)
  return self.render(context)

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/template/loader_tags.py in render(65)
  result = block.nodelist.render(context)

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/template/base.py in render(1000)
  return SafeString("".join([node.render_annotated(context) for node in self]))

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/template/base.py in <listcomp>(1000)
  return SafeString("".join([node.render_annotated(context) for node in self]))

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/template/base.py in render_annotated(961)
  return self.render(context)

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/template/defaulttags.py in render(198)
  len_values = len(values)
31 </select>
32 <select class="uk-select uk-form-small" name="published_by">
33 <option value="">Published By...</option>
34 {% for pb in published_by_list %}
35 {% if pb == published_by %}
36 <option value="{{ pb }}" selected>{{ pb }}</option>
37 {% elif pb %}
38 <option value="{{ pb }}">{{ pb }}</option>

/mnt/disks/pennyloupe_disk/pennyloupe/app/core/templates/ticker_content.html
SELECT "pl_content"."created_dt",
       "pl_content"."updated_dt",
       "pl_content"."status_id",
       "pl_content"."id",
       "pl_content"."key",
       "pl_content"."fetch_ref_id",
       "pl_content"."ticker",
       "pl_content"."publish_dt",
       "pl_content"."external_id",
       "pl_content"."published_by",
       "pl_content"."title",
       "pl_content"."summary",
       "pl_content"."tags",
       "pl_content"."url",
       "pl_content"."author",
       "pl_content"."author_reputation_score",
       "pl_content"."content_length",
       "pl_content"."sentiment_positive",
       "pl_content"."sentiment_negative",
       "pl_content"."sentiment_neutral",
       "pl_content"."sentiment",
       "pl_content"."relevance_score",
       "pl_content"."votes_positive",
       "pl_content"."votes_negative",
       "pl_content"."is_processing_flag",
       "pl_content"."data_source_id",
       "pl_content"."publisher_id",
       "pl_data_source"."created_dt",
       "pl_data_source"."updated_dt",
       "pl_data_source"."status_id",
       "pl_data_source"."id",
       "pl_data_source"."name",
       "pl_data_source"."type",
       "pl_data_source"."url",
       "pl_data_source"."description",
       "pl_data_source"."weight",
       "pl_data_source"."class_name",
       "pl_data_source"."class_params_json",
       "pl_content_publisher"."created_dt",
       "pl_content_publisher"."updated_dt",
       "pl_content_publisher"."status_id",
       "pl_content_publisher"."id",
       "pl_content_publisher"."name",
       "pl_content_publisher"."url",
       "pl_content_publisher"."domain",
       "pl_content_publisher"."description",
       "pl_content_publisher"."weight",
       "pl_content_publisher"."trust_flow_score",
       "pl_content_publisher"."citation_flow_score"
  FROM "pl_content"
 INNER JOIN "pl_data_source"
    ON ("pl_content"."data_source_id" = "pl_data_source"."id")
  LEFT OUTER JOIN "pl_content_publisher"
    ON ("pl_content"."publisher_id" = "pl_content_publisher"."id")
 WHERE (("pl_content"."publish_dt" AT TIME ZONE 'America/Chicago')::date >= '2024-09-15'::date AND ("pl_content"."publish_dt" AT TIME ZONE 'America/Chicago')::date <= '2025-03-14'::date AND "pl_content"."status_id" = 10 AND "pl_content"."ticker" = 'NKTR')
 ORDER BY "pl_content"."publish_dt" ASCSELECT ••• FROM "pl_content" INNER JOIN "pl_data_source" ON ("pl_content"."data_source_id" = "pl_data_source"."id") LEFT OUTER JOIN "pl_content_publisher" ON ("pl_content"."publisher_id" = "pl_content_publisher"."id") WHERE (("pl_content"."publish_dt" AT TIME ZONE 'America/Chicago')::date >= '2024-09-15'::date AND ("pl_content"."publish_dt" AT TIME ZONE 'America/Chicago')::date <= '2025-03-14'::date AND "pl_content"."status_id" = 10 AND "pl_content"."ticker" = 'NKTR') ORDER BY "pl_content"."publish_dt" ASC
 31.63

Connection: default

Transaction status: Idle

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/whitenoise/middleware.py in __call__(124)
  return self.get_response(request)

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django_htmx/middleware.py in __call__(43)
  return self.get_response(request)

/mnt/disks/pennyloupe_disk/pennyloupe/app/core/views/app.py in ticker_content(1398)
  return render(request, "ticker_content.html", context)

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/shortcuts.py in render(25)
  content = loader.render_to_string(template_name, context, request, using=using)

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/template/loader.py in render_to_string(62)
  return template.render(context, request)

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/template/backends/django.py in render(61)
  return self.template.render(context)

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/template/base.py in render(171)
  return self._render(context)

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/test/utils.py in instrumented_test_render(111)
  return self.nodelist.render(context)

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/template/base.py in render(1000)
  return SafeString("".join([node.render_annotated(context) for node in self]))

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/template/base.py in <listcomp>(1000)
  return SafeString("".join([node.render_annotated(context) for node in self]))

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/template/base.py in render_annotated(961)
  return self.render(context)

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/template/loader_tags.py in render(159)
  return compiled_parent._render(context)

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/test/utils.py in instrumented_test_render(111)
  return self.nodelist.render(context)

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/template/base.py in render(1000)
  return SafeString("".join([node.render_annotated(context) for node in self]))

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/template/base.py in <listcomp>(1000)
  return SafeString("".join([node.render_annotated(context) for node in self]))

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/template/base.py in render_annotated(961)
  return self.render(context)

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/template/loader_tags.py in render(65)
  result = block.nodelist.render(context)

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/template/base.py in render(1000)
  return SafeString("".join([node.render_annotated(context) for node in self]))

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/template/base.py in <listcomp>(1000)
  return SafeString("".join([node.render_annotated(context) for node in self]))

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/template/base.py in render_annotated(961)
  return self.render(context)

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/template/defaulttags.py in render(319)
  match = condition.eval(context)

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/template/smartif.py in eval(87)
  return func(context, self.first)

/mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/template/smartif.py in <lambda>(100)
  "not": prefix(8, lambda context, x: not x.eval(context)),
53
54 <hr/>
55
56 {% if not content %}
57 <br/>
58 <p style="text-align:center;">
59 No Content exists for <b>{{ ticker }}</b> in this date range.
60 Please review your dates and try again.

/mnt/disks/pennyloupe_disk/pennyloupe/app/core/templates/ticker_content.html

Static files (717 found, 2 used)

Static file paths

None

Static file apps

  1. grappelli
  2. django.contrib.admin
  3. django_htmx
  4. app.core
  5. django_extensions
  6. debug_toolbar

Static files

css/pennyloupe.css
/mnt/disks/pennyloupe_disk/pennyloupe/app/core/static/css/pennyloupe.css
img/penny_loupe_logo.png
/mnt/disks/pennyloupe_disk/pennyloupe/app/core/static/img/penny_loupe_logo.png

django.contrib.staticfiles.finders.AppDirectoriesFinder (717 files)

Path Location
.DS_Store /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/.DS_Store
grappelli/.DS_Store /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/.DS_Store
grappelli/js/grappelli.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/js/grappelli.js
grappelli/js/jquery.grp_related_m2m.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/js/jquery.grp_related_m2m.js
grappelli/js/jquery.grp_autocomplete_fk.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/js/jquery.grp_autocomplete_fk.js
grappelli/js/jquery.grp_autocomplete_generic.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/js/jquery.grp_autocomplete_generic.js
grappelli/js/jquery.grp_timepicker.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/js/jquery.grp_timepicker.js
grappelli/js/jquery.grp_collapsible_group.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/js/jquery.grp_collapsible_group.js
grappelli/js/jquery.grp_related_generic.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/js/jquery.grp_related_generic.js
grappelli/js/jquery.grp_related_fk.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/js/jquery.grp_related_fk.js
grappelli/js/jquery.grp_collapsible.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/js/jquery.grp_collapsible.js
grappelli/js/grappelli.min.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/js/grappelli.min.js
grappelli/js/jquery.grp_autocomplete_m2m.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/js/jquery.grp_autocomplete_m2m.js
grappelli/js/jquery.grp_inline.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/js/jquery.grp_inline.js
grappelli/images/spritesheet-1694777276.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/spritesheet-1694777276.png
grappelli/images/backgrounds/loading-small.gif /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/backgrounds/loading-small.gif
grappelli/images/backgrounds/changelist-results.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/backgrounds/changelist-results.png
grappelli/images/backgrounds/ui-sortable-placeholder.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/backgrounds/ui-sortable-placeholder.png
grappelli/images/backgrounds/nav-grabber.gif /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/backgrounds/nav-grabber.gif
grappelli/images/backgrounds/messagelist.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/backgrounds/messagelist.png
grappelli/images/icons/ui-datepicker-next.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/ui-datepicker-next.png
grappelli/images/icons/link-external-small_hover.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/link-external-small_hover.png
grappelli/images/icons/tools-arrow-up-handler_hover.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/tools-arrow-up-handler_hover.png
grappelli/images/icons/date-hierarchy-back.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/date-hierarchy-back.png
grappelli/images/icons/tools-delete-handler-predelete.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/tools-delete-handler-predelete.png
grappelli/images/icons/breadcrumbs-rtl.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/breadcrumbs-rtl.png
grappelli/images/icons/datepicker_hover.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/datepicker_hover.png
grappelli/images/icons/tools-trash-handler_hover.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/tools-trash-handler_hover.png
grappelli/images/icons/selector-add-m2m-vertical_hover.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/selector-add-m2m-vertical_hover.png
grappelli/images/icons/tools-related-remove-handler-small_hover.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/tools-related-remove-handler-small_hover.png
grappelli/images/icons/sorted-descending.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/sorted-descending.png
grappelli/images/icons/breadcrumbs_hover.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/breadcrumbs_hover.png
grappelli/images/icons/tools-viewsite-link_hover.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/tools-viewsite-link_hover.png
grappelli/images/icons/object-tools-add-link.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/object-tools-add-link.png
grappelli/images/icons/tools-related-edit-handler-small-disabled.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/tools-related-edit-handler-small-disabled.png
grappelli/images/icons/tools-related-remove-handler-small-disabled.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/tools-related-remove-handler-small-disabled.png
grappelli/images/icons/sorted-ascending.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/sorted-ascending.png
grappelli/images/icons/link-internal-rtl-small_hover.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/link-internal-rtl-small_hover.png
grappelli/images/icons/pulldown-handler_selected.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/pulldown-handler_selected.png
grappelli/images/icons/tools-delete-handler_hover.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/tools-delete-handler_hover.png
grappelli/images/icons/tools-trash-handler.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/tools-trash-handler.png
grappelli/images/icons/related-lookup-m2m_hover.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/related-lookup-m2m_hover.png
grappelli/images/icons/tools-arrow-down-handler.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/tools-arrow-down-handler.png
grappelli/images/icons/tools-arrow-down-handler_hover.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/tools-arrow-down-handler_hover.png
grappelli/images/icons/selector-filter.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/selector-filter.png
grappelli/images/icons/link-external-small.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/link-external-small.png
grappelli/images/icons/link-external-rtl-small.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/link-external-rtl-small.png
grappelli/images/icons/date-hierarchy-back_hover.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/date-hierarchy-back_hover.png
grappelli/images/icons/change-link-small_hover.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/change-link-small_hover.png
grappelli/images/icons/datetime-now.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/datetime-now.png
grappelli/images/icons/change-link-small.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/change-link-small.png
grappelli/images/icons/sort-remove_hover.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/sort-remove_hover.png
grappelli/images/icons/tools-related-edit-handler-small.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/tools-related-edit-handler-small.png
grappelli/images/icons/link-internal-small_hover.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/link-internal-small_hover.png
grappelli/images/icons/th-ascending.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/th-ascending.png
grappelli/images/icons/related-lookup-m2m.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/related-lookup-m2m.png
grappelli/images/icons/tools-related-remove-handler-small.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/tools-related-remove-handler-small.png
grappelli/images/icons/autocomplete-single-small.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/autocomplete-single-small.png
grappelli/images/icons/breadcrumbs.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/breadcrumbs.png
grappelli/images/icons/selector-add-m2m-horizontal_hover.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/selector-add-m2m-horizontal_hover.png
grappelli/images/icons/tools-related-add-handler-small_hover.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/tools-related-add-handler-small_hover.png
grappelli/images/icons/add-link-small_hover.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/add-link-small_hover.png
grappelli/images/icons/add-link-small.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/add-link-small.png
grappelli/images/icons/add-another.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/add-another.png
grappelli/images/icons/tools-drag-handler_hover.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/tools-drag-handler_hover.png
grappelli/images/icons/related-remove_hover.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/related-remove_hover.png
grappelli/images/icons/pulldown-handler.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/pulldown-handler.png
grappelli/images/icons/ui-datepicker-prev.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/ui-datepicker-prev.png
grappelli/images/icons/selector-remove-m2m-horizontal_hover.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/selector-remove-m2m-horizontal_hover.png
grappelli/images/icons/tools-close-handler_hover.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/tools-close-handler_hover.png
grappelli/images/icons/tools-trash-list-toggle-handler.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/tools-trash-list-toggle-handler.png
grappelli/images/icons/tools-related-remove-handler.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/tools-related-remove-handler.png
grappelli/images/icons/link-internal-rtl_hover.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/link-internal-rtl_hover.png
grappelli/images/icons/object-tools-viewsite-link.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/object-tools-viewsite-link.png
grappelli/images/icons/tools-related-remove-handler-disabled.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/tools-related-remove-handler-disabled.png
grappelli/images/icons/timepicker.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/timepicker.png
grappelli/images/icons/tools-related-edit-handler-small_hover.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/tools-related-edit-handler-small_hover.png
grappelli/images/icons/selector-add-m2m-vertical.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/selector-add-m2m-vertical.png
grappelli/images/icons/date-hierarchy-back-rtl.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/date-hierarchy-back-rtl.png
grappelli/images/icons/selector-remove-m2m-vertical_hover.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/selector-remove-m2m-vertical_hover.png
grappelli/images/icons/datepicker.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/datepicker.png
grappelli/images/icons/datetime-now_hover.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/datetime-now_hover.png
grappelli/images/icons/breadcrumbs-rtl_hover.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/breadcrumbs-rtl_hover.png
grappelli/images/icons/selector-add-m2m-horizontal.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/selector-add-m2m-horizontal.png
grappelli/images/icons/status-no.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/status-no.png
grappelli/images/icons/status-unknown.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/status-unknown.png
grappelli/images/icons/tools-open-handler-hover.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/tools-open-handler-hover.png
grappelli/images/icons/pulldown-handler_hover.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/pulldown-handler_hover.png
grappelli/images/icons/back-link-rtl.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/back-link-rtl.png
grappelli/images/icons/tools-remove-handler.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/tools-remove-handler.png
grappelli/images/icons/ui-datepicker-next_hover.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/ui-datepicker-next_hover.png
grappelli/images/icons/date-hierarchy-back-rtl_hover.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/date-hierarchy-back-rtl_hover.png
grappelli/images/icons/delete-link-small.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/delete-link-small.png
grappelli/images/icons/tools-edit-handler_hover.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/tools-edit-handler_hover.png
grappelli/images/icons/tools-viewsite-link.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/tools-viewsite-link.png
grappelli/images/icons/tools-open-handler.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/tools-open-handler.png
grappelli/images/icons/tools-add-handler.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/tools-add-handler.png
grappelli/images/icons/th-descending.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/th-descending.png
grappelli/images/icons/tools-drag-handler.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/tools-drag-handler.png
grappelli/images/icons/tools-related-edit-handler.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/tools-related-edit-handler.png
grappelli/images/icons/tools-related-add-handler-small.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/tools-related-add-handler-small.png
grappelli/images/icons/sort-remove-small.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/sort-remove-small.png
grappelli/images/icons/related-lookup.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/related-lookup.png
grappelli/images/icons/tools-trash-list-toggle-handler_hover.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/tools-trash-list-toggle-handler_hover.png
grappelli/images/icons/sort-remove.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/sort-remove.png
grappelli/images/icons/autocomplete-multiple-small.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/autocomplete-multiple-small.png
grappelli/images/icons/back-link-rtl_hover.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/back-link-rtl_hover.png
grappelli/images/icons/link-internal-rtl.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/link-internal-rtl.png
grappelli/images/icons/link-external-rtl-small_hover.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/link-external-rtl-small_hover.png
grappelli/images/icons/tools-add-handler_hover.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/tools-add-handler_hover.png
grappelli/images/icons/tools-close-handler.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/tools-close-handler.png
grappelli/images/icons/back-link.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/back-link.png
grappelli/images/icons/selector-remove-m2m-vertical.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/selector-remove-m2m-vertical.png
grappelli/images/icons/status-yes.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/status-yes.png
grappelli/images/icons/form-select.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/form-select.png
grappelli/images/icons/tools-related-add-handler-small-disabled.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/tools-related-add-handler-small-disabled.png
grappelli/images/icons/related-remove.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/related-remove.png
grappelli/images/icons/tools-edit-handler.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/tools-edit-handler.png
grappelli/images/icons/tools-remove-handler_hover.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/tools-remove-handler_hover.png
grappelli/images/icons/tools-delete-handler.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/tools-delete-handler.png
grappelli/images/icons/tools-arrow-up-handler.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/tools-arrow-up-handler.png
grappelli/images/icons/ui-datepicker-prev_hover.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/ui-datepicker-prev_hover.png
grappelli/images/icons/timepicker_hover.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/timepicker_hover.png
grappelli/images/icons/filter-choice-selected-small.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/filter-choice-selected-small.png
grappelli/images/icons/related-lookup_hover.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/related-lookup_hover.png
grappelli/images/icons/link-internal-small.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/link-internal-small.png
grappelli/images/icons/link-internal-rtl-small.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/link-internal-rtl-small.png
grappelli/images/icons/tools-related-remove-handler_hover.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/tools-related-remove-handler_hover.png
grappelli/images/icons/add-another_hover.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/add-another_hover.png
grappelli/images/icons/selector-remove-m2m-horizontal.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/selector-remove-m2m-horizontal.png
grappelli/images/icons/searchbox.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/searchbox.png
grappelli/images/icons/back-link_hover.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/images/icons/back-link_hover.png
grappelli/img/admin/arrow-up.gif /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/img/admin/arrow-up.gif
grappelli/img/admin/arrow-down.gif /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/img/admin/arrow-down.gif
grappelli/tinymce_setup/tinymce_setup.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce_setup/tinymce_setup.js
grappelli/stylesheets/screen.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/stylesheets/screen.css
grappelli/stylesheets/rtl.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/stylesheets/rtl.css
grappelli/stylesheets/mueller/screen.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/stylesheets/mueller/screen.css
grappelli/stylesheets/mueller/grid/output.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/stylesheets/mueller/grid/output.css
grappelli/stylesheets/mueller/grid/output-rtl.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/stylesheets/mueller/grid/output-rtl.css
grappelli/stylesheets/partials/custom/tinymce.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/stylesheets/partials/custom/tinymce.css
grappelli/tinymce/.DS_Store /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/.DS_Store
grappelli/tinymce/changelog.txt /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/changelog.txt
grappelli/tinymce/examples/word.html /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/examples/word.html
grappelli/tinymce/examples/simple.html /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/examples/simple.html
grappelli/tinymce/examples/skins.html /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/examples/skins.html
grappelli/tinymce/examples/.DS_Store /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/examples/.DS_Store
grappelli/tinymce/examples/index.html /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/examples/index.html
grappelli/tinymce/examples/full.html /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/examples/full.html
grappelli/tinymce/examples/menu.html /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/examples/menu.html
grappelli/tinymce/examples/custom_formats.html /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/examples/custom_formats.html
grappelli/tinymce/examples/accessibility.html /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/examples/accessibility.html
grappelli/tinymce/examples/templates/layout1.htm /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/examples/templates/layout1.htm
grappelli/tinymce/examples/templates/snippet1.htm /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/examples/templates/snippet1.htm
grappelli/tinymce/examples/lists/template_list.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/examples/lists/template_list.js
grappelli/tinymce/examples/lists/media_list.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/examples/lists/media_list.js
grappelli/tinymce/examples/lists/image_list.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/examples/lists/image_list.js
grappelli/tinymce/examples/lists/link_list.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/examples/lists/link_list.js
grappelli/tinymce/examples/css/word.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/examples/css/word.css
grappelli/tinymce/examples/css/content.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/examples/css/content.css
grappelli/tinymce/examples/media/sample.ram /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/examples/media/sample.ram
grappelli/tinymce/examples/media/sample.mov /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/examples/media/sample.mov
grappelli/tinymce/examples/media/sample.rm /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/examples/media/sample.rm
grappelli/tinymce/examples/media/sample.avi /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/examples/media/sample.avi
grappelli/tinymce/examples/media/sample.swf /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/examples/media/sample.swf
grappelli/tinymce/examples/media/sample.dcr /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/examples/media/sample.dcr
grappelli/tinymce/examples/media/logo.jpg /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/examples/media/logo.jpg
grappelli/tinymce/examples/media/sample.flv /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/examples/media/sample.flv
grappelli/tinymce/examples/media/logo_over.jpg /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/examples/media/logo_over.jpg
grappelli/tinymce/jscripts/tiny_mce/tiny_mce_popup.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/tiny_mce_popup.js
grappelli/tinymce/jscripts/tiny_mce/license.txt /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/license.txt
grappelli/tinymce/jscripts/tiny_mce/tiny_mce.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/tiny_mce.js
grappelli/tinymce/jscripts/tiny_mce/tiny_mce_src.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/tiny_mce_src.js
grappelli/tinymce/jscripts/tiny_mce/utils/mctabs.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/utils/mctabs.js
grappelli/tinymce/jscripts/tiny_mce/utils/form_utils.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/utils/form_utils.js
grappelli/tinymce/jscripts/tiny_mce/utils/editable_selects.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/utils/editable_selects.js
grappelli/tinymce/jscripts/tiny_mce/utils/validate.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/utils/validate.js
grappelli/tinymce/jscripts/tiny_mce/themes/simple/editor_template.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/simple/editor_template.js
grappelli/tinymce/jscripts/tiny_mce/themes/simple/editor_template_src.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/simple/editor_template_src.js
grappelli/tinymce/jscripts/tiny_mce/themes/simple/img/icons.gif /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/simple/img/icons.gif
grappelli/tinymce/jscripts/tiny_mce/themes/simple/langs/en.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/simple/langs/en.js
grappelli/tinymce/jscripts/tiny_mce/themes/simple/skins/default/ui.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/simple/skins/default/ui.css
grappelli/tinymce/jscripts/tiny_mce/themes/simple/skins/default/content.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/simple/skins/default/content.css
grappelli/tinymce/jscripts/tiny_mce/themes/simple/skins/o2k7/ui.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/simple/skins/o2k7/ui.css
grappelli/tinymce/jscripts/tiny_mce/themes/simple/skins/o2k7/content.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/simple/skins/o2k7/content.css
grappelli/tinymce/jscripts/tiny_mce/themes/simple/skins/o2k7/img/button_bg.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/simple/skins/o2k7/img/button_bg.png
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/color_picker.htm /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/color_picker.htm
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/charmap.htm /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/charmap.htm
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/editor_template.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/editor_template.js
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/image.htm /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/image.htm
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/anchor.htm /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/anchor.htm
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/source_editor.htm /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/source_editor.htm
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/shortcuts.htm /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/shortcuts.htm
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/editor_template_src.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/editor_template_src.js
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/about.htm /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/about.htm
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/js/source_editor.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/js/source_editor.js
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/js/charmap.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/js/charmap.js
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/js/image.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/js/image.js
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/js/about.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/js/about.js
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/js/link.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/js/link.js
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/js/color_picker.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/js/color_picker.js
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/js/anchor.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/js/anchor.js
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/img/shockwave.gif /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/img/shockwave.gif
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/img/quicktime.gif /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/img/quicktime.gif
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/img/iframe.gif /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/img/iframe.gif
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/img/icons.gif /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/img/icons.gif
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/img/video.gif /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/img/video.gif
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/img/trans.gif /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/img/trans.gif
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/img/colorpicker.jpg /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/img/colorpicker.jpg
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/img/realmedia.gif /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/img/realmedia.gif
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/img/flash.gif /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/img/flash.gif
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/img/pagebreak.gif /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/img/pagebreak.gif
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/img/windowsmedia.gif /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/img/windowsmedia.gif
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/langs/en_dlg.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/langs/en_dlg.js
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/langs/en.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/langs/en.js
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/content_documentstructure_pl.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/content_documentstructure_pl.css
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/content_documentstructure.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/content_documentstructure.css
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/content_base.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/content_base.css
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/content_typography.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/content_typography.css
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/ui.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/ui.css
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/customized.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/customized.css
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/content_documentstructure_de.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/content_documentstructure_de.css
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/content_documentstructure_en.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/content_documentstructure_en.css
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/content_documentstructure_cs.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/content_documentstructure_cs.css
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/content_grid.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/content_grid.css
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/content.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/content.css
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/dialog.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/dialog.css
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/icons/icon-fb_show.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/icons/icon-fb_show.png
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/icons/icon-fb_show-hover.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/icons/icon-fb_show-hover.png
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/icons/icon-mceResize.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/icons/icon-mceResize.png
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/menu/icon-mceOpen.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/menu/icon-mceOpen.png
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/customized/button_pagebreak.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/customized/button_pagebreak.png
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/customized/pagebreak.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/customized/pagebreak.png
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/unlink.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/unlink.png
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/visualchars.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/visualchars.png
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/table_row_after.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/table_row_after.png
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/justifycenter.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/justifycenter.png
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/redo.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/redo.png
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/link.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/link.png
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/table_delete_row.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/table_delete_row.png
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/table.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/table.png
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/pasteword.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/pasteword.png
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/italic.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/italic.png
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/fullscreen.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/fullscreen.png
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/code.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/code.png
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/image.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/image.png
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/justifyright.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/justifyright.png
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/table_row_before.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/table_row_before.png
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/template.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/template.png
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/show_advanced.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/show_advanced.png
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/table_row_props.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/table_row_props.png
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/undo.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/undo.png
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/justifyleft.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/justifyleft.png
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/underline.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/underline.png
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/table_delete_col.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/table_delete_col.png
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/media.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/media.png
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/justifyfull.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/justifyfull.png
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/table_merge_cells.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/table_merge_cells.png
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/table_col_after.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/table_col_after.png
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/table_split_cells.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/table_split_cells.png
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/table_col_before.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/table_col_before.png
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/bold.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/bold.png
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/charmap.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/charmap.png
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/numlist.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/numlist.png
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/bullist.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/bullist.png
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/table_cell_props.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/table_cell_props.png
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/search.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/search.png
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/blockquote.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/blockquote.png
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/cleanup.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/grappelli/img/buttons/cleanup.png
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/default/ui.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/default/ui.css
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/default/content.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/default/content.css
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/default/dialog.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/default/dialog.css
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/default/img/menu_arrow.gif /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/default/img/menu_arrow.gif
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/default/img/buttons.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/default/img/buttons.png
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/default/img/tabs.gif /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/default/img/tabs.gif
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/default/img/menu_check.gif /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/default/img/menu_check.gif
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/default/img/progress.gif /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/default/img/progress.gif
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/default/img/items.gif /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/default/img/items.gif
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/o2k7/ui_silver.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/o2k7/ui_silver.css
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/o2k7/ui.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/o2k7/ui.css
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/o2k7/content.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/o2k7/content.css
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/o2k7/dialog.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/o2k7/dialog.css
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/o2k7/ui_black.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/o2k7/ui_black.css
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/o2k7/img/button_bg.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/o2k7/img/button_bg.png
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/o2k7/img/button_bg_silver.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/o2k7/img/button_bg_silver.png
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/o2k7/img/button_bg_black.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/o2k7/img/button_bg_black.png
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/highcontrast/ui.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/highcontrast/ui.css
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/highcontrast/content.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/highcontrast/content.css
grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/highcontrast/dialog.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/themes/advanced/skins/highcontrast/dialog.css
grappelli/tinymce/jscripts/tiny_mce/langs/en.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/langs/en.js
grappelli/tinymce/jscripts/tiny_mce/plugins/table/merge_cells.htm /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/table/merge_cells.htm
grappelli/tinymce/jscripts/tiny_mce/plugins/table/table.htm /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/table/table.htm
grappelli/tinymce/jscripts/tiny_mce/plugins/table/row.htm /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/table/row.htm
grappelli/tinymce/jscripts/tiny_mce/plugins/table/editor_plugin_src.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/table/editor_plugin_src.js
grappelli/tinymce/jscripts/tiny_mce/plugins/table/editor_plugin.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/table/editor_plugin.js
grappelli/tinymce/jscripts/tiny_mce/plugins/table/cell.htm /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/table/cell.htm
grappelli/tinymce/jscripts/tiny_mce/plugins/table/js/row.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/table/js/row.js
grappelli/tinymce/jscripts/tiny_mce/plugins/table/js/merge_cells.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/table/js/merge_cells.js
grappelli/tinymce/jscripts/tiny_mce/plugins/table/js/cell.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/table/js/cell.js
grappelli/tinymce/jscripts/tiny_mce/plugins/table/js/table.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/table/js/table.js
grappelli/tinymce/jscripts/tiny_mce/plugins/table/css/row.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/table/css/row.css
grappelli/tinymce/jscripts/tiny_mce/plugins/table/css/table.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/table/css/table.css
grappelli/tinymce/jscripts/tiny_mce/plugins/table/css/cell.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/table/css/cell.css
grappelli/tinymce/jscripts/tiny_mce/plugins/table/langs/en_dlg.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/table/langs/en_dlg.js
grappelli/tinymce/jscripts/tiny_mce/plugins/advimage/editor_plugin_src.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/advimage/editor_plugin_src.js
grappelli/tinymce/jscripts/tiny_mce/plugins/advimage/image.htm /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/advimage/image.htm
grappelli/tinymce/jscripts/tiny_mce/plugins/advimage/editor_plugin.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/advimage/editor_plugin.js
grappelli/tinymce/jscripts/tiny_mce/plugins/advimage/js/image.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/advimage/js/image.js
grappelli/tinymce/jscripts/tiny_mce/plugins/advimage/img/sample.gif /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/advimage/img/sample.gif
grappelli/tinymce/jscripts/tiny_mce/plugins/advimage/css/advimage.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/advimage/css/advimage.css
grappelli/tinymce/jscripts/tiny_mce/plugins/advimage/langs/en_dlg.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/advimage/langs/en_dlg.js
grappelli/tinymce/jscripts/tiny_mce/plugins/style/editor_plugin_src.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/style/editor_plugin_src.js
grappelli/tinymce/jscripts/tiny_mce/plugins/style/editor_plugin.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/style/editor_plugin.js
grappelli/tinymce/jscripts/tiny_mce/plugins/style/readme.txt /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/style/readme.txt
grappelli/tinymce/jscripts/tiny_mce/plugins/style/props.htm /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/style/props.htm
grappelli/tinymce/jscripts/tiny_mce/plugins/style/js/props.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/style/js/props.js
grappelli/tinymce/jscripts/tiny_mce/plugins/style/css/props.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/style/css/props.css
grappelli/tinymce/jscripts/tiny_mce/plugins/style/langs/en_dlg.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/style/langs/en_dlg.js
grappelli/tinymce/jscripts/tiny_mce/plugins/fullpage/fullpage.htm /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/fullpage/fullpage.htm
grappelli/tinymce/jscripts/tiny_mce/plugins/fullpage/editor_plugin_src.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/fullpage/editor_plugin_src.js
grappelli/tinymce/jscripts/tiny_mce/plugins/fullpage/editor_plugin.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/fullpage/editor_plugin.js
grappelli/tinymce/jscripts/tiny_mce/plugins/fullpage/js/fullpage.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/fullpage/js/fullpage.js
grappelli/tinymce/jscripts/tiny_mce/plugins/fullpage/css/fullpage.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/fullpage/css/fullpage.css
grappelli/tinymce/jscripts/tiny_mce/plugins/fullpage/langs/en_dlg.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/fullpage/langs/en_dlg.js
grappelli/tinymce/jscripts/tiny_mce/plugins/autosave/editor_plugin_src.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/autosave/editor_plugin_src.js
grappelli/tinymce/jscripts/tiny_mce/plugins/autosave/editor_plugin.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/autosave/editor_plugin.js
grappelli/tinymce/jscripts/tiny_mce/plugins/directionality/editor_plugin_src.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/directionality/editor_plugin_src.js
grappelli/tinymce/jscripts/tiny_mce/plugins/directionality/editor_plugin.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/directionality/editor_plugin.js
grappelli/tinymce/jscripts/tiny_mce/plugins/media_orig/moxieplayer.swf /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/media_orig/moxieplayer.swf
grappelli/tinymce/jscripts/tiny_mce/plugins/media_orig/media.htm /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/media_orig/media.htm
grappelli/tinymce/jscripts/tiny_mce/plugins/media_orig/editor_plugin_src.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/media_orig/editor_plugin_src.js
grappelli/tinymce/jscripts/tiny_mce/plugins/media_orig/editor_plugin.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/media_orig/editor_plugin.js
grappelli/tinymce/jscripts/tiny_mce/plugins/media_orig/js/media.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/media_orig/js/media.js
grappelli/tinymce/jscripts/tiny_mce/plugins/media_orig/js/embed.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/media_orig/js/embed.js
grappelli/tinymce/jscripts/tiny_mce/plugins/media_orig/css/media.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/media_orig/css/media.css
grappelli/tinymce/jscripts/tiny_mce/plugins/media_orig/langs/en_dlg.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/media_orig/langs/en_dlg.js
grappelli/tinymce/jscripts/tiny_mce/plugins/preview/editor_plugin_src.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/preview/editor_plugin_src.js
grappelli/tinymce/jscripts/tiny_mce/plugins/preview/editor_plugin.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/preview/editor_plugin.js
grappelli/tinymce/jscripts/tiny_mce/plugins/preview/example.html /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/preview/example.html
grappelli/tinymce/jscripts/tiny_mce/plugins/preview/preview.html /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/preview/preview.html
grappelli/tinymce/jscripts/tiny_mce/plugins/preview/jscripts/embed.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/preview/jscripts/embed.js
grappelli/tinymce/jscripts/tiny_mce/plugins/print/editor_plugin_src.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/print/editor_plugin_src.js
grappelli/tinymce/jscripts/tiny_mce/plugins/print/editor_plugin.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/print/editor_plugin.js
grappelli/tinymce/jscripts/tiny_mce/plugins/template_orig/blank.htm /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/template_orig/blank.htm
grappelli/tinymce/jscripts/tiny_mce/plugins/template_orig/template.htm /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/template_orig/template.htm
grappelli/tinymce/jscripts/tiny_mce/plugins/template_orig/editor_plugin_src.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/template_orig/editor_plugin_src.js
grappelli/tinymce/jscripts/tiny_mce/plugins/template_orig/editor_plugin.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/template_orig/editor_plugin.js
grappelli/tinymce/jscripts/tiny_mce/plugins/template_orig/js/template.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/template_orig/js/template.js
grappelli/tinymce/jscripts/tiny_mce/plugins/template_orig/css/template.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/template_orig/css/template.css
grappelli/tinymce/jscripts/tiny_mce/plugins/template_orig/langs/en_dlg.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/template_orig/langs/en_dlg.js
grappelli/tinymce/jscripts/tiny_mce/plugins/grappelli/editor_plugin_src.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/grappelli/editor_plugin_src.js
grappelli/tinymce/jscripts/tiny_mce/plugins/grappelli/editor_plugin.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/grappelli/editor_plugin.js
grappelli/tinymce/jscripts/tiny_mce/plugins/grappelli/img/visualchars.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/grappelli/img/visualchars.png
grappelli/tinymce/jscripts/tiny_mce/plugins/grappelli/img/show_advanced.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/grappelli/img/show_advanced.png
grappelli/tinymce/jscripts/tiny_mce/plugins/grappelli/langs/fr.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/grappelli/langs/fr.js
grappelli/tinymce/jscripts/tiny_mce/plugins/grappelli/langs/cs.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/grappelli/langs/cs.js
grappelli/tinymce/jscripts/tiny_mce/plugins/grappelli/langs/pl.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/grappelli/langs/pl.js
grappelli/tinymce/jscripts/tiny_mce/plugins/grappelli/langs/en.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/grappelli/langs/en.js
grappelli/tinymce/jscripts/tiny_mce/plugins/grappelli/langs/de.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/grappelli/langs/de.js
grappelli/tinymce/jscripts/tiny_mce/plugins/grappelli/langs/ru.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/grappelli/langs/ru.js
grappelli/tinymce/jscripts/tiny_mce/plugins/visualchars/editor_plugin_src.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/visualchars/editor_plugin_src.js
grappelli/tinymce/jscripts/tiny_mce/plugins/visualchars/editor_plugin.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/visualchars/editor_plugin.js
grappelli/tinymce/jscripts/tiny_mce/plugins/advlist/editor_plugin_src.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/advlist/editor_plugin_src.js
grappelli/tinymce/jscripts/tiny_mce/plugins/advlist/editor_plugin.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/advlist/editor_plugin.js
grappelli/tinymce/jscripts/tiny_mce/plugins/advimage_orig/editor_plugin_src.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/advimage_orig/editor_plugin_src.js
grappelli/tinymce/jscripts/tiny_mce/plugins/advimage_orig/image.htm /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/advimage_orig/image.htm
grappelli/tinymce/jscripts/tiny_mce/plugins/advimage_orig/editor_plugin.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/advimage_orig/editor_plugin.js
grappelli/tinymce/jscripts/tiny_mce/plugins/advimage_orig/js/image.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/advimage_orig/js/image.js
grappelli/tinymce/jscripts/tiny_mce/plugins/advimage_orig/img/sample.gif /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/advimage_orig/img/sample.gif
grappelli/tinymce/jscripts/tiny_mce/plugins/advimage_orig/css/advimage.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/advimage_orig/css/advimage.css
grappelli/tinymce/jscripts/tiny_mce/plugins/advimage_orig/langs/en_dlg.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/advimage_orig/langs/en_dlg.js
grappelli/tinymce/jscripts/tiny_mce/plugins/paste/editor_plugin_src.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/paste/editor_plugin_src.js
grappelli/tinymce/jscripts/tiny_mce/plugins/paste/editor_plugin.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/paste/editor_plugin.js
grappelli/tinymce/jscripts/tiny_mce/plugins/paste/pastetext.htm /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/paste/pastetext.htm
grappelli/tinymce/jscripts/tiny_mce/plugins/paste/pasteword.htm /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/paste/pasteword.htm
grappelli/tinymce/jscripts/tiny_mce/plugins/paste/js/pasteword.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/paste/js/pasteword.js
grappelli/tinymce/jscripts/tiny_mce/plugins/paste/js/pastetext.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/paste/js/pastetext.js
grappelli/tinymce/jscripts/tiny_mce/plugins/paste/langs/en_dlg.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/paste/langs/en_dlg.js
grappelli/tinymce/jscripts/tiny_mce/plugins/visualblocks/editor_plugin_src.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/visualblocks/editor_plugin_src.js
grappelli/tinymce/jscripts/tiny_mce/plugins/visualblocks/editor_plugin.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/visualblocks/editor_plugin.js
grappelli/tinymce/jscripts/tiny_mce/plugins/visualblocks/css/visualblocks.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/visualblocks/css/visualblocks.css
grappelli/tinymce/jscripts/tiny_mce/plugins/advhr/editor_plugin_src.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/advhr/editor_plugin_src.js
grappelli/tinymce/jscripts/tiny_mce/plugins/advhr/editor_plugin.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/advhr/editor_plugin.js
grappelli/tinymce/jscripts/tiny_mce/plugins/advhr/rule.htm /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/advhr/rule.htm
grappelli/tinymce/jscripts/tiny_mce/plugins/advhr/js/rule.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/advhr/js/rule.js
grappelli/tinymce/jscripts/tiny_mce/plugins/advhr/css/advhr.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/advhr/css/advhr.css
grappelli/tinymce/jscripts/tiny_mce/plugins/advhr/langs/en_dlg.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/advhr/langs/en_dlg.js
grappelli/tinymce/jscripts/tiny_mce/plugins/save/editor_plugin_src.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/save/editor_plugin_src.js
grappelli/tinymce/jscripts/tiny_mce/plugins/save/editor_plugin.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/save/editor_plugin.js
grappelli/tinymce/jscripts/tiny_mce/plugins/fullscreen/fullscreen.htm /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/fullscreen/fullscreen.htm
grappelli/tinymce/jscripts/tiny_mce/plugins/fullscreen/editor_plugin_src.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/fullscreen/editor_plugin_src.js
grappelli/tinymce/jscripts/tiny_mce/plugins/fullscreen/editor_plugin.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/fullscreen/editor_plugin.js
grappelli/tinymce/jscripts/tiny_mce/plugins/bbcode/editor_plugin_src.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/bbcode/editor_plugin_src.js
grappelli/tinymce/jscripts/tiny_mce/plugins/bbcode/editor_plugin.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/bbcode/editor_plugin.js
grappelli/tinymce/jscripts/tiny_mce/plugins/example_dependency/editor_plugin_src.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/example_dependency/editor_plugin_src.js
grappelli/tinymce/jscripts/tiny_mce/plugins/example_dependency/editor_plugin.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/example_dependency/editor_plugin.js
grappelli/tinymce/jscripts/tiny_mce/plugins/autoresize/editor_plugin_src.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/autoresize/editor_plugin_src.js
grappelli/tinymce/jscripts/tiny_mce/plugins/autoresize/editor_plugin.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/autoresize/editor_plugin.js
grappelli/tinymce/jscripts/tiny_mce/plugins/lists/editor_plugin_src.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/lists/editor_plugin_src.js
grappelli/tinymce/jscripts/tiny_mce/plugins/lists/editor_plugin.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/lists/editor_plugin.js
grappelli/tinymce/jscripts/tiny_mce/plugins/paste_orig/editor_plugin_src.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/paste_orig/editor_plugin_src.js
grappelli/tinymce/jscripts/tiny_mce/plugins/paste_orig/editor_plugin.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/paste_orig/editor_plugin.js
grappelli/tinymce/jscripts/tiny_mce/plugins/paste_orig/pastetext.htm /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/paste_orig/pastetext.htm
grappelli/tinymce/jscripts/tiny_mce/plugins/paste_orig/pasteword.htm /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/paste_orig/pasteword.htm
grappelli/tinymce/jscripts/tiny_mce/plugins/paste_orig/js/pasteword.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/paste_orig/js/pasteword.js
grappelli/tinymce/jscripts/tiny_mce/plugins/paste_orig/js/pastetext.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/paste_orig/js/pastetext.js
grappelli/tinymce/jscripts/tiny_mce/plugins/paste_orig/langs/en_dlg.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/paste_orig/langs/en_dlg.js
grappelli/tinymce/jscripts/tiny_mce/plugins/template/blank.htm /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/template/blank.htm
grappelli/tinymce/jscripts/tiny_mce/plugins/template/template.htm /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/template/template.htm
grappelli/tinymce/jscripts/tiny_mce/plugins/template/editor_plugin_src.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/template/editor_plugin_src.js
grappelli/tinymce/jscripts/tiny_mce/plugins/template/editor_plugin.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/template/editor_plugin.js
grappelli/tinymce/jscripts/tiny_mce/plugins/template/js/template.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/template/js/template.js
grappelli/tinymce/jscripts/tiny_mce/plugins/template/css/template.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/template/css/template.css
grappelli/tinymce/jscripts/tiny_mce/plugins/template/langs/en_dlg.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/template/langs/en_dlg.js
grappelli/tinymce/jscripts/tiny_mce/plugins/inlinepopups/template.htm /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/inlinepopups/template.htm
grappelli/tinymce/jscripts/tiny_mce/plugins/inlinepopups/editor_plugin_src.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/inlinepopups/editor_plugin_src.js
grappelli/tinymce/jscripts/tiny_mce/plugins/inlinepopups/editor_plugin.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/inlinepopups/editor_plugin.js
grappelli/tinymce/jscripts/tiny_mce/plugins/inlinepopups/skins/clearlooks2/window.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/inlinepopups/skins/clearlooks2/window.css
grappelli/tinymce/jscripts/tiny_mce/plugins/inlinepopups/skins/clearlooks2/img/alert.gif /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/inlinepopups/skins/clearlooks2/img/alert.gif
grappelli/tinymce/jscripts/tiny_mce/plugins/inlinepopups/skins/clearlooks2/img/buttons.gif /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/inlinepopups/skins/clearlooks2/img/buttons.gif
grappelli/tinymce/jscripts/tiny_mce/plugins/inlinepopups/skins/clearlooks2/img/corners.gif /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/inlinepopups/skins/clearlooks2/img/corners.gif
grappelli/tinymce/jscripts/tiny_mce/plugins/inlinepopups/skins/clearlooks2/img/confirm.gif /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/inlinepopups/skins/clearlooks2/img/confirm.gif
grappelli/tinymce/jscripts/tiny_mce/plugins/inlinepopups/skins/clearlooks2/img/horizontal.gif /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/inlinepopups/skins/clearlooks2/img/horizontal.gif
grappelli/tinymce/jscripts/tiny_mce/plugins/inlinepopups/skins/clearlooks2/img/vertical.gif /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/inlinepopups/skins/clearlooks2/img/vertical.gif
grappelli/tinymce/jscripts/tiny_mce/plugins/inlinepopups/skins/clearlooks2/img/button.gif /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/inlinepopups/skins/clearlooks2/img/button.gif
grappelli/tinymce/jscripts/tiny_mce/plugins/searchreplace_orig/editor_plugin_src.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/searchreplace_orig/editor_plugin_src.js
grappelli/tinymce/jscripts/tiny_mce/plugins/searchreplace_orig/editor_plugin.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/searchreplace_orig/editor_plugin.js
grappelli/tinymce/jscripts/tiny_mce/plugins/searchreplace_orig/searchreplace.htm /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/searchreplace_orig/searchreplace.htm
grappelli/tinymce/jscripts/tiny_mce/plugins/searchreplace_orig/js/searchreplace.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/searchreplace_orig/js/searchreplace.js
grappelli/tinymce/jscripts/tiny_mce/plugins/searchreplace_orig/css/searchreplace.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/searchreplace_orig/css/searchreplace.css
grappelli/tinymce/jscripts/tiny_mce/plugins/searchreplace_orig/langs/en_dlg.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/searchreplace_orig/langs/en_dlg.js
grappelli/tinymce/jscripts/tiny_mce/plugins/advlink/editor_plugin_src.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/advlink/editor_plugin_src.js
grappelli/tinymce/jscripts/tiny_mce/plugins/advlink/editor_plugin.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/advlink/editor_plugin.js
grappelli/tinymce/jscripts/tiny_mce/plugins/advlink/link.htm /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/advlink/link.htm
grappelli/tinymce/jscripts/tiny_mce/plugins/advlink/js/advlink.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/advlink/js/advlink.js
grappelli/tinymce/jscripts/tiny_mce/plugins/advlink/css/advlink.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/advlink/css/advlink.css
grappelli/tinymce/jscripts/tiny_mce/plugins/advlink/langs/en_dlg.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/advlink/langs/en_dlg.js
grappelli/tinymce/jscripts/tiny_mce/plugins/tabfocus/editor_plugin_src.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/tabfocus/editor_plugin_src.js
grappelli/tinymce/jscripts/tiny_mce/plugins/tabfocus/editor_plugin.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/tabfocus/editor_plugin.js
grappelli/tinymce/jscripts/tiny_mce/plugins/layer/editor_plugin_src.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/layer/editor_plugin_src.js
grappelli/tinymce/jscripts/tiny_mce/plugins/layer/editor_plugin.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/layer/editor_plugin.js
grappelli/tinymce/jscripts/tiny_mce/plugins/pagebreak/editor_plugin_src.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/pagebreak/editor_plugin_src.js
grappelli/tinymce/jscripts/tiny_mce/plugins/pagebreak/editor_plugin.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/pagebreak/editor_plugin.js
grappelli/tinymce/jscripts/tiny_mce/plugins/iespell/editor_plugin_src.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/iespell/editor_plugin_src.js
grappelli/tinymce/jscripts/tiny_mce/plugins/iespell/editor_plugin.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/iespell/editor_plugin.js
grappelli/tinymce/jscripts/tiny_mce/plugins/example/dialog.htm /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/example/dialog.htm
grappelli/tinymce/jscripts/tiny_mce/plugins/example/editor_plugin_src.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/example/editor_plugin_src.js
grappelli/tinymce/jscripts/tiny_mce/plugins/example/editor_plugin.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/example/editor_plugin.js
grappelli/tinymce/jscripts/tiny_mce/plugins/example/js/dialog.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/example/js/dialog.js
grappelli/tinymce/jscripts/tiny_mce/plugins/example/img/example.gif /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/example/img/example.gif
grappelli/tinymce/jscripts/tiny_mce/plugins/example/langs/en_dlg.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/example/langs/en_dlg.js
grappelli/tinymce/jscripts/tiny_mce/plugins/example/langs/en.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/example/langs/en.js
grappelli/tinymce/jscripts/tiny_mce/plugins/xhtmlxtras/editor_plugin_src.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/xhtmlxtras/editor_plugin_src.js
grappelli/tinymce/jscripts/tiny_mce/plugins/xhtmlxtras/cite.htm /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/xhtmlxtras/cite.htm
grappelli/tinymce/jscripts/tiny_mce/plugins/xhtmlxtras/editor_plugin.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/xhtmlxtras/editor_plugin.js
grappelli/tinymce/jscripts/tiny_mce/plugins/xhtmlxtras/del.htm /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/xhtmlxtras/del.htm
grappelli/tinymce/jscripts/tiny_mce/plugins/xhtmlxtras/acronym.htm /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/xhtmlxtras/acronym.htm
grappelli/tinymce/jscripts/tiny_mce/plugins/xhtmlxtras/ins.htm /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/xhtmlxtras/ins.htm
grappelli/tinymce/jscripts/tiny_mce/plugins/xhtmlxtras/abbr.htm /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/xhtmlxtras/abbr.htm
grappelli/tinymce/jscripts/tiny_mce/plugins/xhtmlxtras/attributes.htm /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/xhtmlxtras/attributes.htm
grappelli/tinymce/jscripts/tiny_mce/plugins/xhtmlxtras/js/ins.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/xhtmlxtras/js/ins.js
grappelli/tinymce/jscripts/tiny_mce/plugins/xhtmlxtras/js/cite.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/xhtmlxtras/js/cite.js
grappelli/tinymce/jscripts/tiny_mce/plugins/xhtmlxtras/js/acronym.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/xhtmlxtras/js/acronym.js
grappelli/tinymce/jscripts/tiny_mce/plugins/xhtmlxtras/js/attributes.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/xhtmlxtras/js/attributes.js
grappelli/tinymce/jscripts/tiny_mce/plugins/xhtmlxtras/js/element_common.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/xhtmlxtras/js/element_common.js
grappelli/tinymce/jscripts/tiny_mce/plugins/xhtmlxtras/js/abbr.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/xhtmlxtras/js/abbr.js
grappelli/tinymce/jscripts/tiny_mce/plugins/xhtmlxtras/js/del.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/xhtmlxtras/js/del.js
grappelli/tinymce/jscripts/tiny_mce/plugins/xhtmlxtras/css/popup.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/xhtmlxtras/css/popup.css
grappelli/tinymce/jscripts/tiny_mce/plugins/xhtmlxtras/css/attributes.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/xhtmlxtras/css/attributes.css
grappelli/tinymce/jscripts/tiny_mce/plugins/xhtmlxtras/langs/en_dlg.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/xhtmlxtras/langs/en_dlg.js
grappelli/tinymce/jscripts/tiny_mce/plugins/noneditable/editor_plugin_src.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/noneditable/editor_plugin_src.js
grappelli/tinymce/jscripts/tiny_mce/plugins/noneditable/editor_plugin.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/noneditable/editor_plugin.js
grappelli/tinymce/jscripts/tiny_mce/plugins/grappelli_contextmenu/editor_plugin_src.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/grappelli_contextmenu/editor_plugin_src.js
grappelli/tinymce/jscripts/tiny_mce/plugins/grappelli_contextmenu/editor_plugin.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/grappelli_contextmenu/editor_plugin.js
grappelli/tinymce/jscripts/tiny_mce/plugins/grappelli_contextmenu/langs/fr.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/grappelli_contextmenu/langs/fr.js
grappelli/tinymce/jscripts/tiny_mce/plugins/grappelli_contextmenu/langs/cs.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/grappelli_contextmenu/langs/cs.js
grappelli/tinymce/jscripts/tiny_mce/plugins/grappelli_contextmenu/langs/pl.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/grappelli_contextmenu/langs/pl.js
grappelli/tinymce/jscripts/tiny_mce/plugins/grappelli_contextmenu/langs/en.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/grappelli_contextmenu/langs/en.js
grappelli/tinymce/jscripts/tiny_mce/plugins/grappelli_contextmenu/langs/de.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/grappelli_contextmenu/langs/de.js
grappelli/tinymce/jscripts/tiny_mce/plugins/grappelli_contextmenu/langs/ru.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/grappelli_contextmenu/langs/ru.js
grappelli/tinymce/jscripts/tiny_mce/plugins/contextmenu/editor_plugin_src.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/contextmenu/editor_plugin_src.js
grappelli/tinymce/jscripts/tiny_mce/plugins/contextmenu/editor_plugin.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/contextmenu/editor_plugin.js
grappelli/tinymce/jscripts/tiny_mce/plugins/legacyoutput/editor_plugin_src.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/legacyoutput/editor_plugin_src.js
grappelli/tinymce/jscripts/tiny_mce/plugins/legacyoutput/editor_plugin.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/legacyoutput/editor_plugin.js
grappelli/tinymce/jscripts/tiny_mce/plugins/autolink/editor_plugin_src.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/autolink/editor_plugin_src.js
grappelli/tinymce/jscripts/tiny_mce/plugins/autolink/editor_plugin.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/autolink/editor_plugin.js
grappelli/tinymce/jscripts/tiny_mce/plugins/wordcount/editor_plugin_src.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/wordcount/editor_plugin_src.js
grappelli/tinymce/jscripts/tiny_mce/plugins/wordcount/editor_plugin.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/wordcount/editor_plugin.js
grappelli/tinymce/jscripts/tiny_mce/plugins/emotions/editor_plugin_src.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/emotions/editor_plugin_src.js
grappelli/tinymce/jscripts/tiny_mce/plugins/emotions/editor_plugin.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/emotions/editor_plugin.js
grappelli/tinymce/jscripts/tiny_mce/plugins/emotions/emotions.htm /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/emotions/emotions.htm
grappelli/tinymce/jscripts/tiny_mce/plugins/emotions/js/emotions.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/emotions/js/emotions.js
grappelli/tinymce/jscripts/tiny_mce/plugins/emotions/img/smiley-tongue-out.gif /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/emotions/img/smiley-tongue-out.gif
grappelli/tinymce/jscripts/tiny_mce/plugins/emotions/img/smiley-smile.gif /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/emotions/img/smiley-smile.gif
grappelli/tinymce/jscripts/tiny_mce/plugins/emotions/img/smiley-laughing.gif /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/emotions/img/smiley-laughing.gif
grappelli/tinymce/jscripts/tiny_mce/plugins/emotions/img/smiley-cool.gif /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/emotions/img/smiley-cool.gif
grappelli/tinymce/jscripts/tiny_mce/plugins/emotions/img/smiley-money-mouth.gif /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/emotions/img/smiley-money-mouth.gif
grappelli/tinymce/jscripts/tiny_mce/plugins/emotions/img/smiley-foot-in-mouth.gif /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/emotions/img/smiley-foot-in-mouth.gif
grappelli/tinymce/jscripts/tiny_mce/plugins/emotions/img/smiley-kiss.gif /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/emotions/img/smiley-kiss.gif
grappelli/tinymce/jscripts/tiny_mce/plugins/emotions/img/smiley-surprised.gif /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/emotions/img/smiley-surprised.gif
grappelli/tinymce/jscripts/tiny_mce/plugins/emotions/img/smiley-wink.gif /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/emotions/img/smiley-wink.gif
grappelli/tinymce/jscripts/tiny_mce/plugins/emotions/img/smiley-sealed.gif /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/emotions/img/smiley-sealed.gif
grappelli/tinymce/jscripts/tiny_mce/plugins/emotions/img/smiley-frown.gif /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/emotions/img/smiley-frown.gif
grappelli/tinymce/jscripts/tiny_mce/plugins/emotions/img/smiley-cry.gif /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/emotions/img/smiley-cry.gif
grappelli/tinymce/jscripts/tiny_mce/plugins/emotions/img/smiley-embarassed.gif /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/emotions/img/smiley-embarassed.gif
grappelli/tinymce/jscripts/tiny_mce/plugins/emotions/img/smiley-undecided.gif /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/emotions/img/smiley-undecided.gif
grappelli/tinymce/jscripts/tiny_mce/plugins/emotions/img/smiley-yell.gif /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/emotions/img/smiley-yell.gif
grappelli/tinymce/jscripts/tiny_mce/plugins/emotions/img/smiley-innocent.gif /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/emotions/img/smiley-innocent.gif
grappelli/tinymce/jscripts/tiny_mce/plugins/emotions/langs/en_dlg.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/emotions/langs/en_dlg.js
grappelli/tinymce/jscripts/tiny_mce/plugins/advlink_orig/editor_plugin_src.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/advlink_orig/editor_plugin_src.js
grappelli/tinymce/jscripts/tiny_mce/plugins/advlink_orig/editor_plugin.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/advlink_orig/editor_plugin.js
grappelli/tinymce/jscripts/tiny_mce/plugins/advlink_orig/link.htm /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/advlink_orig/link.htm
grappelli/tinymce/jscripts/tiny_mce/plugins/advlink_orig/js/advlink.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/advlink_orig/js/advlink.js
grappelli/tinymce/jscripts/tiny_mce/plugins/advlink_orig/css/advlink.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/advlink_orig/css/advlink.css
grappelli/tinymce/jscripts/tiny_mce/plugins/advlink_orig/langs/en_dlg.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/advlink_orig/langs/en_dlg.js
grappelli/tinymce/jscripts/tiny_mce/plugins/spellchecker/editor_plugin_src.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/spellchecker/editor_plugin_src.js
grappelli/tinymce/jscripts/tiny_mce/plugins/spellchecker/editor_plugin.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/spellchecker/editor_plugin.js
grappelli/tinymce/jscripts/tiny_mce/plugins/spellchecker/img/wline.gif /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/spellchecker/img/wline.gif
grappelli/tinymce/jscripts/tiny_mce/plugins/spellchecker/css/content.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/spellchecker/css/content.css
grappelli/tinymce/jscripts/tiny_mce/plugins/insertdatetime/editor_plugin_src.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/insertdatetime/editor_plugin_src.js
grappelli/tinymce/jscripts/tiny_mce/plugins/insertdatetime/editor_plugin.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/insertdatetime/editor_plugin.js
grappelli/tinymce/jscripts/tiny_mce/plugins/searchreplace/editor_plugin_src.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/searchreplace/editor_plugin_src.js
grappelli/tinymce/jscripts/tiny_mce/plugins/searchreplace/editor_plugin.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/searchreplace/editor_plugin.js
grappelli/tinymce/jscripts/tiny_mce/plugins/searchreplace/searchreplace.htm /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/searchreplace/searchreplace.htm
grappelli/tinymce/jscripts/tiny_mce/plugins/searchreplace/js/searchreplace.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/searchreplace/js/searchreplace.js
grappelli/tinymce/jscripts/tiny_mce/plugins/searchreplace/css/searchreplace.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/searchreplace/css/searchreplace.css
grappelli/tinymce/jscripts/tiny_mce/plugins/searchreplace/langs/en_dlg.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/searchreplace/langs/en_dlg.js
grappelli/tinymce/jscripts/tiny_mce/plugins/media/moxieplayer.swf /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/media/moxieplayer.swf
grappelli/tinymce/jscripts/tiny_mce/plugins/media/media.htm /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/media/media.htm
grappelli/tinymce/jscripts/tiny_mce/plugins/media/editor_plugin_src.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/media/editor_plugin_src.js
grappelli/tinymce/jscripts/tiny_mce/plugins/media/editor_plugin.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/media/editor_plugin.js
grappelli/tinymce/jscripts/tiny_mce/plugins/media/js/media.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/media/js/media.js
grappelli/tinymce/jscripts/tiny_mce/plugins/media/js/embed.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/media/js/embed.js
grappelli/tinymce/jscripts/tiny_mce/plugins/media/css/media.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/media/css/media.css
grappelli/tinymce/jscripts/tiny_mce/plugins/media/langs/en_dlg.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/media/langs/en_dlg.js
grappelli/tinymce/jscripts/tiny_mce/plugins/nonbreaking/editor_plugin_src.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/nonbreaking/editor_plugin_src.js
grappelli/tinymce/jscripts/tiny_mce/plugins/nonbreaking/editor_plugin.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/tinymce/jscripts/tiny_mce/plugins/nonbreaking/editor_plugin.js
grappelli/jquery/jquery.min.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/jquery/jquery.min.js
grappelli/jquery/jquery.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/jquery/jquery.js
grappelli/jquery/LICENSE-JQUERY.txt /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/jquery/LICENSE-JQUERY.txt
grappelli/jquery/.DS_Store /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/jquery/.DS_Store
grappelli/jquery/jquery-migrate-3.0.1.min.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/jquery/jquery-migrate-3.0.1.min.js
grappelli/jquery/LICENSE.txt /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/jquery/LICENSE.txt
grappelli/jquery/jquery-migrate-3.0.1.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/jquery/jquery-migrate-3.0.1.js
grappelli/jquery/ui/jquery-ui.structure.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/jquery/ui/jquery-ui.structure.css
grappelli/jquery/ui/jquery-ui.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/jquery/ui/jquery-ui.css
grappelli/jquery/ui/jquery-ui.structure.min.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/jquery/ui/jquery-ui.structure.min.css
grappelli/jquery/ui/jquery-ui.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/jquery/ui/jquery-ui.js
grappelli/jquery/ui/AUTHORS.txt /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/jquery/ui/AUTHORS.txt
grappelli/jquery/ui/.DS_Store /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/jquery/ui/.DS_Store
grappelli/jquery/ui/jquery-ui.theme.min.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/jquery/ui/jquery-ui.theme.min.css
grappelli/jquery/ui/index.html /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/jquery/ui/index.html
grappelli/jquery/ui/LICENSE.txt /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/jquery/ui/LICENSE.txt
grappelli/jquery/ui/jquery-ui.min.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/jquery/ui/jquery-ui.min.css
grappelli/jquery/ui/jquery-ui.theme.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/jquery/ui/jquery-ui.theme.css
grappelli/jquery/ui/jquery-ui.min.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/jquery/ui/jquery-ui.min.js
grappelli/jquery/ui/images/ui-icons_cc0000_256x240.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/jquery/ui/images/ui-icons_cc0000_256x240.png
grappelli/jquery/ui/images/ui-icons_777620_256x240.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/jquery/ui/images/ui-icons_777620_256x240.png
grappelli/jquery/ui/images/ui-icons_555555_256x240.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/jquery/ui/images/ui-icons_555555_256x240.png
grappelli/jquery/ui/images/ui-icons_777777_256x240.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/jquery/ui/images/ui-icons_777777_256x240.png
grappelli/jquery/ui/images/ui-icons_444444_256x240.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/jquery/ui/images/ui-icons_444444_256x240.png
grappelli/jquery/ui/images/ui-icons_ffffff_256x240.png /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/jquery/ui/images/ui-icons_ffffff_256x240.png
grappelli/jquery/ui/external/jquery/jquery.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/grappelli/jquery/ui/external/jquery/jquery.js
admin/js/actions.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/admin/js/actions.js
admin/js/admin/.DS_Store /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/admin/js/admin/.DS_Store
admin/js/admin/DateTimeShortcuts.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/admin/js/admin/DateTimeShortcuts.js
admin/js/admin/RelatedObjectLookups.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/grappelli/static/admin/js/admin/RelatedObjectLookups.js
admin/js/nav_sidebar.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/nav_sidebar.js
admin/js/autocomplete.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/autocomplete.js
admin/js/jquery.init.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/jquery.init.js
admin/js/urlify.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/urlify.js
admin/js/calendar.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/calendar.js
admin/js/actions.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/actions.js
admin/js/core.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/core.js
admin/js/SelectFilter2.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/SelectFilter2.js
admin/js/prepopulate_init.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/prepopulate_init.js
admin/js/change_form.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/change_form.js
admin/js/inlines.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/inlines.js
admin/js/cancel.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/cancel.js
admin/js/prepopulate.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/prepopulate.js
admin/js/theme.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/theme.js
admin/js/popup_response.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/popup_response.js
admin/js/SelectBox.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/SelectBox.js
admin/js/collapse.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/collapse.js
admin/js/filters.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/filters.js
admin/js/vendor/xregexp/LICENSE.txt /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/xregexp/LICENSE.txt
admin/js/vendor/xregexp/xregexp.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/xregexp/xregexp.js
admin/js/vendor/xregexp/xregexp.min.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/xregexp/xregexp.min.js
admin/js/vendor/select2/LICENSE.md /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/LICENSE.md
admin/js/vendor/select2/select2.full.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/select2.full.js
admin/js/vendor/select2/select2.full.min.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/select2.full.min.js
admin/js/vendor/select2/i18n/bs.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/bs.js
admin/js/vendor/select2/i18n/ja.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/ja.js
admin/js/vendor/select2/i18n/sr.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/sr.js
admin/js/vendor/select2/i18n/he.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/he.js
admin/js/vendor/select2/i18n/ca.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/ca.js
admin/js/vendor/select2/i18n/bn.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/bn.js
admin/js/vendor/select2/i18n/sk.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/sk.js
admin/js/vendor/select2/i18n/hr.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/hr.js
admin/js/vendor/select2/i18n/ar.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/ar.js
admin/js/vendor/select2/i18n/hy.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/hy.js
admin/js/vendor/select2/i18n/th.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/th.js
admin/js/vendor/select2/i18n/vi.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/vi.js
admin/js/vendor/select2/i18n/mk.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/mk.js
admin/js/vendor/select2/i18n/hi.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/hi.js
admin/js/vendor/select2/i18n/lt.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/lt.js
admin/js/vendor/select2/i18n/tk.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/tk.js
admin/js/vendor/select2/i18n/fr.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/fr.js
admin/js/vendor/select2/i18n/fi.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/fi.js
admin/js/vendor/select2/i18n/zh-CN.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/zh-CN.js
admin/js/vendor/select2/i18n/sr-Cyrl.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/sr-Cyrl.js
admin/js/vendor/select2/i18n/pt-BR.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/pt-BR.js
admin/js/vendor/select2/i18n/ne.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/ne.js
admin/js/vendor/select2/i18n/ko.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/ko.js
admin/js/vendor/select2/i18n/et.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/et.js
admin/js/vendor/select2/i18n/pt.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/pt.js
admin/js/vendor/select2/i18n/da.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/da.js
admin/js/vendor/select2/i18n/bg.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/bg.js
admin/js/vendor/select2/i18n/es.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/es.js
admin/js/vendor/select2/i18n/is.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/is.js
admin/js/vendor/select2/i18n/hu.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/hu.js
admin/js/vendor/select2/i18n/af.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/af.js
admin/js/vendor/select2/i18n/cs.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/cs.js
admin/js/vendor/select2/i18n/nl.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/nl.js
admin/js/vendor/select2/i18n/sv.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/sv.js
admin/js/vendor/select2/i18n/el.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/el.js
admin/js/vendor/select2/i18n/fa.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/fa.js
admin/js/vendor/select2/i18n/it.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/it.js
admin/js/vendor/select2/i18n/dsb.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/dsb.js
admin/js/vendor/select2/i18n/zh-TW.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/zh-TW.js
admin/js/vendor/select2/i18n/ro.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/ro.js
admin/js/vendor/select2/i18n/km.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/km.js
admin/js/vendor/select2/i18n/pl.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/pl.js
admin/js/vendor/select2/i18n/ms.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/ms.js
admin/js/vendor/select2/i18n/ps.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/ps.js
admin/js/vendor/select2/i18n/tr.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/tr.js
admin/js/vendor/select2/i18n/en.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/en.js
admin/js/vendor/select2/i18n/nb.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/nb.js
admin/js/vendor/select2/i18n/gl.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/gl.js
admin/js/vendor/select2/i18n/de.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/de.js
admin/js/vendor/select2/i18n/eu.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/eu.js
admin/js/vendor/select2/i18n/id.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/id.js
admin/js/vendor/select2/i18n/ru.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/ru.js
admin/js/vendor/select2/i18n/hsb.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/hsb.js
admin/js/vendor/select2/i18n/az.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/az.js
admin/js/vendor/select2/i18n/lv.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/lv.js
admin/js/vendor/select2/i18n/ka.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/ka.js
admin/js/vendor/select2/i18n/sl.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/sl.js
admin/js/vendor/select2/i18n/uk.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/uk.js
admin/js/vendor/select2/i18n/sq.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/select2/i18n/sq.js
admin/js/vendor/jquery/jquery.min.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/jquery/jquery.min.js
admin/js/vendor/jquery/jquery.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/jquery/jquery.js
admin/js/vendor/jquery/LICENSE.txt /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/vendor/jquery/LICENSE.txt
admin/js/admin/DateTimeShortcuts.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/admin/DateTimeShortcuts.js
admin/js/admin/RelatedObjectLookups.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/js/admin/RelatedObjectLookups.js
admin/img/search.svg /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/img/search.svg
admin/img/icon-unknown.svg /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/img/icon-unknown.svg
admin/img/tooltag-arrowright.svg /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/img/tooltag-arrowright.svg
admin/img/icon-deletelink.svg /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/img/icon-deletelink.svg
admin/img/icon-viewlink.svg /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/img/icon-viewlink.svg
admin/img/icon-alert.svg /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/img/icon-alert.svg
admin/img/inline-delete.svg /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/img/inline-delete.svg
admin/img/icon-addlink.svg /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/img/icon-addlink.svg
admin/img/selector-icons.svg /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/img/selector-icons.svg
admin/img/tooltag-add.svg /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/img/tooltag-add.svg
admin/img/icon-calendar.svg /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/img/icon-calendar.svg
admin/img/icon-unknown-alt.svg /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/img/icon-unknown-alt.svg
admin/img/icon-clock.svg /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/img/icon-clock.svg
admin/img/icon-no.svg /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/img/icon-no.svg
admin/img/LICENSE /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/img/LICENSE
admin/img/icon-hidelink.svg /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/img/icon-hidelink.svg
admin/img/README.txt /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/img/README.txt
admin/img/sorting-icons.svg /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/img/sorting-icons.svg
admin/img/icon-changelink.svg /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/img/icon-changelink.svg
admin/img/calendar-icons.svg /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/img/calendar-icons.svg
admin/img/icon-yes.svg /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/img/icon-yes.svg
admin/img/gis/move_vertex_off.svg /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/img/gis/move_vertex_off.svg
admin/img/gis/move_vertex_on.svg /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/img/gis/move_vertex_on.svg
admin/css/base.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/css/base.css
admin/css/dark_mode.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/css/dark_mode.css
admin/css/login.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/css/login.css
admin/css/responsive_rtl.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/css/responsive_rtl.css
admin/css/responsive.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/css/responsive.css
admin/css/rtl.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/css/rtl.css
admin/css/widgets.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/css/widgets.css
admin/css/autocomplete.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/css/autocomplete.css
admin/css/dashboard.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/css/dashboard.css
admin/css/nav_sidebar.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/css/nav_sidebar.css
admin/css/changelists.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/css/changelists.css
admin/css/forms.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/css/forms.css
admin/css/vendor/select2/LICENSE-SELECT2.md /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/css/vendor/select2/LICENSE-SELECT2.md
admin/css/vendor/select2/select2.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/css/vendor/select2/select2.css
admin/css/vendor/select2/select2.min.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django/contrib/admin/static/admin/css/vendor/select2/select2.min.css
django-htmx.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django_htmx/static/django-htmx.js
js/htmx.min.js /mnt/disks/pennyloupe_disk/pennyloupe/app/core/static/js/htmx.min.js
js/tradingview/charting_library/charting_library.standalone.js /mnt/disks/pennyloupe_disk/pennyloupe/app/core/static/js/tradingview/charting_library/charting_library.standalone.js
img/how-it-works.png /mnt/disks/pennyloupe_disk/pennyloupe/app/core/static/img/how-it-works.png
img/penny_loupe_logo_bw.png /mnt/disks/pennyloupe_disk/pennyloupe/app/core/static/img/penny_loupe_logo_bw.png
img/volatility.png /mnt/disks/pennyloupe_disk/pennyloupe/app/core/static/img/volatility.png
img/penny_loupe_bg.png /mnt/disks/pennyloupe_disk/pennyloupe/app/core/static/img/penny_loupe_bg.png
img/penny_loupe_logo.png /mnt/disks/pennyloupe_disk/pennyloupe/app/core/static/img/penny_loupe_logo.png
img/news_sites.png /mnt/disks/pennyloupe_disk/pennyloupe/app/core/static/img/news_sites.png
img/pennyloupe_icon.png /mnt/disks/pennyloupe_disk/pennyloupe/app/core/static/img/pennyloupe_icon.png
img/penny_loupe_logo_inv.png /mnt/disks/pennyloupe_disk/pennyloupe/app/core/static/img/penny_loupe_logo_inv.png
css/pennyloupe.css /mnt/disks/pennyloupe_disk/pennyloupe/app/core/static/css/pennyloupe.css
django_extensions/js/jquery.ajaxQueue.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django_extensions/static/django_extensions/js/jquery.ajaxQueue.js
django_extensions/js/jquery.bgiframe.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django_extensions/static/django_extensions/js/jquery.bgiframe.js
django_extensions/js/jquery.autocomplete.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django_extensions/static/django_extensions/js/jquery.autocomplete.js
django_extensions/img/indicator.gif /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django_extensions/static/django_extensions/img/indicator.gif
django_extensions/css/jquery.autocomplete.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/django_extensions/static/django_extensions/css/jquery.autocomplete.css
debug_toolbar/js/utils.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/debug_toolbar/static/debug_toolbar/js/utils.js
debug_toolbar/js/history.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/debug_toolbar/static/debug_toolbar/js/history.js
debug_toolbar/js/toolbar.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/debug_toolbar/static/debug_toolbar/js/toolbar.js
debug_toolbar/js/timer.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/debug_toolbar/static/debug_toolbar/js/timer.js
debug_toolbar/js/redirect.js /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/debug_toolbar/static/debug_toolbar/js/redirect.js
debug_toolbar/css/toolbar.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/debug_toolbar/static/debug_toolbar/css/toolbar.css
debug_toolbar/css/print.css /mnt/disks/pennyloupe_disk/pennyloupe/.venv/lib/python3.11/site-packages/debug_toolbar/static/debug_toolbar/css/print.css

Templates (6 rendered)

Template path

  1. templates

Templates

ticker_content.html
/mnt/disks/pennyloupe_disk/pennyloupe/app/core/templates/ticker_content.html
Toggle context {'False': False, 'None': None, 'True': True} {'DEFAULT_MESSAGE_LEVELS': {'DEBUG': 10, 'ERROR': 40, 'INFO': 20, 'SUCCESS': 25, 'WARNING': 30}, 'csrf_token': '<SimpleLazyObject: ' "'1eDiy3Dsy6cn6dxepdGrQpmeILx8v0y4oXUpk2VdcM3hieBhImg8uBiDYKglotYg'>", 'messages': <FallbackStorage: request=<WSGIRequest: GET '/ticker/NKTR/content?date_from=2024-09-15&date_to=2025-03-14'>>, 'perms': PermWrapper(<SimpleLazyObject: <function AuthenticationMiddleware.process_request.<locals>.<lambda> at 0x7ff653d89f80>>), 'request': '<<request>>', 'user': '<SimpleLazyObject: <function ' 'AuthenticationMiddleware.process_request.<locals>.<lambda> at ' '0x7ff653d89f80>>'} {'content': '<<queryset of core.Content>>', 'data_source_id': '', 'data_sources': '<<queryset of core.DataSource>>', 'date_from': '2024-09-15', 'date_to': '2025-03-14', 'published_by': '', 'published_by_list': '<<queryset of core.Content>>', 'report': {'items_count': [0, 1, 0, 0, 1, 0, 0, 0, 0, 0, 2, 1, 4, 0, 0, 6, 3, 2, 2, 1, 0, 0, 0, 1, 2, 1, 3, 0, 1, 2, 1, 0, 14, 4, 0, 0, 1, 3, 0, 0, 1, 0, 0, 2, 3, 0, 14, 5, 1, 2, 12, 7, 5, 26, 13, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 4, 2, 1, 1, 5, 0, 0, 2, 1, 2, 0, 16, 4, 1, 0, 2, 3, 0, 3, 8, 5, 14, 5, 2, 4, 3, 4, 0, 3, 9, 4, 3, 2, 2, 1, 1, 5, 1, 2, 0, 1, 0, 0, 1, 5, 1, 0, 2, 8, 9, 19, 5, 1, 3, 7, 5, 1, 2, 2, 1, 0, 1, 1, 3, 1, 0, 1, 1, 13, 2, 4, 5, 0, 0, 5, 4, 10, 4, 7, 0, 2, 14, 5, 6, 8, 23, 3, 2, 2, 2, 1, 1, 2, 6, 1, 19, 10, 16, 3, 5, 1, 1, 1, 0, 22, 2, 0, 3, 0, 0, 1, 25, 18, 2], 'items_negative_count': [0, 1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 3, 1, 2, 2, 0, 0, 0, 0, 0, 1, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 2, 3, 1, 1, 1, 3, 4, 6, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 1, 0, 0, 1, 2, 0, 1, 0, 0, 0, 1, 1, 2, 1, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 1, 0, 0, 2, 1, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 2, 1, 1, 0, 0, 0, 0, 1, 5, 1, 0, 0, 1, 1, 1, 1, 0, 2, 0, 0, 0, 0, 0, 0, 0, 3, 0, 4, 0, 0, 1, 2, 0, 1, 1, 0, 0, 0, 0, 1, 0, 0, 0, 16, 4, 0], 'items_neutral_count': [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 3, 0, 0, 2, 2, 0, 0, 1, 0, 0, 0, 1, 1, 0, 0, 0, 1, 1, 0, 0, 7, 4, 0, 0, 1, 1, 0, 0, 1, 0, 0, 1, 1, 0, 12, 2, 0, 1, 3, 2, 1, 6, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 5, 0, 0, 2, 1, 0, 0, 5, 4, 1, 0, 1, 1, 0, 2, 6, 3, 12, 3, 2, 3, 3, 4, 0, 2, 8, 2, 2, 2, 2, 1, 1, 3, 0, 1, 0, 1, 0, 0, 0, 4, 0, 0, 0, 7, 8, 7, 4, 1, 1, 5, 4, 1, 2, 1, 1, 0, 0, 1, 1, 1, 0, 0, 0, 10, 1, 2, 4, 0, 0, 3, 1, 3, 3, 6, 0, 1, 4, 3, 5, 8, 21, 3, 1, 2, 1, 1, 0, 1, 3, 1, 8, 7, 2, 2, 3, 1, 0, 0, 0, 22, 2, 0, 1, 0, 0, 1, 4, 10, 1], 'items_positive_count': [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 1, 1, 0, 7, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0, 0, 0, 8, 2, 0, 14, 7, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 11, 0, 0, 0, 0, 2, 0, 0, 2, 2, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 2, 1, 0, 10, 0, 0, 2, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 1, 1, 1, 0, 1, 1, 0, 0, 2, 2, 2, 0, 1, 0, 0, 9, 1, 0, 0, 0, 0, 1, 0, 1, 0, 1, 1, 0, 0, 7, 3, 14, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 5, 4, 1], 'labels': ['2024-09-15', '2024-09-16', '2024-09-17', '2024-09-18', '2024-09-19', '2024-09-20', '2024-09-21', '2024-09-22', '2024-09-23', '2024-09-24', '2024-09-25', '2024-09-26', '2024-09-27', '2024-09-28', '2024-09-29', '2024-09-30', '2024-10-01', '2024-10-02', '2024-10-03', '2024-10-04', '2024-10-05', '2024-10-06', '2024-10-07', '2024-10-08', '2024-10-09', '2024-10-10', '2024-10-11', '2024-10-12', '2024-10-13', '2024-10-14', '2024-10-15', '2024-10-16', '2024-10-17', '2024-10-18', '2024-10-19', '2024-10-20', '2024-10-21', '2024-10-22', '2024-10-23', '2024-10-24', '2024-10-25', '2024-10-26', '2024-10-27', '2024-10-28', '2024-10-29', '2024-10-30', '2024-10-31', '2024-11-01', '2024-11-02', '2024-11-03', '2024-11-04', '2024-11-05', '2024-11-06', '2024-11-07', '2024-11-08', '2024-11-09', '2024-11-10', '2024-11-11', '2024-11-12', '2024-11-13', '2024-11-14', '2024-11-15', '2024-11-16', '2024-11-17', '2024-11-18', '2024-11-19', '2024-11-20', '2024-11-21', '2024-11-22', '2024-11-23', '2024-11-24', '2024-11-25', '2024-11-26', '2024-11-27', '2024-11-28', '2024-11-29', '2024-11-30', '2024-12-01', '2024-12-02', '2024-12-03', '2024-12-04', '2024-12-05', '2024-12-06', '2024-12-07', '2024-12-08', '2024-12-09', '2024-12-10', '2024-12-11', '2024-12-12', '2024-12-13', '2024-12-14', '2024-12-15', '2024-12-16', '2024-12-17', '2024-12-18', '2024-12-19', '2024-12-20', '2024-12-21', '2024-12-22', '2024-12-23', '2024-12-24', '2024-12-25', '2024-12-26', '2024-12-27', '2024-12-28', '2024-12-29', '2024-12-30', '2024-12-31', '2025-01-01', '2025-01-02', '2025-01-03', '2025-01-04', '2025-01-05', '2025-01-06', '2025-01-07', '2025-01-08', '2025-01-09', '2025-01-10', '2025-01-11', '2025-01-12', '2025-01-13', '2025-01-14', '2025-01-15', '2025-01-16', '2025-01-17', '2025-01-18', '2025-01-19', '2025-01-20', '2025-01-21', '2025-01-22', '2025-01-23', '2025-01-24', '2025-01-25', '2025-01-26', '2025-01-27', '2025-01-28', '2025-01-29', '2025-01-30', '2025-01-31', '2025-02-01', '2025-02-02', '2025-02-03', '2025-02-04', '2025-02-05', '2025-02-06', '2025-02-07', '2025-02-08', '2025-02-09', '2025-02-10', '2025-02-11', '2025-02-12', '2025-02-13', '2025-02-14', '2025-02-15', '2025-02-16', '2025-02-17', '2025-02-18', '2025-02-19', '2025-02-20', '2025-02-21', '2025-02-22', '2025-02-23', '2025-02-24', '2025-02-25', '2025-02-26', '2025-02-27', '2025-02-28', '2025-03-01', '2025-03-02', '2025-03-03', '2025-03-04', '2025-03-05', '2025-03-06', '2025-03-07', '2025-03-08', '2025-03-09', '2025-03-10', '2025-03-11', '2025-03-12', '2025-03-13', '2025-03-14'], 'sentiment_avg': [0.0, -0.88, 0.0, 0.0, -0.53, 0.0, 0.0, 0.0, 0.0, 0.0, 0.15, 0.82, -0.15, 0.0, 0.0, -0.14, -0.18, -0.73, -0.58, 0.01, 0.0, 0.0, 0.0, -0.03, -0.23, -0.74, -0.2, 0.0, 0.24, 0.23, 0.32, 0.0, 0.31, 0.21, 0.0, 0.0, -0.03, -0.74, 0.0, 0.0, -0.02, 0.0, 0.0, 0.15, 0.49, 0.0, -0.12, -0.31, -0.43, -0.33, 0.31, -0.17, -0.36, 0.14, 0.08, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.61, 0.33, 0.0, -0.6, -0.26, -0.01, 0.13, 0.12, 0.0, 0.0, 0.1, 0.04, 0.37, 0.0, 0.44, 0.0, 0.0, 0.0, -0.22, 0.68, 0.0, -0.13, 0.14, 0.19, 0.01, -0.22, 0.03, 0.0, 0.04, 0.02, 0.0, -0.18, -0.04, -0.21, -0.26, -0.06, 0.0, -0.05, 0.0, 0.22, -0.44, -0.17, 0.0, 0.02, 0.0, 0.0, 0.35, 0.08, 0.54, 0.0, 0.89, 0.02, -0.03, 0.31, -0.06, 0.01, 0.36, -0.1, -0.11, -0.02, -0.18, 0.32, -0.01, 0.0, -0.92, 0.04, 0.02, 0.07, 0.0, 0.33, 0.28, -0.08, -0.25, -0.29, 0.15, 0.0, 0.0, 0.38, 0.49, -0.15, -0.02, 0.07, 0.0, -0.26, 0.31, -0.12, -0.08, -0.01, 0.02, -0.03, 0.18, 0.15, 0.36, 0.0, 0.77, 0.13, -0.16, -0.13, 0.03, 0.11, 0.5, -0.05, -0.28, -0.05, -0.45, -0.53, 0.0, 0.01, 0.01, 0.0, -0.05, 0.0, 0.0, -0.12, -0.16, 0.03, 0.38], 'sentiment_avg_negative': [-0.0, -0.94, -0.0, -0.0, -0.73, -0.0, -0.0, -0.0, -0.0, -0.0, -0.03, -0.02, -0.29, -0.0, -0.0, -0.36, -0.27, -0.86, -0.77, -0.05, -0.0, -0.0, -0.0, -0.17, -0.37, -0.86, -0.52, -0.0, -0.02, -0.1, -0.02, -0.0, -0.02, -0.02, -0.0, -0.0, -0.19, -0.83, -0.0, -0.0, -0.2, -0.0, -0.0, -0.12, -0.01, -0.0, -0.15, -0.43, -0.66, -0.52, -0.08, -0.38, -0.54, -0.29, -0.39, -0.0, -0.0, -0.0, -0.0, -0.0, -0.0, -0.0, -0.0, -0.0, -0.01, -0.24, -0.0, -0.68, -0.52, -0.09, -0.02, -0.03, -0.0, -0.0, -0.02, -0.01, -0.01, -0.0, -0.01, -0.03, -0.01, -0.0, -0.36, -0.02, -0.0, -0.23, -0.02, -0.04, -0.09, -0.42, -0.06, -0.08, -0.02, -0.08, -0.0, -0.34, -0.16, -0.43, -0.46, -0.25, -0.06, -0.24, -0.04, -0.12, -0.66, -0.4, -0.0, -0.02, -0.0, -0.0, -0.02, -0.04, -0.02, -0.0, -0.02, -0.08, -0.12, -0.11, -0.17, -0.02, -0.03, -0.27, -0.27, -0.17, -0.41, -0.06, -0.13, -0.0, -0.96, -0.02, -0.24, -0.02, -0.0, -0.02, -0.02, -0.21, -0.51, -0.47, -0.1, -0.0, -0.0, -0.09, -0.15, -0.43, -0.11, -0.19, -0.0, -0.49, -0.06, -0.29, -0.16, -0.1, -0.02, -0.12, -0.1, -0.02, -0.17, -0.03, -0.03, -0.19, -0.38, -0.36, -0.17, -0.06, -0.03, -0.17, -0.42, -0.23, -0.67, -0.75, -0.0, -0.01, -0.01, -0.0, -0.39, -0.0, -0.0, -0.35, -0.48, -0.26, -0.01], 'sentiment_avg_neutral': [0.0, 0.04, 0.0, 0.0, 0.22, 0.0, 0.0, 0.0, 0.0, 0.0, 0.62, 0.07, 0.63, 0.0, 0.0, 0.46, 0.62, 0.1, 0.17, 0.86, 0.0, 0.0, 0.0, 0.8, 0.48, 0.12, 0.1, 0.0, 0.5, 0.53, 0.41, 0.0, 0.5, 0.53, 0.0, 0.0, 0.77, 0.15, 0.0, 0.0, 0.64, 0.0, 0.0, 0.51, 0.39, 0.0, 0.76, 0.5, 0.26, 0.37, 0.41, 0.33, 0.41, 0.26, 0.13, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.21, 0.14, 0.0, 0.3, 0.36, 0.86, 0.62, 0.68, 0.0, 0.0, 0.66, 0.79, 0.38, 0.0, 0.4, 0.93, 0.93, 0.0, 0.49, 0.19, 0.0, 0.66, 0.75, 0.62, 0.82, 0.53, 0.79, 0.79, 0.79, 0.76, 0.0, 0.54, 0.73, 0.43, 0.42, 0.67, 0.89, 0.69, 0.92, 0.52, 0.3, 0.55, 0.0, 0.84, 0.0, 0.0, 0.39, 0.76, 0.25, 0.0, 0.04, 0.78, 0.78, 0.39, 0.67, 0.89, 0.46, 0.67, 0.66, 0.74, 0.51, 0.39, 0.76, 0.0, 0.03, 0.77, 0.47, 0.72, 0.0, 0.41, 0.45, 0.68, 0.31, 0.3, 0.67, 0.0, 0.0, 0.41, 0.15, 0.27, 0.82, 0.55, 0.0, 0.48, 0.46, 0.53, 0.72, 0.78, 0.81, 0.83, 0.56, 0.59, 0.37, 0.93, 0.09, 0.4, 0.49, 0.59, 0.5, 0.66, 0.3, 0.71, 0.49, 0.71, 0.3, 0.04, 0.0, 0.9, 0.89, 0.0, 0.34, 0.0, 0.0, 0.62, 0.27, 0.43, 0.5], 'sentiment_avg_positive': [0.0, 0.02, 0.0, 0.0, 0.05, 0.0, 0.0, 0.0, 0.0, 0.0, 0.36, 0.91, 0.08, 0.0, 0.0, 0.18, 0.12, 0.04, 0.06, 0.09, 0.0, 0.0, 0.0, 0.03, 0.15, 0.03, 0.37, 0.0, 0.49, 0.37, 0.57, 0.0, 0.48, 0.45, 0.0, 0.0, 0.05, 0.02, 0.0, 0.0, 0.15, 0.0, 0.0, 0.37, 0.6, 0.0, 0.1, 0.06, 0.07, 0.11, 0.51, 0.28, 0.05, 0.46, 0.48, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.78, 0.62, 0.0, 0.03, 0.12, 0.05, 0.37, 0.29, 0.0, 0.0, 0.32, 0.2, 0.6, 0.0, 0.58, 0.04, 0.06, 0.0, 0.15, 0.8, 0.0, 0.1, 0.23, 0.35, 0.09, 0.05, 0.15, 0.14, 0.18, 0.17, 0.0, 0.12, 0.1, 0.14, 0.11, 0.07, 0.06, 0.08, 0.04, 0.37, 0.04, 0.06, 0.0, 0.14, 0.0, 0.0, 0.6, 0.19, 0.73, 0.0, 0.94, 0.14, 0.09, 0.5, 0.15, 0.09, 0.52, 0.06, 0.07, 0.08, 0.07, 0.55, 0.1, 0.0, 0.01, 0.21, 0.29, 0.27, 0.0, 0.57, 0.53, 0.11, 0.18, 0.23, 0.23, 0.0, 0.0, 0.5, 0.7, 0.29, 0.08, 0.26, 0.0, 0.03, 0.49, 0.18, 0.13, 0.12, 0.16, 0.05, 0.34, 0.39, 0.47, 0.05, 0.88, 0.39, 0.13, 0.04, 0.32, 0.28, 0.67, 0.12, 0.1, 0.06, 0.03, 0.2, 0.0, 0.09, 0.1, 0.0, 0.28, 0.0, 0.0, 0.04, 0.26, 0.32, 0.49]}, 'ticker': 'NKTR'}
base.html
/mnt/disks/pennyloupe_disk/pennyloupe/templates/base.html
Toggle context {'False': False, 'None': None, 'True': True} {'DEFAULT_MESSAGE_LEVELS': {'DEBUG': 10, 'ERROR': 40, 'INFO': 20, 'SUCCESS': 25, 'WARNING': 30}, 'csrf_token': '<SimpleLazyObject: ' "'1eDiy3Dsy6cn6dxepdGrQpmeILx8v0y4oXUpk2VdcM3hieBhImg8uBiDYKglotYg'>", 'messages': <FallbackStorage: request=<WSGIRequest: GET '/ticker/NKTR/content?date_from=2024-09-15&date_to=2025-03-14'>>, 'perms': PermWrapper(<SimpleLazyObject: <function AuthenticationMiddleware.process_request.<locals>.<lambda> at 0x7ff653d89f80>>), 'request': '<<request>>', 'user': '<SimpleLazyObject: <function ' 'AuthenticationMiddleware.process_request.<locals>.<lambda> at ' '0x7ff653d89f80>>'} {'content': '<<queryset of core.Content>>', 'data_source_id': '', 'data_sources': '<<queryset of core.DataSource>>', 'date_from': '2024-09-15', 'date_to': '2025-03-14', 'published_by': '', 'published_by_list': '<<queryset of core.Content>>', 'report': {'items_count': [0, 1, 0, 0, 1, 0, 0, 0, 0, 0, 2, 1, 4, 0, 0, 6, 3, 2, 2, 1, 0, 0, 0, 1, 2, 1, 3, 0, 1, 2, 1, 0, 14, 4, 0, 0, 1, 3, 0, 0, 1, 0, 0, 2, 3, 0, 14, 5, 1, 2, 12, 7, 5, 26, 13, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 4, 2, 1, 1, 5, 0, 0, 2, 1, 2, 0, 16, 4, 1, 0, 2, 3, 0, 3, 8, 5, 14, 5, 2, 4, 3, 4, 0, 3, 9, 4, 3, 2, 2, 1, 1, 5, 1, 2, 0, 1, 0, 0, 1, 5, 1, 0, 2, 8, 9, 19, 5, 1, 3, 7, 5, 1, 2, 2, 1, 0, 1, 1, 3, 1, 0, 1, 1, 13, 2, 4, 5, 0, 0, 5, 4, 10, 4, 7, 0, 2, 14, 5, 6, 8, 23, 3, 2, 2, 2, 1, 1, 2, 6, 1, 19, 10, 16, 3, 5, 1, 1, 1, 0, 22, 2, 0, 3, 0, 0, 1, 25, 18, 2], 'items_negative_count': [0, 1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 3, 1, 2, 2, 0, 0, 0, 0, 0, 1, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 2, 3, 1, 1, 1, 3, 4, 6, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 1, 0, 0, 1, 2, 0, 1, 0, 0, 0, 1, 1, 2, 1, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 1, 0, 0, 2, 1, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 2, 1, 1, 0, 0, 0, 0, 1, 5, 1, 0, 0, 1, 1, 1, 1, 0, 2, 0, 0, 0, 0, 0, 0, 0, 3, 0, 4, 0, 0, 1, 2, 0, 1, 1, 0, 0, 0, 0, 1, 0, 0, 0, 16, 4, 0], 'items_neutral_count': [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 3, 0, 0, 2, 2, 0, 0, 1, 0, 0, 0, 1, 1, 0, 0, 0, 1, 1, 0, 0, 7, 4, 0, 0, 1, 1, 0, 0, 1, 0, 0, 1, 1, 0, 12, 2, 0, 1, 3, 2, 1, 6, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 5, 0, 0, 2, 1, 0, 0, 5, 4, 1, 0, 1, 1, 0, 2, 6, 3, 12, 3, 2, 3, 3, 4, 0, 2, 8, 2, 2, 2, 2, 1, 1, 3, 0, 1, 0, 1, 0, 0, 0, 4, 0, 0, 0, 7, 8, 7, 4, 1, 1, 5, 4, 1, 2, 1, 1, 0, 0, 1, 1, 1, 0, 0, 0, 10, 1, 2, 4, 0, 0, 3, 1, 3, 3, 6, 0, 1, 4, 3, 5, 8, 21, 3, 1, 2, 1, 1, 0, 1, 3, 1, 8, 7, 2, 2, 3, 1, 0, 0, 0, 22, 2, 0, 1, 0, 0, 1, 4, 10, 1], 'items_positive_count': [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 1, 1, 0, 7, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0, 0, 0, 8, 2, 0, 14, 7, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 11, 0, 0, 0, 0, 2, 0, 0, 2, 2, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 2, 1, 0, 10, 0, 0, 2, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 1, 1, 1, 0, 1, 1, 0, 0, 2, 2, 2, 0, 1, 0, 0, 9, 1, 0, 0, 0, 0, 1, 0, 1, 0, 1, 1, 0, 0, 7, 3, 14, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 5, 4, 1], 'labels': ['2024-09-15', '2024-09-16', '2024-09-17', '2024-09-18', '2024-09-19', '2024-09-20', '2024-09-21', '2024-09-22', '2024-09-23', '2024-09-24', '2024-09-25', '2024-09-26', '2024-09-27', '2024-09-28', '2024-09-29', '2024-09-30', '2024-10-01', '2024-10-02', '2024-10-03', '2024-10-04', '2024-10-05', '2024-10-06', '2024-10-07', '2024-10-08', '2024-10-09', '2024-10-10', '2024-10-11', '2024-10-12', '2024-10-13', '2024-10-14', '2024-10-15', '2024-10-16', '2024-10-17', '2024-10-18', '2024-10-19', '2024-10-20', '2024-10-21', '2024-10-22', '2024-10-23', '2024-10-24', '2024-10-25', '2024-10-26', '2024-10-27', '2024-10-28', '2024-10-29', '2024-10-30', '2024-10-31', '2024-11-01', '2024-11-02', '2024-11-03', '2024-11-04', '2024-11-05', '2024-11-06', '2024-11-07', '2024-11-08', '2024-11-09', '2024-11-10', '2024-11-11', '2024-11-12', '2024-11-13', '2024-11-14', '2024-11-15', '2024-11-16', '2024-11-17', '2024-11-18', '2024-11-19', '2024-11-20', '2024-11-21', '2024-11-22', '2024-11-23', '2024-11-24', '2024-11-25', '2024-11-26', '2024-11-27', '2024-11-28', '2024-11-29', '2024-11-30', '2024-12-01', '2024-12-02', '2024-12-03', '2024-12-04', '2024-12-05', '2024-12-06', '2024-12-07', '2024-12-08', '2024-12-09', '2024-12-10', '2024-12-11', '2024-12-12', '2024-12-13', '2024-12-14', '2024-12-15', '2024-12-16', '2024-12-17', '2024-12-18', '2024-12-19', '2024-12-20', '2024-12-21', '2024-12-22', '2024-12-23', '2024-12-24', '2024-12-25', '2024-12-26', '2024-12-27', '2024-12-28', '2024-12-29', '2024-12-30', '2024-12-31', '2025-01-01', '2025-01-02', '2025-01-03', '2025-01-04', '2025-01-05', '2025-01-06', '2025-01-07', '2025-01-08', '2025-01-09', '2025-01-10', '2025-01-11', '2025-01-12', '2025-01-13', '2025-01-14', '2025-01-15', '2025-01-16', '2025-01-17', '2025-01-18', '2025-01-19', '2025-01-20', '2025-01-21', '2025-01-22', '2025-01-23', '2025-01-24', '2025-01-25', '2025-01-26', '2025-01-27', '2025-01-28', '2025-01-29', '2025-01-30', '2025-01-31', '2025-02-01', '2025-02-02', '2025-02-03', '2025-02-04', '2025-02-05', '2025-02-06', '2025-02-07', '2025-02-08', '2025-02-09', '2025-02-10', '2025-02-11', '2025-02-12', '2025-02-13', '2025-02-14', '2025-02-15', '2025-02-16', '2025-02-17', '2025-02-18', '2025-02-19', '2025-02-20', '2025-02-21', '2025-02-22', '2025-02-23', '2025-02-24', '2025-02-25', '2025-02-26', '2025-02-27', '2025-02-28', '2025-03-01', '2025-03-02', '2025-03-03', '2025-03-04', '2025-03-05', '2025-03-06', '2025-03-07', '2025-03-08', '2025-03-09', '2025-03-10', '2025-03-11', '2025-03-12', '2025-03-13', '2025-03-14'], 'sentiment_avg': [0.0, -0.88, 0.0, 0.0, -0.53, 0.0, 0.0, 0.0, 0.0, 0.0, 0.15, 0.82, -0.15, 0.0, 0.0, -0.14, -0.18, -0.73, -0.58, 0.01, 0.0, 0.0, 0.0, -0.03, -0.23, -0.74, -0.2, 0.0, 0.24, 0.23, 0.32, 0.0, 0.31, 0.21, 0.0, 0.0, -0.03, -0.74, 0.0, 0.0, -0.02, 0.0, 0.0, 0.15, 0.49, 0.0, -0.12, -0.31, -0.43, -0.33, 0.31, -0.17, -0.36, 0.14, 0.08, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.61, 0.33, 0.0, -0.6, -0.26, -0.01, 0.13, 0.12, 0.0, 0.0, 0.1, 0.04, 0.37, 0.0, 0.44, 0.0, 0.0, 0.0, -0.22, 0.68, 0.0, -0.13, 0.14, 0.19, 0.01, -0.22, 0.03, 0.0, 0.04, 0.02, 0.0, -0.18, -0.04, -0.21, -0.26, -0.06, 0.0, -0.05, 0.0, 0.22, -0.44, -0.17, 0.0, 0.02, 0.0, 0.0, 0.35, 0.08, 0.54, 0.0, 0.89, 0.02, -0.03, 0.31, -0.06, 0.01, 0.36, -0.1, -0.11, -0.02, -0.18, 0.32, -0.01, 0.0, -0.92, 0.04, 0.02, 0.07, 0.0, 0.33, 0.28, -0.08, -0.25, -0.29, 0.15, 0.0, 0.0, 0.38, 0.49, -0.15, -0.02, 0.07, 0.0, -0.26, 0.31, -0.12, -0.08, -0.01, 0.02, -0.03, 0.18, 0.15, 0.36, 0.0, 0.77, 0.13, -0.16, -0.13, 0.03, 0.11, 0.5, -0.05, -0.28, -0.05, -0.45, -0.53, 0.0, 0.01, 0.01, 0.0, -0.05, 0.0, 0.0, -0.12, -0.16, 0.03, 0.38], 'sentiment_avg_negative': [-0.0, -0.94, -0.0, -0.0, -0.73, -0.0, -0.0, -0.0, -0.0, -0.0, -0.03, -0.02, -0.29, -0.0, -0.0, -0.36, -0.27, -0.86, -0.77, -0.05, -0.0, -0.0, -0.0, -0.17, -0.37, -0.86, -0.52, -0.0, -0.02, -0.1, -0.02, -0.0, -0.02, -0.02, -0.0, -0.0, -0.19, -0.83, -0.0, -0.0, -0.2, -0.0, -0.0, -0.12, -0.01, -0.0, -0.15, -0.43, -0.66, -0.52, -0.08, -0.38, -0.54, -0.29, -0.39, -0.0, -0.0, -0.0, -0.0, -0.0, -0.0, -0.0, -0.0, -0.0, -0.01, -0.24, -0.0, -0.68, -0.52, -0.09, -0.02, -0.03, -0.0, -0.0, -0.02, -0.01, -0.01, -0.0, -0.01, -0.03, -0.01, -0.0, -0.36, -0.02, -0.0, -0.23, -0.02, -0.04, -0.09, -0.42, -0.06, -0.08, -0.02, -0.08, -0.0, -0.34, -0.16, -0.43, -0.46, -0.25, -0.06, -0.24, -0.04, -0.12, -0.66, -0.4, -0.0, -0.02, -0.0, -0.0, -0.02, -0.04, -0.02, -0.0, -0.02, -0.08, -0.12, -0.11, -0.17, -0.02, -0.03, -0.27, -0.27, -0.17, -0.41, -0.06, -0.13, -0.0, -0.96, -0.02, -0.24, -0.02, -0.0, -0.02, -0.02, -0.21, -0.51, -0.47, -0.1, -0.0, -0.0, -0.09, -0.15, -0.43, -0.11, -0.19, -0.0, -0.49, -0.06, -0.29, -0.16, -0.1, -0.02, -0.12, -0.1, -0.02, -0.17, -0.03, -0.03, -0.19, -0.38, -0.36, -0.17, -0.06, -0.03, -0.17, -0.42, -0.23, -0.67, -0.75, -0.0, -0.01, -0.01, -0.0, -0.39, -0.0, -0.0, -0.35, -0.48, -0.26, -0.01], 'sentiment_avg_neutral': [0.0, 0.04, 0.0, 0.0, 0.22, 0.0, 0.0, 0.0, 0.0, 0.0, 0.62, 0.07, 0.63, 0.0, 0.0, 0.46, 0.62, 0.1, 0.17, 0.86, 0.0, 0.0, 0.0, 0.8, 0.48, 0.12, 0.1, 0.0, 0.5, 0.53, 0.41, 0.0, 0.5, 0.53, 0.0, 0.0, 0.77, 0.15, 0.0, 0.0, 0.64, 0.0, 0.0, 0.51, 0.39, 0.0, 0.76, 0.5, 0.26, 0.37, 0.41, 0.33, 0.41, 0.26, 0.13, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.21, 0.14, 0.0, 0.3, 0.36, 0.86, 0.62, 0.68, 0.0, 0.0, 0.66, 0.79, 0.38, 0.0, 0.4, 0.93, 0.93, 0.0, 0.49, 0.19, 0.0, 0.66, 0.75, 0.62, 0.82, 0.53, 0.79, 0.79, 0.79, 0.76, 0.0, 0.54, 0.73, 0.43, 0.42, 0.67, 0.89, 0.69, 0.92, 0.52, 0.3, 0.55, 0.0, 0.84, 0.0, 0.0, 0.39, 0.76, 0.25, 0.0, 0.04, 0.78, 0.78, 0.39, 0.67, 0.89, 0.46, 0.67, 0.66, 0.74, 0.51, 0.39, 0.76, 0.0, 0.03, 0.77, 0.47, 0.72, 0.0, 0.41, 0.45, 0.68, 0.31, 0.3, 0.67, 0.0, 0.0, 0.41, 0.15, 0.27, 0.82, 0.55, 0.0, 0.48, 0.46, 0.53, 0.72, 0.78, 0.81, 0.83, 0.56, 0.59, 0.37, 0.93, 0.09, 0.4, 0.49, 0.59, 0.5, 0.66, 0.3, 0.71, 0.49, 0.71, 0.3, 0.04, 0.0, 0.9, 0.89, 0.0, 0.34, 0.0, 0.0, 0.62, 0.27, 0.43, 0.5], 'sentiment_avg_positive': [0.0, 0.02, 0.0, 0.0, 0.05, 0.0, 0.0, 0.0, 0.0, 0.0, 0.36, 0.91, 0.08, 0.0, 0.0, 0.18, 0.12, 0.04, 0.06, 0.09, 0.0, 0.0, 0.0, 0.03, 0.15, 0.03, 0.37, 0.0, 0.49, 0.37, 0.57, 0.0, 0.48, 0.45, 0.0, 0.0, 0.05, 0.02, 0.0, 0.0, 0.15, 0.0, 0.0, 0.37, 0.6, 0.0, 0.1, 0.06, 0.07, 0.11, 0.51, 0.28, 0.05, 0.46, 0.48, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.78, 0.62, 0.0, 0.03, 0.12, 0.05, 0.37, 0.29, 0.0, 0.0, 0.32, 0.2, 0.6, 0.0, 0.58, 0.04, 0.06, 0.0, 0.15, 0.8, 0.0, 0.1, 0.23, 0.35, 0.09, 0.05, 0.15, 0.14, 0.18, 0.17, 0.0, 0.12, 0.1, 0.14, 0.11, 0.07, 0.06, 0.08, 0.04, 0.37, 0.04, 0.06, 0.0, 0.14, 0.0, 0.0, 0.6, 0.19, 0.73, 0.0, 0.94, 0.14, 0.09, 0.5, 0.15, 0.09, 0.52, 0.06, 0.07, 0.08, 0.07, 0.55, 0.1, 0.0, 0.01, 0.21, 0.29, 0.27, 0.0, 0.57, 0.53, 0.11, 0.18, 0.23, 0.23, 0.0, 0.0, 0.5, 0.7, 0.29, 0.08, 0.26, 0.0, 0.03, 0.49, 0.18, 0.13, 0.12, 0.16, 0.05, 0.34, 0.39, 0.47, 0.05, 0.88, 0.39, 0.13, 0.04, 0.32, 0.28, 0.67, 0.12, 0.1, 0.06, 0.03, 0.2, 0.0, 0.09, 0.1, 0.0, 0.28, 0.0, 0.0, 0.04, 0.26, 0.32, 0.49]}, 'ticker': 'NKTR'}
components/leftnav.html
/mnt/disks/pennyloupe_disk/pennyloupe/templates/components/leftnav.html
Toggle context {'False': False, 'None': None, 'True': True} {'DEFAULT_MESSAGE_LEVELS': {'DEBUG': 10, 'ERROR': 40, 'INFO': 20, 'SUCCESS': 25, 'WARNING': 30}, 'csrf_token': '<SimpleLazyObject: ' "'1eDiy3Dsy6cn6dxepdGrQpmeILx8v0y4oXUpk2VdcM3hieBhImg8uBiDYKglotYg'>", 'messages': <FallbackStorage: request=<WSGIRequest: GET '/ticker/NKTR/content?date_from=2024-09-15&date_to=2025-03-14'>>, 'perms': PermWrapper(<SimpleLazyObject: <function AuthenticationMiddleware.process_request.<locals>.<lambda> at 0x7ff653d89f80>>), 'request': '<<request>>', 'user': '<SimpleLazyObject: <function ' 'AuthenticationMiddleware.process_request.<locals>.<lambda> at ' '0x7ff653d89f80>>'} {'content': '<<queryset of core.Content>>', 'data_source_id': '', 'data_sources': '<<queryset of core.DataSource>>', 'date_from': '2024-09-15', 'date_to': '2025-03-14', 'published_by': '', 'published_by_list': '<<queryset of core.Content>>', 'report': {'items_count': [0, 1, 0, 0, 1, 0, 0, 0, 0, 0, 2, 1, 4, 0, 0, 6, 3, 2, 2, 1, 0, 0, 0, 1, 2, 1, 3, 0, 1, 2, 1, 0, 14, 4, 0, 0, 1, 3, 0, 0, 1, 0, 0, 2, 3, 0, 14, 5, 1, 2, 12, 7, 5, 26, 13, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 4, 2, 1, 1, 5, 0, 0, 2, 1, 2, 0, 16, 4, 1, 0, 2, 3, 0, 3, 8, 5, 14, 5, 2, 4, 3, 4, 0, 3, 9, 4, 3, 2, 2, 1, 1, 5, 1, 2, 0, 1, 0, 0, 1, 5, 1, 0, 2, 8, 9, 19, 5, 1, 3, 7, 5, 1, 2, 2, 1, 0, 1, 1, 3, 1, 0, 1, 1, 13, 2, 4, 5, 0, 0, 5, 4, 10, 4, 7, 0, 2, 14, 5, 6, 8, 23, 3, 2, 2, 2, 1, 1, 2, 6, 1, 19, 10, 16, 3, 5, 1, 1, 1, 0, 22, 2, 0, 3, 0, 0, 1, 25, 18, 2], 'items_negative_count': [0, 1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 3, 1, 2, 2, 0, 0, 0, 0, 0, 1, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 2, 3, 1, 1, 1, 3, 4, 6, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 1, 0, 0, 1, 2, 0, 1, 0, 0, 0, 1, 1, 2, 1, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 1, 0, 0, 2, 1, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 2, 1, 1, 0, 0, 0, 0, 1, 5, 1, 0, 0, 1, 1, 1, 1, 0, 2, 0, 0, 0, 0, 0, 0, 0, 3, 0, 4, 0, 0, 1, 2, 0, 1, 1, 0, 0, 0, 0, 1, 0, 0, 0, 16, 4, 0], 'items_neutral_count': [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 3, 0, 0, 2, 2, 0, 0, 1, 0, 0, 0, 1, 1, 0, 0, 0, 1, 1, 0, 0, 7, 4, 0, 0, 1, 1, 0, 0, 1, 0, 0, 1, 1, 0, 12, 2, 0, 1, 3, 2, 1, 6, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 5, 0, 0, 2, 1, 0, 0, 5, 4, 1, 0, 1, 1, 0, 2, 6, 3, 12, 3, 2, 3, 3, 4, 0, 2, 8, 2, 2, 2, 2, 1, 1, 3, 0, 1, 0, 1, 0, 0, 0, 4, 0, 0, 0, 7, 8, 7, 4, 1, 1, 5, 4, 1, 2, 1, 1, 0, 0, 1, 1, 1, 0, 0, 0, 10, 1, 2, 4, 0, 0, 3, 1, 3, 3, 6, 0, 1, 4, 3, 5, 8, 21, 3, 1, 2, 1, 1, 0, 1, 3, 1, 8, 7, 2, 2, 3, 1, 0, 0, 0, 22, 2, 0, 1, 0, 0, 1, 4, 10, 1], 'items_positive_count': [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 1, 1, 0, 7, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0, 0, 0, 8, 2, 0, 14, 7, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 11, 0, 0, 0, 0, 2, 0, 0, 2, 2, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 2, 1, 0, 10, 0, 0, 2, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 1, 1, 1, 0, 1, 1, 0, 0, 2, 2, 2, 0, 1, 0, 0, 9, 1, 0, 0, 0, 0, 1, 0, 1, 0, 1, 1, 0, 0, 7, 3, 14, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 5, 4, 1], 'labels': ['2024-09-15', '2024-09-16', '2024-09-17', '2024-09-18', '2024-09-19', '2024-09-20', '2024-09-21', '2024-09-22', '2024-09-23', '2024-09-24', '2024-09-25', '2024-09-26', '2024-09-27', '2024-09-28', '2024-09-29', '2024-09-30', '2024-10-01', '2024-10-02', '2024-10-03', '2024-10-04', '2024-10-05', '2024-10-06', '2024-10-07', '2024-10-08', '2024-10-09', '2024-10-10', '2024-10-11', '2024-10-12', '2024-10-13', '2024-10-14', '2024-10-15', '2024-10-16', '2024-10-17', '2024-10-18', '2024-10-19', '2024-10-20', '2024-10-21', '2024-10-22', '2024-10-23', '2024-10-24', '2024-10-25', '2024-10-26', '2024-10-27', '2024-10-28', '2024-10-29', '2024-10-30', '2024-10-31', '2024-11-01', '2024-11-02', '2024-11-03', '2024-11-04', '2024-11-05', '2024-11-06', '2024-11-07', '2024-11-08', '2024-11-09', '2024-11-10', '2024-11-11', '2024-11-12', '2024-11-13', '2024-11-14', '2024-11-15', '2024-11-16', '2024-11-17', '2024-11-18', '2024-11-19', '2024-11-20', '2024-11-21', '2024-11-22', '2024-11-23', '2024-11-24', '2024-11-25', '2024-11-26', '2024-11-27', '2024-11-28', '2024-11-29', '2024-11-30', '2024-12-01', '2024-12-02', '2024-12-03', '2024-12-04', '2024-12-05', '2024-12-06', '2024-12-07', '2024-12-08', '2024-12-09', '2024-12-10', '2024-12-11', '2024-12-12', '2024-12-13', '2024-12-14', '2024-12-15', '2024-12-16', '2024-12-17', '2024-12-18', '2024-12-19', '2024-12-20', '2024-12-21', '2024-12-22', '2024-12-23', '2024-12-24', '2024-12-25', '2024-12-26', '2024-12-27', '2024-12-28', '2024-12-29', '2024-12-30', '2024-12-31', '2025-01-01', '2025-01-02', '2025-01-03', '2025-01-04', '2025-01-05', '2025-01-06', '2025-01-07', '2025-01-08', '2025-01-09', '2025-01-10', '2025-01-11', '2025-01-12', '2025-01-13', '2025-01-14', '2025-01-15', '2025-01-16', '2025-01-17', '2025-01-18', '2025-01-19', '2025-01-20', '2025-01-21', '2025-01-22', '2025-01-23', '2025-01-24', '2025-01-25', '2025-01-26', '2025-01-27', '2025-01-28', '2025-01-29', '2025-01-30', '2025-01-31', '2025-02-01', '2025-02-02', '2025-02-03', '2025-02-04', '2025-02-05', '2025-02-06', '2025-02-07', '2025-02-08', '2025-02-09', '2025-02-10', '2025-02-11', '2025-02-12', '2025-02-13', '2025-02-14', '2025-02-15', '2025-02-16', '2025-02-17', '2025-02-18', '2025-02-19', '2025-02-20', '2025-02-21', '2025-02-22', '2025-02-23', '2025-02-24', '2025-02-25', '2025-02-26', '2025-02-27', '2025-02-28', '2025-03-01', '2025-03-02', '2025-03-03', '2025-03-04', '2025-03-05', '2025-03-06', '2025-03-07', '2025-03-08', '2025-03-09', '2025-03-10', '2025-03-11', '2025-03-12', '2025-03-13', '2025-03-14'], 'sentiment_avg': [0.0, -0.88, 0.0, 0.0, -0.53, 0.0, 0.0, 0.0, 0.0, 0.0, 0.15, 0.82, -0.15, 0.0, 0.0, -0.14, -0.18, -0.73, -0.58, 0.01, 0.0, 0.0, 0.0, -0.03, -0.23, -0.74, -0.2, 0.0, 0.24, 0.23, 0.32, 0.0, 0.31, 0.21, 0.0, 0.0, -0.03, -0.74, 0.0, 0.0, -0.02, 0.0, 0.0, 0.15, 0.49, 0.0, -0.12, -0.31, -0.43, -0.33, 0.31, -0.17, -0.36, 0.14, 0.08, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.61, 0.33, 0.0, -0.6, -0.26, -0.01, 0.13, 0.12, 0.0, 0.0, 0.1, 0.04, 0.37, 0.0, 0.44, 0.0, 0.0, 0.0, -0.22, 0.68, 0.0, -0.13, 0.14, 0.19, 0.01, -0.22, 0.03, 0.0, 0.04, 0.02, 0.0, -0.18, -0.04, -0.21, -0.26, -0.06, 0.0, -0.05, 0.0, 0.22, -0.44, -0.17, 0.0, 0.02, 0.0, 0.0, 0.35, 0.08, 0.54, 0.0, 0.89, 0.02, -0.03, 0.31, -0.06, 0.01, 0.36, -0.1, -0.11, -0.02, -0.18, 0.32, -0.01, 0.0, -0.92, 0.04, 0.02, 0.07, 0.0, 0.33, 0.28, -0.08, -0.25, -0.29, 0.15, 0.0, 0.0, 0.38, 0.49, -0.15, -0.02, 0.07, 0.0, -0.26, 0.31, -0.12, -0.08, -0.01, 0.02, -0.03, 0.18, 0.15, 0.36, 0.0, 0.77, 0.13, -0.16, -0.13, 0.03, 0.11, 0.5, -0.05, -0.28, -0.05, -0.45, -0.53, 0.0, 0.01, 0.01, 0.0, -0.05, 0.0, 0.0, -0.12, -0.16, 0.03, 0.38], 'sentiment_avg_negative': [-0.0, -0.94, -0.0, -0.0, -0.73, -0.0, -0.0, -0.0, -0.0, -0.0, -0.03, -0.02, -0.29, -0.0, -0.0, -0.36, -0.27, -0.86, -0.77, -0.05, -0.0, -0.0, -0.0, -0.17, -0.37, -0.86, -0.52, -0.0, -0.02, -0.1, -0.02, -0.0, -0.02, -0.02, -0.0, -0.0, -0.19, -0.83, -0.0, -0.0, -0.2, -0.0, -0.0, -0.12, -0.01, -0.0, -0.15, -0.43, -0.66, -0.52, -0.08, -0.38, -0.54, -0.29, -0.39, -0.0, -0.0, -0.0, -0.0, -0.0, -0.0, -0.0, -0.0, -0.0, -0.01, -0.24, -0.0, -0.68, -0.52, -0.09, -0.02, -0.03, -0.0, -0.0, -0.02, -0.01, -0.01, -0.0, -0.01, -0.03, -0.01, -0.0, -0.36, -0.02, -0.0, -0.23, -0.02, -0.04, -0.09, -0.42, -0.06, -0.08, -0.02, -0.08, -0.0, -0.34, -0.16, -0.43, -0.46, -0.25, -0.06, -0.24, -0.04, -0.12, -0.66, -0.4, -0.0, -0.02, -0.0, -0.0, -0.02, -0.04, -0.02, -0.0, -0.02, -0.08, -0.12, -0.11, -0.17, -0.02, -0.03, -0.27, -0.27, -0.17, -0.41, -0.06, -0.13, -0.0, -0.96, -0.02, -0.24, -0.02, -0.0, -0.02, -0.02, -0.21, -0.51, -0.47, -0.1, -0.0, -0.0, -0.09, -0.15, -0.43, -0.11, -0.19, -0.0, -0.49, -0.06, -0.29, -0.16, -0.1, -0.02, -0.12, -0.1, -0.02, -0.17, -0.03, -0.03, -0.19, -0.38, -0.36, -0.17, -0.06, -0.03, -0.17, -0.42, -0.23, -0.67, -0.75, -0.0, -0.01, -0.01, -0.0, -0.39, -0.0, -0.0, -0.35, -0.48, -0.26, -0.01], 'sentiment_avg_neutral': [0.0, 0.04, 0.0, 0.0, 0.22, 0.0, 0.0, 0.0, 0.0, 0.0, 0.62, 0.07, 0.63, 0.0, 0.0, 0.46, 0.62, 0.1, 0.17, 0.86, 0.0, 0.0, 0.0, 0.8, 0.48, 0.12, 0.1, 0.0, 0.5, 0.53, 0.41, 0.0, 0.5, 0.53, 0.0, 0.0, 0.77, 0.15, 0.0, 0.0, 0.64, 0.0, 0.0, 0.51, 0.39, 0.0, 0.76, 0.5, 0.26, 0.37, 0.41, 0.33, 0.41, 0.26, 0.13, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.21, 0.14, 0.0, 0.3, 0.36, 0.86, 0.62, 0.68, 0.0, 0.0, 0.66, 0.79, 0.38, 0.0, 0.4, 0.93, 0.93, 0.0, 0.49, 0.19, 0.0, 0.66, 0.75, 0.62, 0.82, 0.53, 0.79, 0.79, 0.79, 0.76, 0.0, 0.54, 0.73, 0.43, 0.42, 0.67, 0.89, 0.69, 0.92, 0.52, 0.3, 0.55, 0.0, 0.84, 0.0, 0.0, 0.39, 0.76, 0.25, 0.0, 0.04, 0.78, 0.78, 0.39, 0.67, 0.89, 0.46, 0.67, 0.66, 0.74, 0.51, 0.39, 0.76, 0.0, 0.03, 0.77, 0.47, 0.72, 0.0, 0.41, 0.45, 0.68, 0.31, 0.3, 0.67, 0.0, 0.0, 0.41, 0.15, 0.27, 0.82, 0.55, 0.0, 0.48, 0.46, 0.53, 0.72, 0.78, 0.81, 0.83, 0.56, 0.59, 0.37, 0.93, 0.09, 0.4, 0.49, 0.59, 0.5, 0.66, 0.3, 0.71, 0.49, 0.71, 0.3, 0.04, 0.0, 0.9, 0.89, 0.0, 0.34, 0.0, 0.0, 0.62, 0.27, 0.43, 0.5], 'sentiment_avg_positive': [0.0, 0.02, 0.0, 0.0, 0.05, 0.0, 0.0, 0.0, 0.0, 0.0, 0.36, 0.91, 0.08, 0.0, 0.0, 0.18, 0.12, 0.04, 0.06, 0.09, 0.0, 0.0, 0.0, 0.03, 0.15, 0.03, 0.37, 0.0, 0.49, 0.37, 0.57, 0.0, 0.48, 0.45, 0.0, 0.0, 0.05, 0.02, 0.0, 0.0, 0.15, 0.0, 0.0, 0.37, 0.6, 0.0, 0.1, 0.06, 0.07, 0.11, 0.51, 0.28, 0.05, 0.46, 0.48, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.78, 0.62, 0.0, 0.03, 0.12, 0.05, 0.37, 0.29, 0.0, 0.0, 0.32, 0.2, 0.6, 0.0, 0.58, 0.04, 0.06, 0.0, 0.15, 0.8, 0.0, 0.1, 0.23, 0.35, 0.09, 0.05, 0.15, 0.14, 0.18, 0.17, 0.0, 0.12, 0.1, 0.14, 0.11, 0.07, 0.06, 0.08, 0.04, 0.37, 0.04, 0.06, 0.0, 0.14, 0.0, 0.0, 0.6, 0.19, 0.73, 0.0, 0.94, 0.14, 0.09, 0.5, 0.15, 0.09, 0.52, 0.06, 0.07, 0.08, 0.07, 0.55, 0.1, 0.0, 0.01, 0.21, 0.29, 0.27, 0.0, 0.57, 0.53, 0.11, 0.18, 0.23, 0.23, 0.0, 0.0, 0.5, 0.7, 0.29, 0.08, 0.26, 0.0, 0.03, 0.49, 0.18, 0.13, 0.12, 0.16, 0.05, 0.34, 0.39, 0.47, 0.05, 0.88, 0.39, 0.13, 0.04, 0.32, 0.28, 0.67, 0.12, 0.1, 0.06, 0.03, 0.2, 0.0, 0.09, 0.1, 0.0, 0.28, 0.0, 0.0, 0.04, 0.26, 0.32, 0.49]}, 'ticker': 'NKTR'} {'block': <Block Node: leftnav. Contents: [<TextNode: '\n <div'>, <IncludeNode: template=<FilterExpression '"components/leftnav.html"'>>, <TextNode: '\n </di'>]>}
components/header.html
/mnt/disks/pennyloupe_disk/pennyloupe/templates/components/header.html
Toggle context {'False': False, 'None': None, 'True': True} {'DEFAULT_MESSAGE_LEVELS': {'DEBUG': 10, 'ERROR': 40, 'INFO': 20, 'SUCCESS': 25, 'WARNING': 30}, 'csrf_token': '<SimpleLazyObject: ' "'1eDiy3Dsy6cn6dxepdGrQpmeILx8v0y4oXUpk2VdcM3hieBhImg8uBiDYKglotYg'>", 'messages': <FallbackStorage: request=<WSGIRequest: GET '/ticker/NKTR/content?date_from=2024-09-15&date_to=2025-03-14'>>, 'perms': PermWrapper(<SimpleLazyObject: <function AuthenticationMiddleware.process_request.<locals>.<lambda> at 0x7ff653d89f80>>), 'request': '<<request>>', 'user': '<SimpleLazyObject: <function ' 'AuthenticationMiddleware.process_request.<locals>.<lambda> at ' '0x7ff653d89f80>>'} {'content': '<<queryset of core.Content>>', 'data_source_id': '', 'data_sources': '<<queryset of core.DataSource>>', 'date_from': '2024-09-15', 'date_to': '2025-03-14', 'published_by': '', 'published_by_list': '<<queryset of core.Content>>', 'report': {'items_count': [0, 1, 0, 0, 1, 0, 0, 0, 0, 0, 2, 1, 4, 0, 0, 6, 3, 2, 2, 1, 0, 0, 0, 1, 2, 1, 3, 0, 1, 2, 1, 0, 14, 4, 0, 0, 1, 3, 0, 0, 1, 0, 0, 2, 3, 0, 14, 5, 1, 2, 12, 7, 5, 26, 13, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 4, 2, 1, 1, 5, 0, 0, 2, 1, 2, 0, 16, 4, 1, 0, 2, 3, 0, 3, 8, 5, 14, 5, 2, 4, 3, 4, 0, 3, 9, 4, 3, 2, 2, 1, 1, 5, 1, 2, 0, 1, 0, 0, 1, 5, 1, 0, 2, 8, 9, 19, 5, 1, 3, 7, 5, 1, 2, 2, 1, 0, 1, 1, 3, 1, 0, 1, 1, 13, 2, 4, 5, 0, 0, 5, 4, 10, 4, 7, 0, 2, 14, 5, 6, 8, 23, 3, 2, 2, 2, 1, 1, 2, 6, 1, 19, 10, 16, 3, 5, 1, 1, 1, 0, 22, 2, 0, 3, 0, 0, 1, 25, 18, 2], 'items_negative_count': [0, 1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 3, 1, 2, 2, 0, 0, 0, 0, 0, 1, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 2, 3, 1, 1, 1, 3, 4, 6, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 1, 0, 0, 1, 2, 0, 1, 0, 0, 0, 1, 1, 2, 1, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 1, 0, 0, 2, 1, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 2, 1, 1, 0, 0, 0, 0, 1, 5, 1, 0, 0, 1, 1, 1, 1, 0, 2, 0, 0, 0, 0, 0, 0, 0, 3, 0, 4, 0, 0, 1, 2, 0, 1, 1, 0, 0, 0, 0, 1, 0, 0, 0, 16, 4, 0], 'items_neutral_count': [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 3, 0, 0, 2, 2, 0, 0, 1, 0, 0, 0, 1, 1, 0, 0, 0, 1, 1, 0, 0, 7, 4, 0, 0, 1, 1, 0, 0, 1, 0, 0, 1, 1, 0, 12, 2, 0, 1, 3, 2, 1, 6, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 5, 0, 0, 2, 1, 0, 0, 5, 4, 1, 0, 1, 1, 0, 2, 6, 3, 12, 3, 2, 3, 3, 4, 0, 2, 8, 2, 2, 2, 2, 1, 1, 3, 0, 1, 0, 1, 0, 0, 0, 4, 0, 0, 0, 7, 8, 7, 4, 1, 1, 5, 4, 1, 2, 1, 1, 0, 0, 1, 1, 1, 0, 0, 0, 10, 1, 2, 4, 0, 0, 3, 1, 3, 3, 6, 0, 1, 4, 3, 5, 8, 21, 3, 1, 2, 1, 1, 0, 1, 3, 1, 8, 7, 2, 2, 3, 1, 0, 0, 0, 22, 2, 0, 1, 0, 0, 1, 4, 10, 1], 'items_positive_count': [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 1, 1, 0, 7, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0, 0, 0, 8, 2, 0, 14, 7, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 11, 0, 0, 0, 0, 2, 0, 0, 2, 2, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 2, 1, 0, 10, 0, 0, 2, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 1, 1, 1, 0, 1, 1, 0, 0, 2, 2, 2, 0, 1, 0, 0, 9, 1, 0, 0, 0, 0, 1, 0, 1, 0, 1, 1, 0, 0, 7, 3, 14, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 5, 4, 1], 'labels': ['2024-09-15', '2024-09-16', '2024-09-17', '2024-09-18', '2024-09-19', '2024-09-20', '2024-09-21', '2024-09-22', '2024-09-23', '2024-09-24', '2024-09-25', '2024-09-26', '2024-09-27', '2024-09-28', '2024-09-29', '2024-09-30', '2024-10-01', '2024-10-02', '2024-10-03', '2024-10-04', '2024-10-05', '2024-10-06', '2024-10-07', '2024-10-08', '2024-10-09', '2024-10-10', '2024-10-11', '2024-10-12', '2024-10-13', '2024-10-14', '2024-10-15', '2024-10-16', '2024-10-17', '2024-10-18', '2024-10-19', '2024-10-20', '2024-10-21', '2024-10-22', '2024-10-23', '2024-10-24', '2024-10-25', '2024-10-26', '2024-10-27', '2024-10-28', '2024-10-29', '2024-10-30', '2024-10-31', '2024-11-01', '2024-11-02', '2024-11-03', '2024-11-04', '2024-11-05', '2024-11-06', '2024-11-07', '2024-11-08', '2024-11-09', '2024-11-10', '2024-11-11', '2024-11-12', '2024-11-13', '2024-11-14', '2024-11-15', '2024-11-16', '2024-11-17', '2024-11-18', '2024-11-19', '2024-11-20', '2024-11-21', '2024-11-22', '2024-11-23', '2024-11-24', '2024-11-25', '2024-11-26', '2024-11-27', '2024-11-28', '2024-11-29', '2024-11-30', '2024-12-01', '2024-12-02', '2024-12-03', '2024-12-04', '2024-12-05', '2024-12-06', '2024-12-07', '2024-12-08', '2024-12-09', '2024-12-10', '2024-12-11', '2024-12-12', '2024-12-13', '2024-12-14', '2024-12-15', '2024-12-16', '2024-12-17', '2024-12-18', '2024-12-19', '2024-12-20', '2024-12-21', '2024-12-22', '2024-12-23', '2024-12-24', '2024-12-25', '2024-12-26', '2024-12-27', '2024-12-28', '2024-12-29', '2024-12-30', '2024-12-31', '2025-01-01', '2025-01-02', '2025-01-03', '2025-01-04', '2025-01-05', '2025-01-06', '2025-01-07', '2025-01-08', '2025-01-09', '2025-01-10', '2025-01-11', '2025-01-12', '2025-01-13', '2025-01-14', '2025-01-15', '2025-01-16', '2025-01-17', '2025-01-18', '2025-01-19', '2025-01-20', '2025-01-21', '2025-01-22', '2025-01-23', '2025-01-24', '2025-01-25', '2025-01-26', '2025-01-27', '2025-01-28', '2025-01-29', '2025-01-30', '2025-01-31', '2025-02-01', '2025-02-02', '2025-02-03', '2025-02-04', '2025-02-05', '2025-02-06', '2025-02-07', '2025-02-08', '2025-02-09', '2025-02-10', '2025-02-11', '2025-02-12', '2025-02-13', '2025-02-14', '2025-02-15', '2025-02-16', '2025-02-17', '2025-02-18', '2025-02-19', '2025-02-20', '2025-02-21', '2025-02-22', '2025-02-23', '2025-02-24', '2025-02-25', '2025-02-26', '2025-02-27', '2025-02-28', '2025-03-01', '2025-03-02', '2025-03-03', '2025-03-04', '2025-03-05', '2025-03-06', '2025-03-07', '2025-03-08', '2025-03-09', '2025-03-10', '2025-03-11', '2025-03-12', '2025-03-13', '2025-03-14'], 'sentiment_avg': [0.0, -0.88, 0.0, 0.0, -0.53, 0.0, 0.0, 0.0, 0.0, 0.0, 0.15, 0.82, -0.15, 0.0, 0.0, -0.14, -0.18, -0.73, -0.58, 0.01, 0.0, 0.0, 0.0, -0.03, -0.23, -0.74, -0.2, 0.0, 0.24, 0.23, 0.32, 0.0, 0.31, 0.21, 0.0, 0.0, -0.03, -0.74, 0.0, 0.0, -0.02, 0.0, 0.0, 0.15, 0.49, 0.0, -0.12, -0.31, -0.43, -0.33, 0.31, -0.17, -0.36, 0.14, 0.08, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.61, 0.33, 0.0, -0.6, -0.26, -0.01, 0.13, 0.12, 0.0, 0.0, 0.1, 0.04, 0.37, 0.0, 0.44, 0.0, 0.0, 0.0, -0.22, 0.68, 0.0, -0.13, 0.14, 0.19, 0.01, -0.22, 0.03, 0.0, 0.04, 0.02, 0.0, -0.18, -0.04, -0.21, -0.26, -0.06, 0.0, -0.05, 0.0, 0.22, -0.44, -0.17, 0.0, 0.02, 0.0, 0.0, 0.35, 0.08, 0.54, 0.0, 0.89, 0.02, -0.03, 0.31, -0.06, 0.01, 0.36, -0.1, -0.11, -0.02, -0.18, 0.32, -0.01, 0.0, -0.92, 0.04, 0.02, 0.07, 0.0, 0.33, 0.28, -0.08, -0.25, -0.29, 0.15, 0.0, 0.0, 0.38, 0.49, -0.15, -0.02, 0.07, 0.0, -0.26, 0.31, -0.12, -0.08, -0.01, 0.02, -0.03, 0.18, 0.15, 0.36, 0.0, 0.77, 0.13, -0.16, -0.13, 0.03, 0.11, 0.5, -0.05, -0.28, -0.05, -0.45, -0.53, 0.0, 0.01, 0.01, 0.0, -0.05, 0.0, 0.0, -0.12, -0.16, 0.03, 0.38], 'sentiment_avg_negative': [-0.0, -0.94, -0.0, -0.0, -0.73, -0.0, -0.0, -0.0, -0.0, -0.0, -0.03, -0.02, -0.29, -0.0, -0.0, -0.36, -0.27, -0.86, -0.77, -0.05, -0.0, -0.0, -0.0, -0.17, -0.37, -0.86, -0.52, -0.0, -0.02, -0.1, -0.02, -0.0, -0.02, -0.02, -0.0, -0.0, -0.19, -0.83, -0.0, -0.0, -0.2, -0.0, -0.0, -0.12, -0.01, -0.0, -0.15, -0.43, -0.66, -0.52, -0.08, -0.38, -0.54, -0.29, -0.39, -0.0, -0.0, -0.0, -0.0, -0.0, -0.0, -0.0, -0.0, -0.0, -0.01, -0.24, -0.0, -0.68, -0.52, -0.09, -0.02, -0.03, -0.0, -0.0, -0.02, -0.01, -0.01, -0.0, -0.01, -0.03, -0.01, -0.0, -0.36, -0.02, -0.0, -0.23, -0.02, -0.04, -0.09, -0.42, -0.06, -0.08, -0.02, -0.08, -0.0, -0.34, -0.16, -0.43, -0.46, -0.25, -0.06, -0.24, -0.04, -0.12, -0.66, -0.4, -0.0, -0.02, -0.0, -0.0, -0.02, -0.04, -0.02, -0.0, -0.02, -0.08, -0.12, -0.11, -0.17, -0.02, -0.03, -0.27, -0.27, -0.17, -0.41, -0.06, -0.13, -0.0, -0.96, -0.02, -0.24, -0.02, -0.0, -0.02, -0.02, -0.21, -0.51, -0.47, -0.1, -0.0, -0.0, -0.09, -0.15, -0.43, -0.11, -0.19, -0.0, -0.49, -0.06, -0.29, -0.16, -0.1, -0.02, -0.12, -0.1, -0.02, -0.17, -0.03, -0.03, -0.19, -0.38, -0.36, -0.17, -0.06, -0.03, -0.17, -0.42, -0.23, -0.67, -0.75, -0.0, -0.01, -0.01, -0.0, -0.39, -0.0, -0.0, -0.35, -0.48, -0.26, -0.01], 'sentiment_avg_neutral': [0.0, 0.04, 0.0, 0.0, 0.22, 0.0, 0.0, 0.0, 0.0, 0.0, 0.62, 0.07, 0.63, 0.0, 0.0, 0.46, 0.62, 0.1, 0.17, 0.86, 0.0, 0.0, 0.0, 0.8, 0.48, 0.12, 0.1, 0.0, 0.5, 0.53, 0.41, 0.0, 0.5, 0.53, 0.0, 0.0, 0.77, 0.15, 0.0, 0.0, 0.64, 0.0, 0.0, 0.51, 0.39, 0.0, 0.76, 0.5, 0.26, 0.37, 0.41, 0.33, 0.41, 0.26, 0.13, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.21, 0.14, 0.0, 0.3, 0.36, 0.86, 0.62, 0.68, 0.0, 0.0, 0.66, 0.79, 0.38, 0.0, 0.4, 0.93, 0.93, 0.0, 0.49, 0.19, 0.0, 0.66, 0.75, 0.62, 0.82, 0.53, 0.79, 0.79, 0.79, 0.76, 0.0, 0.54, 0.73, 0.43, 0.42, 0.67, 0.89, 0.69, 0.92, 0.52, 0.3, 0.55, 0.0, 0.84, 0.0, 0.0, 0.39, 0.76, 0.25, 0.0, 0.04, 0.78, 0.78, 0.39, 0.67, 0.89, 0.46, 0.67, 0.66, 0.74, 0.51, 0.39, 0.76, 0.0, 0.03, 0.77, 0.47, 0.72, 0.0, 0.41, 0.45, 0.68, 0.31, 0.3, 0.67, 0.0, 0.0, 0.41, 0.15, 0.27, 0.82, 0.55, 0.0, 0.48, 0.46, 0.53, 0.72, 0.78, 0.81, 0.83, 0.56, 0.59, 0.37, 0.93, 0.09, 0.4, 0.49, 0.59, 0.5, 0.66, 0.3, 0.71, 0.49, 0.71, 0.3, 0.04, 0.0, 0.9, 0.89, 0.0, 0.34, 0.0, 0.0, 0.62, 0.27, 0.43, 0.5], 'sentiment_avg_positive': [0.0, 0.02, 0.0, 0.0, 0.05, 0.0, 0.0, 0.0, 0.0, 0.0, 0.36, 0.91, 0.08, 0.0, 0.0, 0.18, 0.12, 0.04, 0.06, 0.09, 0.0, 0.0, 0.0, 0.03, 0.15, 0.03, 0.37, 0.0, 0.49, 0.37, 0.57, 0.0, 0.48, 0.45, 0.0, 0.0, 0.05, 0.02, 0.0, 0.0, 0.15, 0.0, 0.0, 0.37, 0.6, 0.0, 0.1, 0.06, 0.07, 0.11, 0.51, 0.28, 0.05, 0.46, 0.48, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.78, 0.62, 0.0, 0.03, 0.12, 0.05, 0.37, 0.29, 0.0, 0.0, 0.32, 0.2, 0.6, 0.0, 0.58, 0.04, 0.06, 0.0, 0.15, 0.8, 0.0, 0.1, 0.23, 0.35, 0.09, 0.05, 0.15, 0.14, 0.18, 0.17, 0.0, 0.12, 0.1, 0.14, 0.11, 0.07, 0.06, 0.08, 0.04, 0.37, 0.04, 0.06, 0.0, 0.14, 0.0, 0.0, 0.6, 0.19, 0.73, 0.0, 0.94, 0.14, 0.09, 0.5, 0.15, 0.09, 0.52, 0.06, 0.07, 0.08, 0.07, 0.55, 0.1, 0.0, 0.01, 0.21, 0.29, 0.27, 0.0, 0.57, 0.53, 0.11, 0.18, 0.23, 0.23, 0.0, 0.0, 0.5, 0.7, 0.29, 0.08, 0.26, 0.0, 0.03, 0.49, 0.18, 0.13, 0.12, 0.16, 0.05, 0.34, 0.39, 0.47, 0.05, 0.88, 0.39, 0.13, 0.04, 0.32, 0.28, 0.67, 0.12, 0.1, 0.06, 0.03, 0.2, 0.0, 0.09, 0.1, 0.0, 0.28, 0.0, 0.0, 0.04, 0.26, 0.32, 0.49]}, 'ticker': 'NKTR'} {'block': <Block Node: header. Contents: [<TextNode: '\n\n '>, <IncludeNode: template=<FilterExpression '"components/header.html"'>>, <TextNode: '\n\n '>]>}
components/ticker_subnav.html
/mnt/disks/pennyloupe_disk/pennyloupe/app/core/templates/components/ticker_subnav.html
Toggle context {'False': False, 'None': None, 'True': True} {'DEFAULT_MESSAGE_LEVELS': {'DEBUG': 10, 'ERROR': 40, 'INFO': 20, 'SUCCESS': 25, 'WARNING': 30}, 'csrf_token': '<SimpleLazyObject: ' "'1eDiy3Dsy6cn6dxepdGrQpmeILx8v0y4oXUpk2VdcM3hieBhImg8uBiDYKglotYg'>", 'messages': <FallbackStorage: request=<WSGIRequest: GET '/ticker/NKTR/content?date_from=2024-09-15&date_to=2025-03-14'>>, 'perms': PermWrapper(<SimpleLazyObject: <function AuthenticationMiddleware.process_request.<locals>.<lambda> at 0x7ff653d89f80>>), 'request': '<<request>>', 'user': '<SimpleLazyObject: <function ' 'AuthenticationMiddleware.process_request.<locals>.<lambda> at ' '0x7ff653d89f80>>'} {'content': '<<queryset of core.Content>>', 'data_source_id': '', 'data_sources': '<<queryset of core.DataSource>>', 'date_from': '2024-09-15', 'date_to': '2025-03-14', 'published_by': '', 'published_by_list': '<<queryset of core.Content>>', 'report': {'items_count': [0, 1, 0, 0, 1, 0, 0, 0, 0, 0, 2, 1, 4, 0, 0, 6, 3, 2, 2, 1, 0, 0, 0, 1, 2, 1, 3, 0, 1, 2, 1, 0, 14, 4, 0, 0, 1, 3, 0, 0, 1, 0, 0, 2, 3, 0, 14, 5, 1, 2, 12, 7, 5, 26, 13, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 4, 2, 1, 1, 5, 0, 0, 2, 1, 2, 0, 16, 4, 1, 0, 2, 3, 0, 3, 8, 5, 14, 5, 2, 4, 3, 4, 0, 3, 9, 4, 3, 2, 2, 1, 1, 5, 1, 2, 0, 1, 0, 0, 1, 5, 1, 0, 2, 8, 9, 19, 5, 1, 3, 7, 5, 1, 2, 2, 1, 0, 1, 1, 3, 1, 0, 1, 1, 13, 2, 4, 5, 0, 0, 5, 4, 10, 4, 7, 0, 2, 14, 5, 6, 8, 23, 3, 2, 2, 2, 1, 1, 2, 6, 1, 19, 10, 16, 3, 5, 1, 1, 1, 0, 22, 2, 0, 3, 0, 0, 1, 25, 18, 2], 'items_negative_count': [0, 1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 3, 1, 2, 2, 0, 0, 0, 0, 0, 1, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 2, 3, 1, 1, 1, 3, 4, 6, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 1, 0, 0, 1, 2, 0, 1, 0, 0, 0, 1, 1, 2, 1, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 1, 0, 0, 2, 1, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 2, 1, 1, 0, 0, 0, 0, 1, 5, 1, 0, 0, 1, 1, 1, 1, 0, 2, 0, 0, 0, 0, 0, 0, 0, 3, 0, 4, 0, 0, 1, 2, 0, 1, 1, 0, 0, 0, 0, 1, 0, 0, 0, 16, 4, 0], 'items_neutral_count': [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 3, 0, 0, 2, 2, 0, 0, 1, 0, 0, 0, 1, 1, 0, 0, 0, 1, 1, 0, 0, 7, 4, 0, 0, 1, 1, 0, 0, 1, 0, 0, 1, 1, 0, 12, 2, 0, 1, 3, 2, 1, 6, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 5, 0, 0, 2, 1, 0, 0, 5, 4, 1, 0, 1, 1, 0, 2, 6, 3, 12, 3, 2, 3, 3, 4, 0, 2, 8, 2, 2, 2, 2, 1, 1, 3, 0, 1, 0, 1, 0, 0, 0, 4, 0, 0, 0, 7, 8, 7, 4, 1, 1, 5, 4, 1, 2, 1, 1, 0, 0, 1, 1, 1, 0, 0, 0, 10, 1, 2, 4, 0, 0, 3, 1, 3, 3, 6, 0, 1, 4, 3, 5, 8, 21, 3, 1, 2, 1, 1, 0, 1, 3, 1, 8, 7, 2, 2, 3, 1, 0, 0, 0, 22, 2, 0, 1, 0, 0, 1, 4, 10, 1], 'items_positive_count': [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 1, 1, 0, 7, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0, 0, 0, 8, 2, 0, 14, 7, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 11, 0, 0, 0, 0, 2, 0, 0, 2, 2, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 2, 1, 0, 10, 0, 0, 2, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 1, 1, 1, 0, 1, 1, 0, 0, 2, 2, 2, 0, 1, 0, 0, 9, 1, 0, 0, 0, 0, 1, 0, 1, 0, 1, 1, 0, 0, 7, 3, 14, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 5, 4, 1], 'labels': ['2024-09-15', '2024-09-16', '2024-09-17', '2024-09-18', '2024-09-19', '2024-09-20', '2024-09-21', '2024-09-22', '2024-09-23', '2024-09-24', '2024-09-25', '2024-09-26', '2024-09-27', '2024-09-28', '2024-09-29', '2024-09-30', '2024-10-01', '2024-10-02', '2024-10-03', '2024-10-04', '2024-10-05', '2024-10-06', '2024-10-07', '2024-10-08', '2024-10-09', '2024-10-10', '2024-10-11', '2024-10-12', '2024-10-13', '2024-10-14', '2024-10-15', '2024-10-16', '2024-10-17', '2024-10-18', '2024-10-19', '2024-10-20', '2024-10-21', '2024-10-22', '2024-10-23', '2024-10-24', '2024-10-25', '2024-10-26', '2024-10-27', '2024-10-28', '2024-10-29', '2024-10-30', '2024-10-31', '2024-11-01', '2024-11-02', '2024-11-03', '2024-11-04', '2024-11-05', '2024-11-06', '2024-11-07', '2024-11-08', '2024-11-09', '2024-11-10', '2024-11-11', '2024-11-12', '2024-11-13', '2024-11-14', '2024-11-15', '2024-11-16', '2024-11-17', '2024-11-18', '2024-11-19', '2024-11-20', '2024-11-21', '2024-11-22', '2024-11-23', '2024-11-24', '2024-11-25', '2024-11-26', '2024-11-27', '2024-11-28', '2024-11-29', '2024-11-30', '2024-12-01', '2024-12-02', '2024-12-03', '2024-12-04', '2024-12-05', '2024-12-06', '2024-12-07', '2024-12-08', '2024-12-09', '2024-12-10', '2024-12-11', '2024-12-12', '2024-12-13', '2024-12-14', '2024-12-15', '2024-12-16', '2024-12-17', '2024-12-18', '2024-12-19', '2024-12-20', '2024-12-21', '2024-12-22', '2024-12-23', '2024-12-24', '2024-12-25', '2024-12-26', '2024-12-27', '2024-12-28', '2024-12-29', '2024-12-30', '2024-12-31', '2025-01-01', '2025-01-02', '2025-01-03', '2025-01-04', '2025-01-05', '2025-01-06', '2025-01-07', '2025-01-08', '2025-01-09', '2025-01-10', '2025-01-11', '2025-01-12', '2025-01-13', '2025-01-14', '2025-01-15', '2025-01-16', '2025-01-17', '2025-01-18', '2025-01-19', '2025-01-20', '2025-01-21', '2025-01-22', '2025-01-23', '2025-01-24', '2025-01-25', '2025-01-26', '2025-01-27', '2025-01-28', '2025-01-29', '2025-01-30', '2025-01-31', '2025-02-01', '2025-02-02', '2025-02-03', '2025-02-04', '2025-02-05', '2025-02-06', '2025-02-07', '2025-02-08', '2025-02-09', '2025-02-10', '2025-02-11', '2025-02-12', '2025-02-13', '2025-02-14', '2025-02-15', '2025-02-16', '2025-02-17', '2025-02-18', '2025-02-19', '2025-02-20', '2025-02-21', '2025-02-22', '2025-02-23', '2025-02-24', '2025-02-25', '2025-02-26', '2025-02-27', '2025-02-28', '2025-03-01', '2025-03-02', '2025-03-03', '2025-03-04', '2025-03-05', '2025-03-06', '2025-03-07', '2025-03-08', '2025-03-09', '2025-03-10', '2025-03-11', '2025-03-12', '2025-03-13', '2025-03-14'], 'sentiment_avg': [0.0, -0.88, 0.0, 0.0, -0.53, 0.0, 0.0, 0.0, 0.0, 0.0, 0.15, 0.82, -0.15, 0.0, 0.0, -0.14, -0.18, -0.73, -0.58, 0.01, 0.0, 0.0, 0.0, -0.03, -0.23, -0.74, -0.2, 0.0, 0.24, 0.23, 0.32, 0.0, 0.31, 0.21, 0.0, 0.0, -0.03, -0.74, 0.0, 0.0, -0.02, 0.0, 0.0, 0.15, 0.49, 0.0, -0.12, -0.31, -0.43, -0.33, 0.31, -0.17, -0.36, 0.14, 0.08, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.61, 0.33, 0.0, -0.6, -0.26, -0.01, 0.13, 0.12, 0.0, 0.0, 0.1, 0.04, 0.37, 0.0, 0.44, 0.0, 0.0, 0.0, -0.22, 0.68, 0.0, -0.13, 0.14, 0.19, 0.01, -0.22, 0.03, 0.0, 0.04, 0.02, 0.0, -0.18, -0.04, -0.21, -0.26, -0.06, 0.0, -0.05, 0.0, 0.22, -0.44, -0.17, 0.0, 0.02, 0.0, 0.0, 0.35, 0.08, 0.54, 0.0, 0.89, 0.02, -0.03, 0.31, -0.06, 0.01, 0.36, -0.1, -0.11, -0.02, -0.18, 0.32, -0.01, 0.0, -0.92, 0.04, 0.02, 0.07, 0.0, 0.33, 0.28, -0.08, -0.25, -0.29, 0.15, 0.0, 0.0, 0.38, 0.49, -0.15, -0.02, 0.07, 0.0, -0.26, 0.31, -0.12, -0.08, -0.01, 0.02, -0.03, 0.18, 0.15, 0.36, 0.0, 0.77, 0.13, -0.16, -0.13, 0.03, 0.11, 0.5, -0.05, -0.28, -0.05, -0.45, -0.53, 0.0, 0.01, 0.01, 0.0, -0.05, 0.0, 0.0, -0.12, -0.16, 0.03, 0.38], 'sentiment_avg_negative': [-0.0, -0.94, -0.0, -0.0, -0.73, -0.0, -0.0, -0.0, -0.0, -0.0, -0.03, -0.02, -0.29, -0.0, -0.0, -0.36, -0.27, -0.86, -0.77, -0.05, -0.0, -0.0, -0.0, -0.17, -0.37, -0.86, -0.52, -0.0, -0.02, -0.1, -0.02, -0.0, -0.02, -0.02, -0.0, -0.0, -0.19, -0.83, -0.0, -0.0, -0.2, -0.0, -0.0, -0.12, -0.01, -0.0, -0.15, -0.43, -0.66, -0.52, -0.08, -0.38, -0.54, -0.29, -0.39, -0.0, -0.0, -0.0, -0.0, -0.0, -0.0, -0.0, -0.0, -0.0, -0.01, -0.24, -0.0, -0.68, -0.52, -0.09, -0.02, -0.03, -0.0, -0.0, -0.02, -0.01, -0.01, -0.0, -0.01, -0.03, -0.01, -0.0, -0.36, -0.02, -0.0, -0.23, -0.02, -0.04, -0.09, -0.42, -0.06, -0.08, -0.02, -0.08, -0.0, -0.34, -0.16, -0.43, -0.46, -0.25, -0.06, -0.24, -0.04, -0.12, -0.66, -0.4, -0.0, -0.02, -0.0, -0.0, -0.02, -0.04, -0.02, -0.0, -0.02, -0.08, -0.12, -0.11, -0.17, -0.02, -0.03, -0.27, -0.27, -0.17, -0.41, -0.06, -0.13, -0.0, -0.96, -0.02, -0.24, -0.02, -0.0, -0.02, -0.02, -0.21, -0.51, -0.47, -0.1, -0.0, -0.0, -0.09, -0.15, -0.43, -0.11, -0.19, -0.0, -0.49, -0.06, -0.29, -0.16, -0.1, -0.02, -0.12, -0.1, -0.02, -0.17, -0.03, -0.03, -0.19, -0.38, -0.36, -0.17, -0.06, -0.03, -0.17, -0.42, -0.23, -0.67, -0.75, -0.0, -0.01, -0.01, -0.0, -0.39, -0.0, -0.0, -0.35, -0.48, -0.26, -0.01], 'sentiment_avg_neutral': [0.0, 0.04, 0.0, 0.0, 0.22, 0.0, 0.0, 0.0, 0.0, 0.0, 0.62, 0.07, 0.63, 0.0, 0.0, 0.46, 0.62, 0.1, 0.17, 0.86, 0.0, 0.0, 0.0, 0.8, 0.48, 0.12, 0.1, 0.0, 0.5, 0.53, 0.41, 0.0, 0.5, 0.53, 0.0, 0.0, 0.77, 0.15, 0.0, 0.0, 0.64, 0.0, 0.0, 0.51, 0.39, 0.0, 0.76, 0.5, 0.26, 0.37, 0.41, 0.33, 0.41, 0.26, 0.13, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.21, 0.14, 0.0, 0.3, 0.36, 0.86, 0.62, 0.68, 0.0, 0.0, 0.66, 0.79, 0.38, 0.0, 0.4, 0.93, 0.93, 0.0, 0.49, 0.19, 0.0, 0.66, 0.75, 0.62, 0.82, 0.53, 0.79, 0.79, 0.79, 0.76, 0.0, 0.54, 0.73, 0.43, 0.42, 0.67, 0.89, 0.69, 0.92, 0.52, 0.3, 0.55, 0.0, 0.84, 0.0, 0.0, 0.39, 0.76, 0.25, 0.0, 0.04, 0.78, 0.78, 0.39, 0.67, 0.89, 0.46, 0.67, 0.66, 0.74, 0.51, 0.39, 0.76, 0.0, 0.03, 0.77, 0.47, 0.72, 0.0, 0.41, 0.45, 0.68, 0.31, 0.3, 0.67, 0.0, 0.0, 0.41, 0.15, 0.27, 0.82, 0.55, 0.0, 0.48, 0.46, 0.53, 0.72, 0.78, 0.81, 0.83, 0.56, 0.59, 0.37, 0.93, 0.09, 0.4, 0.49, 0.59, 0.5, 0.66, 0.3, 0.71, 0.49, 0.71, 0.3, 0.04, 0.0, 0.9, 0.89, 0.0, 0.34, 0.0, 0.0, 0.62, 0.27, 0.43, 0.5], 'sentiment_avg_positive': [0.0, 0.02, 0.0, 0.0, 0.05, 0.0, 0.0, 0.0, 0.0, 0.0, 0.36, 0.91, 0.08, 0.0, 0.0, 0.18, 0.12, 0.04, 0.06, 0.09, 0.0, 0.0, 0.0, 0.03, 0.15, 0.03, 0.37, 0.0, 0.49, 0.37, 0.57, 0.0, 0.48, 0.45, 0.0, 0.0, 0.05, 0.02, 0.0, 0.0, 0.15, 0.0, 0.0, 0.37, 0.6, 0.0, 0.1, 0.06, 0.07, 0.11, 0.51, 0.28, 0.05, 0.46, 0.48, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.78, 0.62, 0.0, 0.03, 0.12, 0.05, 0.37, 0.29, 0.0, 0.0, 0.32, 0.2, 0.6, 0.0, 0.58, 0.04, 0.06, 0.0, 0.15, 0.8, 0.0, 0.1, 0.23, 0.35, 0.09, 0.05, 0.15, 0.14, 0.18, 0.17, 0.0, 0.12, 0.1, 0.14, 0.11, 0.07, 0.06, 0.08, 0.04, 0.37, 0.04, 0.06, 0.0, 0.14, 0.0, 0.0, 0.6, 0.19, 0.73, 0.0, 0.94, 0.14, 0.09, 0.5, 0.15, 0.09, 0.52, 0.06, 0.07, 0.08, 0.07, 0.55, 0.1, 0.0, 0.01, 0.21, 0.29, 0.27, 0.0, 0.57, 0.53, 0.11, 0.18, 0.23, 0.23, 0.0, 0.0, 0.5, 0.7, 0.29, 0.08, 0.26, 0.0, 0.03, 0.49, 0.18, 0.13, 0.12, 0.16, 0.05, 0.34, 0.39, 0.47, 0.05, 0.88, 0.39, 0.13, 0.04, 0.32, 0.28, 0.67, 0.12, 0.1, 0.06, 0.03, 0.2, 0.0, 0.09, 0.1, 0.0, 0.28, 0.0, 0.0, 0.04, 0.26, 0.32, 0.49]}, 'ticker': 'NKTR'} {'block': <Block Node: content. Contents: [<TextNode: '\n\n <div class="uk-flex'>, <IncludeNode: template=<FilterExpression '"components/ticker_subnav.html"'>>, <TextNode: '\n <!-- /SUB NAV--'>, <django.template.defaulttags.CsrfTokenNode object at 0x7ff65426cfd0>, <TextNode: '\n '>, <Variable Node: date_from>, <TextNode: '" uk-datepicker="format:\''>, <Variable Node: date_to>, <TextNode: '" uk-datepicker="format:'>, <ForNode: for ds in data_sources, tail_len: 3>, <TextNode: '\n '>, <ForNode: for pb in published_by_list, tail_len: 3>, <TextNode: '\n '>, <IfNode>, <TextNode: '\n\n <div class='>, <ForNode: for c in content, tail_len: 35>, <TextNode: '\n\n\n </div>\n\n '>]>} {'ticker': 'NKTR'}
components/footer.html
/mnt/disks/pennyloupe_disk/pennyloupe/templates/components/footer.html
Toggle context {'False': False, 'None': None, 'True': True} {'DEFAULT_MESSAGE_LEVELS': {'DEBUG': 10, 'ERROR': 40, 'INFO': 20, 'SUCCESS': 25, 'WARNING': 30}, 'csrf_token': '<SimpleLazyObject: ' "'1eDiy3Dsy6cn6dxepdGrQpmeILx8v0y4oXUpk2VdcM3hieBhImg8uBiDYKglotYg'>", 'messages': <FallbackStorage: request=<WSGIRequest: GET '/ticker/NKTR/content?date_from=2024-09-15&date_to=2025-03-14'>>, 'perms': PermWrapper(<SimpleLazyObject: <function AuthenticationMiddleware.process_request.<locals>.<lambda> at 0x7ff653d89f80>>), 'request': '<<request>>', 'user': '<SimpleLazyObject: <function ' 'AuthenticationMiddleware.process_request.<locals>.<lambda> at ' '0x7ff653d89f80>>'} {'content': '<<queryset of core.Content>>', 'data_source_id': '', 'data_sources': '<<queryset of core.DataSource>>', 'date_from': '2024-09-15', 'date_to': '2025-03-14', 'published_by': '', 'published_by_list': '<<queryset of core.Content>>', 'report': {'items_count': [0, 1, 0, 0, 1, 0, 0, 0, 0, 0, 2, 1, 4, 0, 0, 6, 3, 2, 2, 1, 0, 0, 0, 1, 2, 1, 3, 0, 1, 2, 1, 0, 14, 4, 0, 0, 1, 3, 0, 0, 1, 0, 0, 2, 3, 0, 14, 5, 1, 2, 12, 7, 5, 26, 13, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 4, 2, 1, 1, 5, 0, 0, 2, 1, 2, 0, 16, 4, 1, 0, 2, 3, 0, 3, 8, 5, 14, 5, 2, 4, 3, 4, 0, 3, 9, 4, 3, 2, 2, 1, 1, 5, 1, 2, 0, 1, 0, 0, 1, 5, 1, 0, 2, 8, 9, 19, 5, 1, 3, 7, 5, 1, 2, 2, 1, 0, 1, 1, 3, 1, 0, 1, 1, 13, 2, 4, 5, 0, 0, 5, 4, 10, 4, 7, 0, 2, 14, 5, 6, 8, 23, 3, 2, 2, 2, 1, 1, 2, 6, 1, 19, 10, 16, 3, 5, 1, 1, 1, 0, 22, 2, 0, 3, 0, 0, 1, 25, 18, 2], 'items_negative_count': [0, 1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 3, 1, 2, 2, 0, 0, 0, 0, 0, 1, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 2, 3, 1, 1, 1, 3, 4, 6, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 1, 0, 0, 1, 2, 0, 1, 0, 0, 0, 1, 1, 2, 1, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 1, 0, 0, 2, 1, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 2, 1, 1, 0, 0, 0, 0, 1, 5, 1, 0, 0, 1, 1, 1, 1, 0, 2, 0, 0, 0, 0, 0, 0, 0, 3, 0, 4, 0, 0, 1, 2, 0, 1, 1, 0, 0, 0, 0, 1, 0, 0, 0, 16, 4, 0], 'items_neutral_count': [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 3, 0, 0, 2, 2, 0, 0, 1, 0, 0, 0, 1, 1, 0, 0, 0, 1, 1, 0, 0, 7, 4, 0, 0, 1, 1, 0, 0, 1, 0, 0, 1, 1, 0, 12, 2, 0, 1, 3, 2, 1, 6, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 5, 0, 0, 2, 1, 0, 0, 5, 4, 1, 0, 1, 1, 0, 2, 6, 3, 12, 3, 2, 3, 3, 4, 0, 2, 8, 2, 2, 2, 2, 1, 1, 3, 0, 1, 0, 1, 0, 0, 0, 4, 0, 0, 0, 7, 8, 7, 4, 1, 1, 5, 4, 1, 2, 1, 1, 0, 0, 1, 1, 1, 0, 0, 0, 10, 1, 2, 4, 0, 0, 3, 1, 3, 3, 6, 0, 1, 4, 3, 5, 8, 21, 3, 1, 2, 1, 1, 0, 1, 3, 1, 8, 7, 2, 2, 3, 1, 0, 0, 0, 22, 2, 0, 1, 0, 0, 1, 4, 10, 1], 'items_positive_count': [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 1, 1, 0, 7, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0, 0, 0, 8, 2, 0, 14, 7, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 11, 0, 0, 0, 0, 2, 0, 0, 2, 2, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 2, 1, 0, 10, 0, 0, 2, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 1, 1, 1, 0, 1, 1, 0, 0, 2, 2, 2, 0, 1, 0, 0, 9, 1, 0, 0, 0, 0, 1, 0, 1, 0, 1, 1, 0, 0, 7, 3, 14, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 5, 4, 1], 'labels': ['2024-09-15', '2024-09-16', '2024-09-17', '2024-09-18', '2024-09-19', '2024-09-20', '2024-09-21', '2024-09-22', '2024-09-23', '2024-09-24', '2024-09-25', '2024-09-26', '2024-09-27', '2024-09-28', '2024-09-29', '2024-09-30', '2024-10-01', '2024-10-02', '2024-10-03', '2024-10-04', '2024-10-05', '2024-10-06', '2024-10-07', '2024-10-08', '2024-10-09', '2024-10-10', '2024-10-11', '2024-10-12', '2024-10-13', '2024-10-14', '2024-10-15', '2024-10-16', '2024-10-17', '2024-10-18', '2024-10-19', '2024-10-20', '2024-10-21', '2024-10-22', '2024-10-23', '2024-10-24', '2024-10-25', '2024-10-26', '2024-10-27', '2024-10-28', '2024-10-29', '2024-10-30', '2024-10-31', '2024-11-01', '2024-11-02', '2024-11-03', '2024-11-04', '2024-11-05', '2024-11-06', '2024-11-07', '2024-11-08', '2024-11-09', '2024-11-10', '2024-11-11', '2024-11-12', '2024-11-13', '2024-11-14', '2024-11-15', '2024-11-16', '2024-11-17', '2024-11-18', '2024-11-19', '2024-11-20', '2024-11-21', '2024-11-22', '2024-11-23', '2024-11-24', '2024-11-25', '2024-11-26', '2024-11-27', '2024-11-28', '2024-11-29', '2024-11-30', '2024-12-01', '2024-12-02', '2024-12-03', '2024-12-04', '2024-12-05', '2024-12-06', '2024-12-07', '2024-12-08', '2024-12-09', '2024-12-10', '2024-12-11', '2024-12-12', '2024-12-13', '2024-12-14', '2024-12-15', '2024-12-16', '2024-12-17', '2024-12-18', '2024-12-19', '2024-12-20', '2024-12-21', '2024-12-22', '2024-12-23', '2024-12-24', '2024-12-25', '2024-12-26', '2024-12-27', '2024-12-28', '2024-12-29', '2024-12-30', '2024-12-31', '2025-01-01', '2025-01-02', '2025-01-03', '2025-01-04', '2025-01-05', '2025-01-06', '2025-01-07', '2025-01-08', '2025-01-09', '2025-01-10', '2025-01-11', '2025-01-12', '2025-01-13', '2025-01-14', '2025-01-15', '2025-01-16', '2025-01-17', '2025-01-18', '2025-01-19', '2025-01-20', '2025-01-21', '2025-01-22', '2025-01-23', '2025-01-24', '2025-01-25', '2025-01-26', '2025-01-27', '2025-01-28', '2025-01-29', '2025-01-30', '2025-01-31', '2025-02-01', '2025-02-02', '2025-02-03', '2025-02-04', '2025-02-05', '2025-02-06', '2025-02-07', '2025-02-08', '2025-02-09', '2025-02-10', '2025-02-11', '2025-02-12', '2025-02-13', '2025-02-14', '2025-02-15', '2025-02-16', '2025-02-17', '2025-02-18', '2025-02-19', '2025-02-20', '2025-02-21', '2025-02-22', '2025-02-23', '2025-02-24', '2025-02-25', '2025-02-26', '2025-02-27', '2025-02-28', '2025-03-01', '2025-03-02', '2025-03-03', '2025-03-04', '2025-03-05', '2025-03-06', '2025-03-07', '2025-03-08', '2025-03-09', '2025-03-10', '2025-03-11', '2025-03-12', '2025-03-13', '2025-03-14'], 'sentiment_avg': [0.0, -0.88, 0.0, 0.0, -0.53, 0.0, 0.0, 0.0, 0.0, 0.0, 0.15, 0.82, -0.15, 0.0, 0.0, -0.14, -0.18, -0.73, -0.58, 0.01, 0.0, 0.0, 0.0, -0.03, -0.23, -0.74, -0.2, 0.0, 0.24, 0.23, 0.32, 0.0, 0.31, 0.21, 0.0, 0.0, -0.03, -0.74, 0.0, 0.0, -0.02, 0.0, 0.0, 0.15, 0.49, 0.0, -0.12, -0.31, -0.43, -0.33, 0.31, -0.17, -0.36, 0.14, 0.08, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.61, 0.33, 0.0, -0.6, -0.26, -0.01, 0.13, 0.12, 0.0, 0.0, 0.1, 0.04, 0.37, 0.0, 0.44, 0.0, 0.0, 0.0, -0.22, 0.68, 0.0, -0.13, 0.14, 0.19, 0.01, -0.22, 0.03, 0.0, 0.04, 0.02, 0.0, -0.18, -0.04, -0.21, -0.26, -0.06, 0.0, -0.05, 0.0, 0.22, -0.44, -0.17, 0.0, 0.02, 0.0, 0.0, 0.35, 0.08, 0.54, 0.0, 0.89, 0.02, -0.03, 0.31, -0.06, 0.01, 0.36, -0.1, -0.11, -0.02, -0.18, 0.32, -0.01, 0.0, -0.92, 0.04, 0.02, 0.07, 0.0, 0.33, 0.28, -0.08, -0.25, -0.29, 0.15, 0.0, 0.0, 0.38, 0.49, -0.15, -0.02, 0.07, 0.0, -0.26, 0.31, -0.12, -0.08, -0.01, 0.02, -0.03, 0.18, 0.15, 0.36, 0.0, 0.77, 0.13, -0.16, -0.13, 0.03, 0.11, 0.5, -0.05, -0.28, -0.05, -0.45, -0.53, 0.0, 0.01, 0.01, 0.0, -0.05, 0.0, 0.0, -0.12, -0.16, 0.03, 0.38], 'sentiment_avg_negative': [-0.0, -0.94, -0.0, -0.0, -0.73, -0.0, -0.0, -0.0, -0.0, -0.0, -0.03, -0.02, -0.29, -0.0, -0.0, -0.36, -0.27, -0.86, -0.77, -0.05, -0.0, -0.0, -0.0, -0.17, -0.37, -0.86, -0.52, -0.0, -0.02, -0.1, -0.02, -0.0, -0.02, -0.02, -0.0, -0.0, -0.19, -0.83, -0.0, -0.0, -0.2, -0.0, -0.0, -0.12, -0.01, -0.0, -0.15, -0.43, -0.66, -0.52, -0.08, -0.38, -0.54, -0.29, -0.39, -0.0, -0.0, -0.0, -0.0, -0.0, -0.0, -0.0, -0.0, -0.0, -0.01, -0.24, -0.0, -0.68, -0.52, -0.09, -0.02, -0.03, -0.0, -0.0, -0.02, -0.01, -0.01, -0.0, -0.01, -0.03, -0.01, -0.0, -0.36, -0.02, -0.0, -0.23, -0.02, -0.04, -0.09, -0.42, -0.06, -0.08, -0.02, -0.08, -0.0, -0.34, -0.16, -0.43, -0.46, -0.25, -0.06, -0.24, -0.04, -0.12, -0.66, -0.4, -0.0, -0.02, -0.0, -0.0, -0.02, -0.04, -0.02, -0.0, -0.02, -0.08, -0.12, -0.11, -0.17, -0.02, -0.03, -0.27, -0.27, -0.17, -0.41, -0.06, -0.13, -0.0, -0.96, -0.02, -0.24, -0.02, -0.0, -0.02, -0.02, -0.21, -0.51, -0.47, -0.1, -0.0, -0.0, -0.09, -0.15, -0.43, -0.11, -0.19, -0.0, -0.49, -0.06, -0.29, -0.16, -0.1, -0.02, -0.12, -0.1, -0.02, -0.17, -0.03, -0.03, -0.19, -0.38, -0.36, -0.17, -0.06, -0.03, -0.17, -0.42, -0.23, -0.67, -0.75, -0.0, -0.01, -0.01, -0.0, -0.39, -0.0, -0.0, -0.35, -0.48, -0.26, -0.01], 'sentiment_avg_neutral': [0.0, 0.04, 0.0, 0.0, 0.22, 0.0, 0.0, 0.0, 0.0, 0.0, 0.62, 0.07, 0.63, 0.0, 0.0, 0.46, 0.62, 0.1, 0.17, 0.86, 0.0, 0.0, 0.0, 0.8, 0.48, 0.12, 0.1, 0.0, 0.5, 0.53, 0.41, 0.0, 0.5, 0.53, 0.0, 0.0, 0.77, 0.15, 0.0, 0.0, 0.64, 0.0, 0.0, 0.51, 0.39, 0.0, 0.76, 0.5, 0.26, 0.37, 0.41, 0.33, 0.41, 0.26, 0.13, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.21, 0.14, 0.0, 0.3, 0.36, 0.86, 0.62, 0.68, 0.0, 0.0, 0.66, 0.79, 0.38, 0.0, 0.4, 0.93, 0.93, 0.0, 0.49, 0.19, 0.0, 0.66, 0.75, 0.62, 0.82, 0.53, 0.79, 0.79, 0.79, 0.76, 0.0, 0.54, 0.73, 0.43, 0.42, 0.67, 0.89, 0.69, 0.92, 0.52, 0.3, 0.55, 0.0, 0.84, 0.0, 0.0, 0.39, 0.76, 0.25, 0.0, 0.04, 0.78, 0.78, 0.39, 0.67, 0.89, 0.46, 0.67, 0.66, 0.74, 0.51, 0.39, 0.76, 0.0, 0.03, 0.77, 0.47, 0.72, 0.0, 0.41, 0.45, 0.68, 0.31, 0.3, 0.67, 0.0, 0.0, 0.41, 0.15, 0.27, 0.82, 0.55, 0.0, 0.48, 0.46, 0.53, 0.72, 0.78, 0.81, 0.83, 0.56, 0.59, 0.37, 0.93, 0.09, 0.4, 0.49, 0.59, 0.5, 0.66, 0.3, 0.71, 0.49, 0.71, 0.3, 0.04, 0.0, 0.9, 0.89, 0.0, 0.34, 0.0, 0.0, 0.62, 0.27, 0.43, 0.5], 'sentiment_avg_positive': [0.0, 0.02, 0.0, 0.0, 0.05, 0.0, 0.0, 0.0, 0.0, 0.0, 0.36, 0.91, 0.08, 0.0, 0.0, 0.18, 0.12, 0.04, 0.06, 0.09, 0.0, 0.0, 0.0, 0.03, 0.15, 0.03, 0.37, 0.0, 0.49, 0.37, 0.57, 0.0, 0.48, 0.45, 0.0, 0.0, 0.05, 0.02, 0.0, 0.0, 0.15, 0.0, 0.0, 0.37, 0.6, 0.0, 0.1, 0.06, 0.07, 0.11, 0.51, 0.28, 0.05, 0.46, 0.48, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.78, 0.62, 0.0, 0.03, 0.12, 0.05, 0.37, 0.29, 0.0, 0.0, 0.32, 0.2, 0.6, 0.0, 0.58, 0.04, 0.06, 0.0, 0.15, 0.8, 0.0, 0.1, 0.23, 0.35, 0.09, 0.05, 0.15, 0.14, 0.18, 0.17, 0.0, 0.12, 0.1, 0.14, 0.11, 0.07, 0.06, 0.08, 0.04, 0.37, 0.04, 0.06, 0.0, 0.14, 0.0, 0.0, 0.6, 0.19, 0.73, 0.0, 0.94, 0.14, 0.09, 0.5, 0.15, 0.09, 0.52, 0.06, 0.07, 0.08, 0.07, 0.55, 0.1, 0.0, 0.01, 0.21, 0.29, 0.27, 0.0, 0.57, 0.53, 0.11, 0.18, 0.23, 0.23, 0.0, 0.0, 0.5, 0.7, 0.29, 0.08, 0.26, 0.0, 0.03, 0.49, 0.18, 0.13, 0.12, 0.16, 0.05, 0.34, 0.39, 0.47, 0.05, 0.88, 0.39, 0.13, 0.04, 0.32, 0.28, 0.67, 0.12, 0.1, 0.06, 0.03, 0.2, 0.0, 0.09, 0.1, 0.0, 0.28, 0.0, 0.0, 0.04, 0.26, 0.32, 0.49]}, 'ticker': 'NKTR'} {'block': <Block Node: footer. Contents: [<TextNode: '\n '>, <IncludeNode: template=<FilterExpression '"components/footer.html"'>>, <TextNode: '\n '>]>}

Context processors

django.template.context_processors.csrf
Toggle context {'csrf_token': <SimpleLazyObject: '1eDiy3Dsy6cn6dxepdGrQpmeILx8v0y4oXUpk2VdcM3hieBhImg8uBiDYKglotYg'>}
django.template.context_processors.debug
Toggle context {}
django.template.context_processors.request
Toggle context {'request': <WSGIRequest: GET '/ticker/NKTR/content?date_from=2024-09-15&date_to=2025-03-14'>}
django.contrib.auth.context_processors.auth
Toggle context {'user': <SimpleLazyObject: <function AuthenticationMiddleware.process_request.<locals>.<lambda> at 0x7ff653d89f80>>, 'perms': PermWrapper(<SimpleLazyObject: <function AuthenticationMiddleware.process_request.<locals>.<lambda> at 0x7ff653d89f80>>)}
django.contrib.messages.context_processors.messages
Toggle context {'messages': <FallbackStorage: request=<WSGIRequest: GET '/ticker/NKTR/content?date_from=2024-09-15&date_to=2025-03-14'>>, 'DEFAULT_MESSAGE_LEVELS': {'DEBUG': 10, 'INFO': 20, 'SUCCESS': 25, 'WARNING': 30, 'ERROR': 40}}

Cache calls from 1 backend

Summary

Total calls Total time Cache hits Cache misses
0 0 ms 0 0

Commands

add get set get_or_set touch delete clear get_many set_many delete_many has_key incr decr incr_version decr_version
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0

Signals

Signal Receivers
class_prepared
connection_created register_type_handlers
got_request_exception
m2m_changed
post_delete
post_init
post_migrate create_permissions, create_contenttypes
post_save create_initial_trade_position
pre_delete
pre_init
pre_migrate inject_rename_contenttypes_operations
pre_save
request_finished close_old_connections, close_caches, reset_urlconf
request_started reset_queries, close_old_connections
setting_changed reset_cache, clear_cache_handlers, update_installed_apps, update_connections_time_zone, clear_routers_cache, reset_template_engines, storages_changed, clear_serializers_cache, language_changed, localize_settings_changed, file_storage_changed, complex_setting_changed, root_urlconf_changed, static_storage_changed, static_finders_changed, auth_password_validators_changed, user_model_swapped, update_toolbar_config, reset_hashers, update_level_tags, uninstall_if_needed, clear_caches, StaticFilesStorage._clear_cached_properties, FileSystemStorage._clear_cached_properties, FileSystemStorage._clear_cached_properties, FileSystemStorage._clear_cached_properties, FileSystemStorage._clear_cached_properties, FileSystemStorage._clear_cached_properties, FileSystemStorage._clear_cached_properties